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Abstract 
Fluorescent dyes have been used frequently to label biomolecules for imaging and detection 
applications. Besides, non-fluorescent substances that present fluorescence emission after 
incorporation into click reactions, so called “fluorogenic click reactions”, are very useful in 
biological and chemical applications. The synthesis and investigation of the properties of 
novel dyes have been studied. Moreover, the click chemistry reactions with the purpose of 
fluorogenic applications were also investigated. The thesis starts with an introduction to the 
click reaction types applied to the fluorescence labeling and the fluorogenic reactions based 
on Huisgen 1,3-dipolar and Diels-Alder cycloadditions with the most important examples 
published in literature.  
 
In this thesis, fluorogenic Diels-Alder reaction based on novel phencyclone derivatives have 
been developed and the optical properties of Diels-Alder adducts are discussed in detail. To 
the best of our knowledge, this is the first example of a fluorogenic Diels-Alder reaction, in 
which the diene part of the reaction is on the fluorogenic substance and the reaction between 
diene and dienophile brings the conjugation of the fluorogenic substance to provide “turn-on” 
fluorescence at room temperature. The crucial properties of this method are that the reaction 
allows to monitor Diels-Alder reaction by color change and up to 33-fold of fluorescence 
increase was achieved. Some nucleoside derivatives containing maleimide groups in order to 
incorporate into this fluorogenic Diels-Alder reaction were also developed and these “bio”-
components were used as models and as a starting point for the development of bioorthogonal 
applications of fluorogenic Diels-Alder reaction.  
 
Furthermore, new BODIPY dyes were designed with the purpose of using them in fluorogenic 
Huisgen 1,3-dipolar cycloaddition. Ortho-, meta- and para-azido substituted BODIPY 
derivatives have been synthesized and as expected, the ortho-azido-substituted BODIPY 
derivative presented relatively less fluorescence compared to the others. The click reaction 
with alkyne modified thymidine derivative promoted the fluorescence of this BODIPY 
derivative. The fluorescence enhancement was 14-fold. Moreover, the new synthetic approach 
of these BODIPY fluorophores permits to synthesize quite higher amounts of azidophenyl-
substituted BODIPYs compared to literature procedures.  
V 
 
 
During the study to invent fluorogenic BODIPY derivatives, novel BODIPY dyes carrying 
nitro and amino groups in the BODIPY core were also produced. The synthetic approach and 
the investigation of optical properties of these new BODIPY derivatives are described. A nitro 
group is known for its fluorescence quenching properties, however, it is not able to quench 
BODIPY fluorescence in every situation, instead, it provides new fluorescence properties.  
 
In conclusion, Diels-Alder cycloaddition and Huisgen 1,3-dipolar cycloaddition as click 
reactions were investigated for fluorescence detection. Moreover, novel phencyclone 
derivatives and new BODIPY based fluorophores were synthesized and their optical 
properties were studied.  
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1 General Introduction  
Between countless chemical reactions, a number of them, called click reactions, draw the 
attention with versatility, efficiency, good chemoselectivity, high yields and bioorthogonality. 
Among these reactions, the copper catalyzed Huisgen 1,3-dipolar cycloaddition reaction 
between azides and terminal alkynes has emerged as a powerful tool in chemical and 
biological applications. Also the Diels-Alder reaction has collected great interest in recent 
years as its click type properties and number of applications in chemical, biological and 
materials processes are increasing.  
The important aspects of these reactions are their orthogonal and/or even bioorthogonal 
applications. Click reactions are orthogonal to each other, meaning two or more reaction types 
can be done in one pot without interfering or disrupting. The bioorthogonal term is used for 
chemical reactions that neither interact nor interfere with a biological environment.
[1]
  
Fluorescence spectroscopy, one of the most informative and sensitive analytical techniques 
has a great importance in modern research. Investigation of biological substances via 
fluorescence labeling enlightens the inner working of biomolecules, cells and organisms.
[2]
 
Nowadays, click chemistry is the mostly preferred reaction for fluorescence labeling as it is 
very efficient and practical. For selective labeling of biomolecules, click chemistry offers high 
yields under biological conditions and biorthogonality, because of the non-reactivity of the 
precursors with common functional groups present in biological systems.
[3]
 
Fluorogenic probes are normally non-fluorescent and emissive fluorescence only after 
reaction with the target substance. On the basis of reducing background noise, fluorogenic 
reactions are an impressive solution.
[4]
 The fluorogenic reactions are depending on mostly the 
formation of a triazole ring via Huisgen 1,3-dipolar cycloaddition or the quenching effect of 
the maleimide group over PET (photoinduced electron transfer) mechanism. Fluorogenic 
application of different types of click reactions have been studied frequently and it will be for 
sure a hot topic for quite a long time.  
Fluorogenic or not, new derivatives of fluorescence dyes are always needed with improved 
properties to be used for developments in the field of diagnostics in medicine and in the area 
of organic electroluminescent devices. Beyond numerous fluorescent dyes, the BODIPY (4,4-
difluoro-4-bora-3a,4a-diaza-s-indacene) family has been attracted great attention over the past 
two decades because of their versatile properties.
[5]
 Adaptable and easy synthetic procedures 
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of BODIPY dyes provide the opportunity to adjust desired optical and physical (solubility, 
stability … etc.) properties.[6] 
1.1 Introduction of Click Reactions 
Click reactions, that offer the efficiency, simplicity and selectivity together, have been 
collecting considerably interest, especially, in the new century. The click term was first 
defined by Sharpless et al.
[7]
 to express the opportunity to focus only on the combination of 
two components via fast and efficient reactions, instead of considering complicated bond 
formations. After creation of the click chemistry concept, the reactions attributed to it,  have 
been applied to a wide range of research areas, including materials science,
[8-9]
 
supramolecular chemistry
[10]
, pharmaceutical sciences
[11]
, and in vitro and vivo labeling
[12]
. 
There are mainly four category of reactions which are taking place under the name of click 
reactions: 
(i) Cycloaddition reactions: Huisgen 1,3-dipolar cycloaddition,[7, 13-14] and Diels–
Alder reaction, 
(ii) ring-opening reactions of strained heterocyclic electrophiles (epoxides, aziridines 
and aziridinium ions, …) via nucleophilic addition,[15] 
(iii) “non-aldol” carbonyl chemistry (for example, the formation of ureas, oximes and 
hydrazones),
[16-17]
  
(iv) addition reactions to carbon–carbon multiple bonds (most importantly thiol–ene 
chemistry and also Michael additions).
[18-20]
 
Among these four major classes, in the literature, the “click” term is mostly used to address 
the Cu(I) catalyzed azide-alkyne cycloadditions,
[9]
 also some Diels–Alder reactions surely 
fulfill the different requirements of click chemistry.
[21-22]
 In fact, the increasing number of 
publications, especially in materials science, are refering “click” term not only for Huisgen 
1,3-dipolar cycloaddition, but also for other categories explained by Sharpless et al.  It is very 
useful to combine click reactions to functionalize materials selectively without destroying 
other functional groups on the structure, because they are orthogonal to each other. This 
allows chemists precisely to position functional groups by parallel or cascade reactions in 
one-pot.
[23]
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Figure 1: Main classes of click reactions (Nu = nucleophile; EWG = electron-withdrawing 
group).
[11]
 
1.1.1 1,3-Dipolar Cycloadditions 
1.1.1.1 Copper(I)-catalyzed Azide-Alkyne Cycloaddition (CuAAC) 
The most preferred example of click reactions is the copper(I)-catalyzed azide-alkyne 
cycloaddition (CuAAC) reaction.
[13-14]
 Indeed, [3+2] cycloadditions of alkynes and azides 
have been known since A. Michael, firstly, synthesized 1,2,3-triazole by reaction of phenyl 
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azide and diethyl acetylenedicarboxylate in 1893.
[24]
 However, detailed studies about this 
reaction were made mainly by Huisgen and coworkers in 1960s.
[25-26]
 Because of its highly 
exothermic (ΔH0 between -50 and -65 kcal mol-1) character and its high activation barrier (as 
an example, reaction between methyl azide and propyne has activation barrier about 25 kcal 
mol
-1 [27]
), the reaction takes place only at high temperatures. In addition, especially in the 
reaction of unsymmetrically substituted alkyne derivatives, a mixture of regioisomeric 1,2,3-
triazoles is generally observed; because HOMO-LUMO energy levels for both reactants 
(azides and alkynes) are similar to each other and dipole-HOMO- and dipole-LUMO-
controlled mechanism of cycloadditions are taking place at the same time (Figure 2).  
 
Figure 2: Formation of two products: 1,4- and 1,5-regioisomers. 
In 2002, Meldal et al.
[13]
 and Sharpless et al.
[14]
 separately presented the copper(I) catalyzed 
reaction of terminal alkynes leading to faster and more efficient formation of 1,4-substituted 
triazoles at mild temperatures. In their work, Sharpless et al. prepared the Cu(I) catalyst in 
situ by reduction of Cu(II) salts (CuSO4
.
5H2O works very good) with ascorbic acid and/or 
sodium ascorbate acting as the reducing agent. At 0.25-2 mol% catalyst loading, one could 
generate a wide variety of 1,4-substituted triazoles in high yields.
[14]
 They suggested a 
reaction mechanism, which starts with the formation of the copper(I) acetylide I. Then, there 
are two possibilies of cycloaddition (Scheme 1). In the first proposal, the B-direct route, a 
direct [2+3] cycloaddition occurs, however, after examination of extensive density functional 
theory calculations they have added another mechanism to the scheme which is a stepwise 
sequence (B1→B2→B3), also named “ligation” pathway (Scheme 1). According to the 
calculations, the energy need of this route is 12-15 kcal less than in the B-direct route.
[14]
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Scheme 1: Copper(I)-catalyzed mechanism of Huisgen 1,3-dipolar cycloaddition proposed by 
Sharpless et. al.
[14, 28]
  
Later, the mechanism was changed by Finn et al.
[29-30]
, approved by Sharpless et al. via 
computational methods
[28]
 and in 2006 a revised mechanism was proposed by Bock et al.
[31]
 
(Scheme 2). According to the mechanism of Sharpless et al., the rate of the catalytic process is 
first order in copper and the acetylide formed is supposed to form an acetylide-azide complex 
immediately. However, the mechanism of Bock et al. expresses the formation of the acetylide 
group as a second order catalytic process with respect to copper; this means, the copper 
acetylide must carry a second copper component to be able to activate the azide functionality 
as a dimer and yielding a copper acetylide-azide complex. This complexation surely reduces 
the alkyne electron density which smooths the cyclization process. The process of cyclization 
triggers the azide to make a nucleophilic attack to the acetylide carbon to generate a 
metallocycle. Related to this mechanism, some literature data prove that the electron-
withdrawing groups on the alkyne speed up the copper(I) catalyzed alkyne–azide 
cycloadditions.
[13, 32]
 Then, the metallocycle transforms quickly into a triazole-copper 
derivative; and lastly, the triazole-copper molecule is protonated and the product separated 
such as the catalyst (Scheme 2).  
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Scheme 2: Proposed mechanism of copper(I)-catalyzed Huisgen 1,3-dipolar cycloaddition by 
Bock et al.
[31]
 
The usage of copper(I) catalysis in Huisgen 1,3-dipolar cycloaddition increases the reaction 
rate up to 10
7
 times,
[33]
 allows mild reaction temperatures and gives higher yields in a variety 
of solvents, including water, over a wide range of pH values. Moreover, work-up and 
purification needed after reaction is minimal. In this respect, CuAAC is an ideal click 
reaction. As a result, numerous applications have been published in the fields of dendrimer 
and polymer grafting,
[34-36]
 bioconjugations,
[37-39]
 combinatorial drug discovery,
[40-41]
 
pharmaceutical sciences,
[11, 42]
 modification of DNA,
[43]
 etc. Besides, CuAAC is exceedingly 
suitable for biological applications due to its reaction conditions which are compatible with 
biological environments such as aqueous medium or low temperatures. Also, azide and alkyne 
groups are quite rare or in many cases absent in the biological environments and this gives the 
opportunity of chemoselective functionalizations or ligations for biological structures.
[44]
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1.1.1.2 Copper-Free Azide–Alkyne Cycloadditions 
CuAAC has several applications in materials, chemical and biological sciences, however, the 
toxicity of copper is restricting the possibility of applications, in vivo and in vitro.
[45-46]
 As a 
solution of this problem, Bertozzi and co-workers developed strain-promoted [3+2] azide-
alkyne cycloaddition by using cyclooctyne derivatives which do not need copper catalysis for 
a fast reaction (Scheme 3).
[46-47]
 Indeed, in 1961, Wittig and Krebs discovered that 
cyclooctyne and phenyl azide react “like an explosion” to yield a single triazole product.[48] 
Differently from a linear [3 + 2] cycloaddion, a large part of ring-strain energy of cyclooctyne 
(18 kcal/mol) releases during the strain-promoted alkyne-azide cycloaddition (SPAAC) 
accelerating the rate of reaction.
[49]
 
 
Scheme 3: General  presentation of strain-promoted  cycloadditions. 
Bertozzi et al. first synthesized a cyclooctyne derivative, which contains a carboxylic acid 
side chain, starting from dibromocyclopropane.
[46]
 They named this first-generation reagent 
OCT.
[47]
 It is assumed that the lowest unoccupied molecular orbital (LUMO) of the alkyne 
and the highest occupied molecular orbital (HOMO) of the azide are entangled during the 
formation of the triazole ring. To this end, lowering the LUMO of the alkyne via substitution 
with electron withdrawing groups results in an increase of the reaction rate.
[50]
 Addition of 
two fluorine atom to the ring of cyclooctyne (DIFO) accelerates the reaction 60 times more 
than OCT.
[51]
 The poor soluability of DIFO directed Bertozzi et al. to produce dimethoxy-
azacyclooctyne (such as DIMAC) by modification with heteroatoms in the ring.
[52]
 
Meanwhile, Boons and coworkers were also working on developing derivatives of 
cyclooctynes and they synthesized a functionalized derivative of dibenzocyclooctyne to 
increase the strain-energy.
[53]
 These dibenzocyclooctynes also give triazole products with 
azides almost as fast as DIFO.
[50]
 In 2010, Bertozzi and coworkers obtained a great reaction 
rate by addition of an amide bond to the structure of DIBO to yield a biarylazacyclooctynone 
(BARAC).
[54]
 In Table 1 and Figure 3, the different examples of cyclooctyne derivatives and 
their reaction rates are summarized.  
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Name Solvent k(x10
-3 
M
-1 
s
-1
) Ref. 
OCT CD3CN 2.4 
[46]
 
DIFO CD3CN 76 
[51]
 
DIFO2 CD3CN 42 
[55]
 
DIFO3 CD3CN 52 
[55]
 
ALO CD3CN 1.3 
[56]
 
MOFO CD3CN 4.3 
[56]
 
NOFO CD3CN 1.2 
[56]
 
DIBO1 CH3OH 57 
[57]
 
DIBO2 CH3OH 76 
[57]
 
BARAC CD3CN 960 
[54]
 
DIBAC CD3OD 310 
[58]
 
BCN CD3CN:D2O (3:1) 140 
[59]
 
DIMAC CD3CN 3 
[52]
 
Table 1: Reactivity of Functionalized Cyclooctynes. 
 
Figure 3: Functionalized Cyclooctynes. 
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1.1.1.3 Azide-Alkyne Cycloadditions for Fluorescent Labeling  
Azide-alkyne click reactions have been employed to label different biomolecules for different 
applications. Applications in cells
[45, 60-62]
 and even animals
[63-64]
 have been also published 
several times. The bioorthonogality of this click chemistry and the small size of the azide and 
alkyne groups allow the modification and fluorescence labeling of amino acids,
[65]
 
nucleosides,
[66-68]
  monosaccharide
[51]
, proteins,
[69]
 and carbohydrates.
[70]
 Many dyes have 
been modified with an azide and/or alkyne function for such labeling-applications.
[62, 71]
 The 
easiest and fastest modification of a substance with a alkyne function, as seen in these 
examples, is using propargyl bromide in a nucleophilic substitution reaction. Most of the 
known and popular dyes can be modified by nucleophilic substitution between their free –OH 
or –NH2 groups and propargyl bromide. Addition of the –N3 group is commonly done by 
conversion of the bromide group into an azido group (Scheme 4). These modifications are not 
applied only to the dyes, but also to the substances that have to be labeled.  
 
Scheme 4: Preparation of dyes for click applications. 
Furthermore, instead of substitution of fluorophores with functional groups as shown in 
Scheme 4, another possibility to functionalize the dye is using readily alkyne and/or azide 
substituted starting materials to synthesize fluorophores. In order to design a wide variety of 
fluorophores, various retro-synthetic approaches can be envisioned. Numerous methods and 
modifications for the synthesis of click derivatives have been presented in the literature. In 
Table 2, commonly prefered organic reactions for the introduction of alkyne and azide 
functional groups are presented.
[43]
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Table 2: Most common organic reactions to introduce alkyne and azide functional groups. 
1.1.2 Conjugations via Diels-Alder Cycloadditions  
1.1.2.1 Diels-Alder Reaction 
The Diels-Alder (DA) reaction is one of the most notable and utilized cycloadditions in 
organic chemistry. It was first discovered by Otto Diels and Kurt Alder in 1928 and this 
invention brought them the Nobel Prize in 1950.
[72]
 The reaction takes place via a suprafacial 
[π4s+π2s] cycloaddition of a diene and a dienophile to form a six-membered cyclohexene ring 
(Figure 4). 
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Figure 4: The Diels-Alder (DA) reaction. 
The Diels-Alder reactions can be classified according to the properties and positions of the 
substituents in normal electron demand and inverse electron demand Diels-Alder 
cycloadditions. In a normal electron demand Diels-Alder reaction, electron donating 
substituents are necessary on the diene and electron withdrawing substituents on the 
dienophile. These substituents are promoting the reaction and determining the rate of it. 
Contrary, by inverse electron demand cycloaddition, the electron withdrawing substituents are 
on the diene and electron donating substituents are connected to the dienophile.  
The effect of substituents on the reaction rate can be explained by Frontier Molecular Orbital 
(FMO) theory, introduced by Woodward and Hoffmann
[73]
 and, independently, by Fukui
[74]
. 
The FMO theory explains the reactions with the intractions of the molecular orbitals of the 
reactants and according to the theory, the efficiency and rate of reaction are best when the 
molecular orbitals of reactants are closest in energy to get highest overlapping. One of the 
reactants carries two electrons in its Highest Occupied Molecular Orbital (HOMO) and these 
electrons interact with other reactant’s Lowest Unoccupied Molecular Orbital (LUMO).  
In normal electron demand Diels-Alder reaction, a dienophile has an electron withdrawing 
group (EWG) decreasing its LUMO energy. Hence, the lower difference between energies of 
the HOMO of the diene and the LUMO of the dienophile makes the reaction rate increase.
[75-
78]
 However, in inverse electron demand Diels-Alder cycloaddition, an electron donating 
group (EDG) substituted on the dienophile accelerates the reaction by lowering dienophile’s 
HOMO to provide donation of its electrons to the LUMO of the diene (Figure 5).  
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Figure 5: Orbital interactions for the Diels-Alder reaction. 
The Diels-Alder reaction is a fascinating organic reaction that allows the formation of not 
only carbon–carbon bonds but also carbon-heteroatom and heteroatom–heteroatom bonds 
(hetero-Diels–Alder[79], HDA). The reaction is stereospecific, atom-economic and gives little 
or no by-products, in addition to these properties, also being chemoselective, catalyst-free and 
bioorthogonal. So the Diels-Alder reaction fulfills clearly the conditions of “click” chemistry. 
As a result of this, like its several applications in classical synthetic organic chemistry,
[80]
 DA 
has also been used for numerous applications in materials science,
[81]
 in the synthesis of 
dendrimers and polymer,
[22]
 and the conjugation of biomolecules
[82]
.  
1.1.2.2 Diels-Alder Reaction in Fluorescence Labeling 
The best alternative of the classical azide-alkyne click reaction is obviously a Diels-Alder 
reaction by being efficient, atom-economical and fast. Many times, both normal and inverse 
electron demand Diels-Alder cycloadditions have been used for labeling or functionalization 
applications. In recent years, rather than electron demand Diels-Alder reaction, an increasing 
amount of tetrazine based inverse electron demand Diels-Alder addition studies can be found 
in the literature, because this reaction type is much faster and furthermore precludes the 
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problem of reversibility which is not wanted in many biological applications.
[83]
 The studies 
of fluorescent tagging with normal Diels-Alder reactions, generally, are based on the reaction 
of maleimide dye and a diene moiety, mostly a furan or a butadiene structure (Scheme 5). 
 
Scheme 5: Schematic presentation of commonly preferred normal electron demand Diels-
Alder by fluorescence tagging. 
In 2001, Hill and coworkers published a post-synthetic route for modified oligonucleotides 
and conjugated them with different maleimide-substituted dyes via Diels-Alder reaction.
[84]
 In 
the next year, an interesting approach was studied by Okamoto et al.: Oligonucleotides 
involving 7-vinyl-7-deaza-2'-deoxyguanosine 3'-phosphoramidite underwent the reaction with 
maleimide modified pyrene (Scheme 6).
[85]
 
 
Scheme 6: Diels-Alder addition of vinyl modified deoxyguanosine derivative with N-(1-
pyrenyl)maleimide. 
In 2002, in a study of Graham and his coworkers, a furan side chain attached to the 5'-end of a 
synthetic oligonucleotide furnished conjugation with a benzotriazole dye maleimide in the 
presence of copper(II)nitrate to create active signals in surface enhanced resonance Raman 
scattering (SERRS). The addition of a catalyst provided shorter reaction time, which is less 
than 1 hour.
[86-87]
 Then, they modified 5-iodo-2'-deoxyuridine with an acetylenic furan 
derivative via palladium catalyzed Sonogashira coupling in order to use it in oligonucleotide 
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labeling.
[88]
 Moreover, Tona and Haner introduced suitable dye maleimides into a 1,3-
butadiene-modified DNA hairpin mimic via Diels-Alder reaction. At 20 
o
C, after seven days 
reaction time, the structure of DNA hairpin retained stable.
[89-90]
 
Labeling of peptides and proteins via Diel-Alder addition was introduced by Araujo et al.
[91-92]
 
Avidin and/or streptavidin were incorporated with a hexadienyl ester and reacted with 
different maleimide-activated dyes (dansyl- and fluorescein-maleimide derivatives). 
After introduction of tetrazine based inverse electron demand Diels-Alder additions into 
bioconjugation reactions,
[83, 93]
 the topic of Diels-Alder [4+2] cycloaddition labeling was 
shifted into this new area. In 2010 an orthogonal system involving both normal and inverse 
electron demand Diels-Alder reaction was demonstrated by Willems et al. leading to a two-
step activity-based labeling of enzymes.
[94]
 A β1-specific proteasome inhibitor was modified 
by different bioorthogonal click reactions and a BODIPY maleimide derivative was 
incorporated into the system by normal electron demand Diels-Alder reaction as a fluorescent 
tag. 
1.2 Fluorogenic Conjugations by Formation of Covalent Bonds 
Fluorogenic reactions, with the formation of covalent bonds by click reactions have gained 
great interest in recent years. Especially, azide-alkyne cycloadditions, thiol-ene and Diels-
Alder reactions are the most commonly studied bioorthogonal reaction types,
[23, 50, 95]
 used as 
fluorogenic reactions. Fluorogenic Cu(I) catalyzed Huisgen 1,3-dipolar cycloadditions take 
place between alkynes and azides of two non-ﬂuorescent molecules to produce highly 
fluorescent triazole complexes.
[4, 96-98]
 The main disadvantage of this method is the need to 
use copper(I), which is toxic and not suitable for in vivo biological applications.
[56]
 Recently, 
Jewett et al. synthesized a cyclooctyne-fused coumarin derivative which has the ability to 
make fluorogenic Cu-free click reaction.
[99]
 Another fluorogenic reaction, the thiol-ene click 
reaction mainly depends on the maleimide group which is added to the structure of dye, 
directly or with a spacer. The maleimide group acts as an acceptor and it quenches the 
fluorescence of the dye (donor) by PET (photoinduced electron transfer) mechanism. The 
Michael addition between the –RSH groups and C=C bond of maleimide inhibits the 
quenching effect of maleimide moiety and restores the fluorescence.
[100-101]
 A new structural 
example of this group, based on chromenoquinoline, has been published recently and ICT 
(intramolecular charge-transfer) was given as a reason for the non-fluorescent effect of 
maleimide.
[102]
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1.2.1 Fluorogenic Copper Catalyzed Azide-Alkyne Cycloadditions 
The fluorogenic dyes based on the Cu(I) catalyzed azide-alkyne cycloaddition (CuAAC) 
depend on the quenching effect of the azide group (electron-donating group) or an alkyne 
group (electron-withdrawing group) connected to the fluorophore. These “click-on” reactions 
form a triazole ring creating a conjugation to delocalize the local electrons and restores 
fluorescence.
[4]
 Coumarin,
[103-106]
 1,8-naphthalimide,
[107]
 anthracene,
[108]
 benzothiazole,
[4, 97]
 
BODIPY
[98]
 derivatives as fluorogenic dyes have been synthesized up to date (Figure 6).  
 
Figure 6: „Click-on“ type fluorogenic dyes. 
Easy synthesis of alkynes and azides, bioorthogonality and mild conditions are the main 
advantages of fluorogenic CuAAC and these features provide the ideal conditions for in vitro 
and in vivo bioconjugation applications. Moreover, fluorogenic CuAAC reactions have been 
demonstrated to be a versatile tool in the application of combinatorial synthesis of 
fluorescence dyes, protein labeling, cell imaging and labeling of DNA.
[96, 105]
 
1.2.2 Fluorogenic and/or Fluorescence Quenching Diels-Alder Reaction by Carbon- 
Carbon Bond Formations 
In fluorogenic or fluorescent quenching detections, due to carbon-carbon bond formation, the 
Diels-Alder reaction has been used several times for catalyst screening,
[109-110]
 the detection of 
carbon-carbon bond formation,
[111-112]
 studies of ﬂuorescent molecular thermometers[113] and 
for monitoring of reaction progresses
[114-115]
.  
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According to these examples, the fluorogenic reactions occur between anthracenes or furans 
as dienes and N-substituted maleimides as dienophiles. By the work of Nierth et al., the Diels-
Alder cycloaddition between anthracene modified BODIPYs and N-pentylmaleimide, 
catalyzed by Diels-Alderase ribozyme, was used to break the conjugated π-system of 
anthracene (Scheme 7). After destroying the conjugation of anthracene, fluorescence 
enhancement was observed. They explained this effect with the strong electron reduction 
potential of anthracene causing reductive photoinduced electron-transfer (PET) which 
quenches the fluorescence of the BODIPY.
[109]
 
 
Scheme 7: Fluorogenic ribozyme-catalyzed Diels-Alder reaction between the probes, 
anthracen-yl-BODIPYs and N-pentylmaleimide.
[109-110]
  
The maleimides’ fluorescence quenching effect over PET or ICT was another commonly used 
phenomenon to create fluorogenic Diels-Alder cycloadditions (Scheme 8). As an interesting 
example, in 2004, Zhang et al. published the first study of the retro-Diels-Alder reaction 
between maleimides and furan bringing reversible fluorescence and at the same time, 
reversible aggregation.
[115-116]
 They used tris(4-maleimidophenyl) amine (TMPA) which is 
non-fluorescent due to ICT mechanism between donor core and acceptor maleimides. At 
room temperature, the Diels-Alder reaction between TMPA and furan takes place and the 
adduct exhibits a strong fluorescence. By heating up to 60 °C, the retro-Diels-Alder reaction 
is achieved which forms the C=C bond of maleimide and quenches the fluorescence again. 
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Scheme 8: Schematic representation of fluorogenic Diels-Alder reaction induced by 
destroying acceptor property of maleimide derivatives connected to a dye (directly or with a 
spacer). 
Other examples were based on combination of two substances to create energy transfer (ET) 
through space with the intention of fluorescence quenching. In Scheme 9, this method is 
schematically illustrated to explain the studies of He at el.
[111]
 and Liu et al.
[114]
. He and 
coworkers developed a strategy for the detection of a Diels-Alder reaction by quenching the 
fluorescence of polyfluorene via Diels-Alder reaction of a maleimide modified electron 
quencher, 1-methyl-4,4-bipyridinium iodide (M–MV2+). One year later, from the same 
institute, similar work was published by Liu et al. In this work, hybrid nanomaterials 
consisting of gold nanoparticles (GNPs) and conjugated polymers (CP) were combined to 
fabricate hybrid nanomaterials. During Diels-Alder addition, they observed spectacular 
photophysical properties by a quenching effect created by electron transfer and proposed the 
possibility to use this procedure to monitor the process of the Diels-Alder reaction.  
 
Scheme 9: Quenching of fluorescence through an electron transfer mechanism by formation 
of Diels-Alder adducts.
[111, 114]
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Differently, in 2003, Tanaka et al. found that the Diels-Alder addition between the 
fluorophore possessing a maleimide group and the α,β-unsaturated ketone in the presence of 
catalytic amount of proline, yields a fluorescent Diels-Alder adduct (Scheme 10). In the 
publication, it is suggested to use this system to monitor C-C bond formation in the Diels-
Alder reaction.
[112]
 In terms of cycloaddition, this approach is interesting, because of usage of 
a catalyst and an α,β-unsaturated ketone as the diene. The possibility to use wide variety of 
dienes enables chemists to consider new applications of fluorogenic reactions.  
 
Scheme 10: Fluorogenic detection method to monitor C-C bond formation developed by 
Tanaka et al. 
1.2.3 Fluorogenic and/or Fluorescence quenching by Heteroatom-Carbon Bond 
Formations via Diels-Alder Reaction 
The inverse electron demand Diels-Alder cycloaddition between 1,2,4,5-tetrazines and 
strained dienophiles (norbornene, cyclooctyne, and trans-cyclooctene, etc.) has 
gained immense importance after discovery of its bioorthogonal coupling applications in 
2008.
[83, 93]
 These reactions are crucially fast compared to the other bioorthogonal coupling 
reactions which also do not need catalyst. Moreover, it is easy to synthesize the starting agents 
and the reaction can be performed in aqueous environments.
[117]
  
Additionally to these essential features, Weissleder and coworkers recognized the tetrazines’ 
quenching effect of some covalently attached fluorophores. The fluorescence is regenerated 
after reaction with trans-cyclooctene (Scheme 11).
[118]
  
 
Scheme 11: The inverse electron demand Diels-Alder cycloaddition between tetrazine-
BODIPY FL and trans-cyclooctenol.
[118]
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Tetrazine conjugates of commercial dyes, BODIPY FL, BODIPY TMR-X, and Oregon Green 
488 showed quite effective quenching. After reaction with trans-cyclooctene, between 15- and 
20-fold enhancements of fluorescence were observed. The result of these studies was that the 
dyes emitting between 510 and 570 nm, like the examples, can efficiently be quenched by 
tetrazine.
[117]
 
1.3 Introduction to BODIPY Dyes 
4,4-Difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) dyes were first discovered in 1968 by 
Treibs and Kreuzer.
[119]
 Ever since, the importance of these versatile organic dyes was 
recognized by chemists and biochemists because of their magnificent properties, like high 
molar extinction coefficients, excellent fluorescence quantum yields and narrow peaks of 
absorption and emission at visible light. Due to these properties, BODIPY dyes have been 
widely used in the application of monitoring biomolecules in living environments.
[120]
 
Moreover, several studies were carried out by attaching BODIPY derivatives to proteins,
[121-
122]
 lipids, DNA,
[123-124]
 carbohydrates,
[125]
 etc. Except biological applications, also numerous 
applications for materials sciences have been studied in the field of optoelectronic devices,
[126-
128]
 light-harvesting materials,
[129-130]
 and optical chemosensors.
[131-134]
 
1.3.1 General Properties of BODIPY Derivatives  
BODIPY dyes consist of difluoroboron chelated half porphyrin structure and this chelation 
provides rigidity of the structure (Figure 7).
[135]
 
 
Figure 7: The IUPAC numbering system of BODIPY and its delocalization. 
The general optical properties of BODIPY dyes are influenced strongly by the substituents 
attached to the core. Especially 3-,5- and meso positions are very sensitive to the substituent 
type.
[96, 135]
 It is very easy to change BODIPY’s properties including ﬂuorescence quantum 
yield (λF), ﬂuorescence lifetime (τF), molar absorption coeﬃcient (εmax), fluorescence (λfl) and 
absorption maximum (λabs) by electron withdrawing and/or donating groups. 
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Another important feature of BODIPYs is that the self-aggregation of BODIPY dyes in 
solution is very little and negligible, compared to other organic dyes such as rhodamine 6G.  
BODIPY fluorophores disclose generally narrow absorption and emission peaks. Both λabs and 
λfl values are usually greater than 500 nm. The increasing number of studies for creating 
BODIPY derivatives that have higher values than 600 nm provides adequate options for 
biological labeling. Moreover, generally, BODIPY derivatives present close values of 
fluorescence and absorption maxima that means small Stokes shifts.  
1.3.2 General Synthesis of BODIPY Dyes  
The synthetic procedure of BODIPY core starts with a condensation reaction of a simple 
pyrrole and a highly electrophilic carbonyl substance such as an aldehyde, an acid anhydride 
or an acyl chloride. However, due to the unstable character of unsubstituted dipyrromethenes, 
2-substituted pyrroles are preferred to avoid rapid polymerization or porphyrin formation. 
There are three main synthetic procedures for the BODIPY family: i) starting from pyrroles 
and aldehydes, ii) from pyrroles and acid chlorides and iii) from ketopyrroles.
[136]
  
The first method to synthesize BODIPYs contains the condensation of aromatic aldehydes 
with pyrroles and oxidation to form dipyrromethenes. Mostly in the same pot (one-pot 
process), the addition of a tertiary amine, followed by BF3
.
OEt2 (boron trifluoride diethyl 
etherate) gives BODIPYs (Scheme 12-A). Commonly, DDQ (2,3-dichloro5,6-dicyano-p-
benzoquinone) is chosen as the oxidizing agent. For example, with this method, α,β-
unsubstituted BODIPYs can be prepared under mild conditions.
[137]
  
The second method to synthesize a BODIPY derivative depended on the condensation of an 
acyl chloride with a pyrrole to give dipyrromethene and addition of Et3N, followed by 
BF3
.
OEt2 to yield BODIPY.
[136]
 Today, this is another popular method to obtain the BODIPY 
structures (Scheme 12-B). 8-Substituted BODIPY dyes can be prepared easily with this 
approach.  
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Scheme 12: General synthetic approaches of BODIPY dyes. 
The first two synthetic approaches allow the preparation of symmetrically substituted 
BODIPYs. For asymmetrically substituted BODIPY derivatives, it is wise to modify pyrroles 
to yield ketopyrroles and then incorporate these structures into a Lewis acid mediated 
condensation with another pyrrole derivative. After obtaining dipyrromethene structure, 
reaction with BF3
.
OEt2 in the presence of Et3N furnishes asymmetric BODIPYs (Scheme 12-
C). 
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1.4 Aims of the Thesis 
Fluorogenic dyes are difficult to design, because of the lack of knowledge in the logic of these 
systems. The fluorogenic approaches are mostly achieved by several trials and it can be said 
that luck is an effective factor. This is the main reason that only a few number of fluorogenic 
dye families are available. However, fluorogenic dyes are used to avoid background noise of 
fluorescence measurements and to get rid of some purification steps in analytical methods.  
In this thesis, the synthesis of novel phencyclone derivatives incorporating fluorogenic Diels-
Alder reactivity was envisioned, as there are not many examples of Diel-Alder based 
fluorogenic reactions. Due to its versatile, efficient and selective character, the search for a 
fluorogenic Diels-Alder reaction is a major need for bioorthogonal applications. The 
photophysical and spectroscopic properties of the Diels-Alder adducts will be investigated in 
detail.  
BODIPY dyes are one of the most important classes of organic fluorophores and their visible 
light absorption and emission characters allow in vivo and in vitro applications. Fluorogenic 
BODIPY derivatives can be very effective agents for monitoring biological systems. The 
synthesis of ortho-, meta-, para-azido substituted BODIPY derivatives was another aim of the 
thesis. A new synthetic approach should be introduced to achieve these derivatives. Some 
ortho-substituted phenyl BODIPY derivatives are known which demonstrate fluorogenic 
reactions. With this in mind, the ortho-azido substituted BODIPY derivative has the 
possibility to show lowest fluorescence quantum efficiency and moreover, the triazole 
formation via click reaction with alkyne carrying substances should enhance the fluorescence 
of this substance.  
The search for BODIPY derivatives should also include another class of BODIPY dyes: nitro 
and amino BODIPYs. It is known that the character of the substituent at the 3- or 5-position 
of the BODIPYs has efficient influence on the ﬂuorescence properties of the fluorophore. 
Therefore 2-nitro, 3-nitro and amino substituted BODIPY derivatives should be synthesized 
and their optical properties examined. 
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2 Diels-Alder Reaction of Furo[3,4-c]coumarin and 
Phencyclone Derivatives 
2.1 Introduction and Motivation 
Fluorophores contain fused aromatic groups or planar multiple π bonds. The conjugation of 
these connected p-orbitals with delocalized electrons allows fluorophores to absorb and re-
emit light upon light excitation. Destroying of the conjugation also disrupts fluorescence of 
the fluorophore. For example, rhodamine, widely used as a ﬂuorescent probe, presents 
reversible non-fluorescent (lactone form) to fluorescent (zwitterionic form) conversion by 
lactone ring opening causing conjugation of the chromophoric groups (Figure 8)
[138]
. 
 
Figure 8: Two forms of rhodamine B as an example of lactone ring opening of rhodamines. 
The same logic can be also visualized with the Diels-Alder reaction of anthracene. There are 
generally two possibilities; loss of fluorescence by Diels-Alder reaction and generation of 
fluorescence by retro-Diels-Alder reaction. By Diels-Alder addition, in one of the simplest 
fluorophore, anthracene’s central ring reacts as a diene, because the resulting products has two 
fully aromatic benzene rings on both sides (Figure 9). The Diels-Alder reaction destroys the 
conjugation of anthracene and the fluorescence of it is not observed anymore.  
 
Figure 9: The schematic presentation of Diels-Alder reaction of anthracene. 
Moreover, the retro-Diels-Alder provides the restoration of fluorescence. An interesting 
example of this process is the release of nitroxyl (HNO) from an anthracene based prodrug via 
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retro-Diels-Alder reaction catalyzed by the catalytic antibody, Ab-9D9 (Figure 10)
[139-140]
. 
The fluorescence release of anthracene derivative allows the detection of HNO by screening 
of fluorescence in cell culture.  
 
Figure 10: An example of application of fluorogenic retro-Diels-Alder reaction. 
The main idea of this chapter is to create a system for “conjugation on-fluorescence on” types 
of fluorogenic Diels-Alder reaction. A diene directly connected to the core of a fluorophore 
can be used to serve as a an auxiliary for fluorogenic Diels-Alder reaction (Figure 11). The 
Diels-Alder reaction leads to completion of conjugation. For this purpose, furan as the diene 
connected to the core of coumarin derivatives is used in the first part of this chapter. The 
Diels-Alder reactions of coumarin based dienes are executed and their characterizations and 
optical properties are discussed. In the second part, the synthesis of novel phencyclone 
derivatives that serve as dienes in successful fluorogenic Diels-Alder reaction is described. In 
the same part, also, maleimide side-chain containing nucleosides are introduced as models for 
dienophiles in this fluorogenic Diels-Alder with potential use for biological applications. The 
complicated NMR-spectroscopic analysis are explained in detail. UV-vis spectroscopy, 
fluorescence spectroscopy and quantum efficiency measurements as optical properties of the 
Diels-Alder adducts also were studied.  
 
Figure 11: The dienes as the precursors of Diels-Alder additions in order to increase the 
conjugation of the fluorophore cores. 
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2.2 Coumarin Derivatives 
2.2.1 Synthesis of Furo[3,4-c]coumarins and Their Diels-Alder Adducts 
The main goal of this study is to create some coumarin derivatives acting as dienes to see the 
effect of the Diels-Alder reaction which changes the molecular structure of the fluorescence 
core. The best choice in order to achieve a coumarin structure having a diene function fused 
with the lactone ring of coumarin, seemed to be furo[3,4-c]coumarins. Brahmbhatt et al.
[141]
 
have already published a synthetic route to such derivatives (Scheme 13). According to their 
strategy, the first step is the synthesis of 1-aryl-2-nitro-prop-1-ene derivatives. In a simple 
reaction procedure, equivalent amounts of phenylnitromethane and methoxy-benzaldehyde 
derivatives were mixed in a flask in the presence of methanolic methylamine solution and the 
flask was placed in the refrigerator for 15 h.
[142]
 The crystal product was filtered, washed with 
ether, dried and the product was pure enough for the next step. The compound 1 was achieved 
in 93% yield and compound 2 in 83% yield. 3-Substituted-4-ethoxycarbonyl furans were then 
formed by the base catalyzed Nef reaction between the corresponding 1-aryl-2-nitro-prop-1-
ene and ethyl acetoacetate in refluxing methanol containing catalytic amount of piperidine, 
giving compound 3 in 40% and compound 4 in 44% yield. Finally, by a demethylation-
cyclization reaction of the 3-substituted-4-ethoxycarbonyl furans led to the desired furo[3,4-
c]coumarins, for compound 5 in 50% and compound 6 in 46% yield. 
 
Scheme 13: Synthesis of furo[3,4-c]coumarins. 
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To test the Diels-Alder reactivity of the furo[3,4-c]coumarins as dienes, their reactions with 
N-phenylmaleimide as dienophile were examined. We first synthesized compound 5, the 
easiest synthesized and cheapest derivative of these coumarins. In order to increase the 
expected fluorescence of these structures, the methoxy derivative 6 was also used. As 
depicted in Scheme 14, the reaction between furo[3,4-c]coumarins and N-phenylmaleimide 
leads to the adducts in toluene, approximately in half an hour and quantitively. Isolation of the 
products could be achieved by the addition of hexane causing precipitation of product. 
 
Scheme 14: The Diels-Alder reactions of furo[3,4-c]coumarins and N-phenylmaleimide. 
However, in the same reaction, 4-phenyl-1,2,4-triazole-3,5-dione ,PTAD, induced only some 
decomposition products (Scheme 15), despite the fact that PTAD is one of the strongest 
dienophiles.
[143]
 But it is known that it reacts in some situations in an unexpected way. Jones, 
D.W.
[144]
 explained the Diels-Alder reaction between 1,3-dimesitylisobenzofuran and PTAD 
as a “foiled” Diels-Alder addition, because the resulting compound was a zwitterion. As an 
assumption, this could also be the case in Diels-Alder reaction between the furo[3,4-
c]coumarins and PTAD. 
 
Scheme 15: The schematic presentation of Diels-Alder reaction of furo[3,4-c]coumarin 5 and 
PTAD which induced only some decomposition products. 
The products of the reactions of furo[3,4-c]coumarins and N-phenylmaleimide were 
investigated by mass spectrometry and NMR spectroscopy. The 
1
H-NMR spectrum of the 
compound 7 in CDCl3 shows two singlets for the methyl groups (protons H-3 and H-4) at δ = 
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2.25 and 2.13 ppm (Figure 12). The doublets at 3.24 and 3.15 with 
3
J = 6.6 Hz can be 
assigned to the protons H-1 and H-2. Moreover, beside the aromatic protons of the phenyl 
group and the coumarin core, the protons H-5 and H-6 can be observed more downfield 
shifted due to their high electron density environment. The 
13
C-NMR of the compound 7 
reveals the primary methyl carbons at δ = 16.87, 14.66 ppm, carbons C-1 and C-2 at 
δ = 52.84, 52.40 ppm and the aromatic carbon atoms’ peaks at δ = 156.19, 155.52, 132.72, 
132.27, 131.58, 129.21, 128.94, 126.47, 124.80, 124.01, 117.95, 114.45 ppm and two peaks 
for the carbonyl groups at δ = 172.22, 159.97 ppm, as  expected. Additionally, the two 
quaternary carbons arise at δ = 87.82, 86.95 ppm and proved by Dept-135. The molecular 
integrity of 7 is also verified by mass spectrometric investigation with a molar peak as [M + 
Na]
+
 at m/z = 410.09. 
 
Figure 12: 
1
H-NMR of 7 in CDCl3. 
In the 
1
H-NMR spectrum of the compound 8 in CDCl3, two singlets for the methyl protons H-
3 and H-4 can be seen at δ = 2.21 and 2.11 ppm and two dublets of protons H-1 and H-2 at δ 
= 3.23 and 3.12 ppm with 
3
J = 6.6 Hz, the same as 7 (Figure 13). Here, as the main structural 
difference, the -OCH3 protons can be observed at δ = 3.93 ppm as a singlet. The electron-
donating properties of the methoxy group makes the aromatic neighbour protons more upfield 
shifted and protons H-6 and H-7 are found at δ = 6.96 ppm. Moreover, H-5 can be assigned to 
a multiplet at δ = 7.78 – 7.71 ppm and the other aromatic protons are found between these two 
signals as different multiplets, as expected. The 
13
C-NMR of the compound 8 shows the 
primary methyl carbons at δ = 16.84, 14.72 ppm, carbons C-1 and C-2 at δ = 53.08, 52.47 
ppm, aromatic carbon atoms’ peak at δ = 160.25, 157.65, 156.51, 131.61, 129.18, 128.89, 
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128.39, 126.47, 124.94, 113.28, 107.80, 101.69 ppm and two peaks for carbonyl groups at 
δ = 172.60, 172.39, 163.48 ppm, as expected. The methoxy groups’ primary carbon can be 
associated with a signal at δ = 55.89 ppm. Additionally, the two quaternary carbons arise at 
δ = 87.73, 86.87 ppm and proved by Dept135. Moreover, the high resolution mass analysis 
discloses a correct molecular peak at [M + Na]
+
 at m/z = 440.1105. 
 
Figure 13: 
1
H-NMR of 8 in CDCl3. 
2.2.2 Optical Properties of Furo[3,4-c]coumarin Adducts 
The pre-investigation was made both during and after reactions via TLC under a handheld 
UV-lamp, but the results were not as expected. Unfortunately, the furo[3,4-c]coumarin 
derivatives 5 and 6 were also fluorescent and after the Diels-Alder reaction, the adducts 7 and 
8 were not stronger fluorescent than the starting compounds 5 and 6 by naked eye 
observation. Moreover, unexpectedly, both reagents and adducts show really weak fluorescent 
under UV radiation. The addition of the electron-donating group, -OCH3 at 7-position of 
coumarin derivatives should increase the fluorescence efficiency.
[145]
 However, here, it did 
not show an effective difference and even derivative 8 barely exhibited fluorescence under 
UV lamp. 
Even so, the optical properties of two different systems – the dienes and the Diels-Alder 
adducts were worth to investigate. The optical properties of these molecules were evaluated in 
CH2Cl2.  
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Figure 14: Normalized absorption spectra of 5 and 7 (left) and their emission spectra (λex = 
266 nm) (right) at 1.0 x 10
-5
 M. 
Generally speaking, λmax of absorbance and emission spectra of the synthesized compounds 
are at shorter wavelength compared to the general characteristics of coumarin derivatives.
[146]
 
As seen in the UV-vis spectra of 5 and 7, the Diels-Alder addition of N-phenylmaleimide 
caused a bathochromic shift which is explained by extended conjugation of the system (Figure 
14). The same situation is also available in the spectra of 6 and 8, too (Figure 15).  
  
 
Figure 15: Normalized absorption spectra of 6 and 8 (left) and their emission spectra (λex = 
266 nm) (right) at 1.0 x 10
-5
 M. 
However, in the emission spectra of both groups, there is not a distinctive difference between 
the spectra of furocoumarins and their Diels-Alder adducts (Figure 14 and Figure 15).  
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2.3 Phencyclone Derivatives 
After the unexpected optical results of Diels-Alder adducts of the synthesized coumarin 
derivatives, we started to search for another alternative in order to create fluorogenic Diels-
Alder reaction. The most appropriate alternative would be phencyclone derivatives due to 
their convenient structures and properties. 
Phencyclone is a strong diene in Diels–Alder reactions, and can react via [4+2] cycloaddition 
with a wide range of dienophiles. Both electron-poor (normal Diels-Alder reaction) as well as 
electron-rich dienophiles (inverse-electron-demand Diels–Alder reaction)[147] can react with 
phencyclone, leading to Diels-Alder adducts of phencyclone that contain a phenanthrene core 
(Scheme 16).  
 
Scheme 16: The Diels-Alder reaction of phencyclone. 
In this part, our purpose is to obtain phenanthrene derivatives as fluorescence markers and 
phencyclone derivatives are the most appropriate candidates to use as a Diels-Alder reaction 
based fluorescent markers. However, the phencyclone, itself, shows no fluorescent and its 
Diels-Alders adducts exhibit extremely weak fluorescence (Figure 16). 
 
Figure 16: The picture of phencyclone adducts under UV light (in CH2Cl2). 
The addition of –R groups at 2,3 and 6,7-positions of phencyclone was expected to give better 
fluorescence properties and some derivatives were synthesized.  
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2.3.1 Synthesis of Phencyclone Derivatives and Their Diels-Alder Adducts 
The synthetic route of compound 15 can be seen in Scheme 17. The reaction sequence started 
with the acyloin reaction of veratraldeyhde and KCN in ethanol-water mixture as solvent. The 
reaction mixture was bubbled with H2 gas while it was heated to reflux for 5 h to obtain 
veratroin 12 in 50% yield.
[148]
 The addition product was further oxidized with DMSO/HBr to 
obtain compound 13 in 90% yield.
[149]
  For the intramolecular coupling reaction, we used the 
procedure of Mohr, et.al.
[150]
 In the paper, it was proved that the usage of 1,1,2,2-
tetrachloroethane as a solvent was necessary to increase the yield for the oxidative reaction 
between VOF3, BF3.Et2O and compound 13 leading compound 14 in 79% yield. The 
Knoevenagel condensation reaction between compound 14 and 1,3-diphenylacetone
[151]
 
finally generated the target compound 15 as a dark green solid in 34% yield.  
 
Scheme 17: Synthesis of compound 15. 
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In the 
1
H-NMR spectrum of 15, two impurity peaks in the aliphatic region could not be 
removed even after several precipitations. Nevertheless, the respective peaks for compound 
15 can be clearly observed. As shown in Figure 17, the protons H-1 and H-2 of the methyl 
groups of 15 can be attributed to the peaks (δ = 3.98 and 3.33 ppm) in the aliphatic region of 
the 
1
H-NMR spectrum. In the aromatic region, the more upfield shifted two singlets obviously 
belong to protons H-3 (δ = 6.96 ppm) and H-4 (δ = 7.03 ppm), due to the electron-donating 
effect of neighboring methoxy groups. Protons H-3 are more downfield shifted compared to 
protons H-4 because of deshielding by the aromatic rings. Lastly, the ten phenyl protons can 
be associated to the multiplet between δ = 7.47-7.33 ppm. In the 13C-NMR of the compound 
15, two peaks for the methyl groups can be observed at δ = 55.99, 55.11 ppm. The electron-
donating methoxy groups are differentiating the neighbouring carbons C-3 and C-4 compared 
to other aromatic peaks as more upfielded at δ = 111.38, 106.49 ppm. Other aromatic carbons 
can be observed at δ = 151.63, 134.14, 130.30, 128.51, 127.85, 121.79, 121.43 ppm. At last, 
the carbonyl carbon can be attributed to the peak at δ = 200.51 ppm. 
 
Figure 17: 
1
H-NMR of 15 in CDCl3. 
The variation of –R groups connected to the phencyclone core are done according to the 
synthetic procedure in Scheme 18. In order to remove methyl groups to have free –OH 
groups, we tried several different procedures, but the one published by Voit et.al.
[152]
 gave the 
best results for easy purification and high yield. According to it, compound 13 was heated to 
reflux in a optimized mixture of aqueous HBr, HBr in acetic acid and glacial acetic acid for 
demethylation. In the next step, the alkylation of compound 16 with 1-bromoheptane and 
K2CO3 in DMF leads to 17. For the intramolecular coupling, the same procedure as in the 
production of compound 14 was used, the oxidative reaction by VOF3 and BF3.Et2O, in order 
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to obtain 18. However, this time the reaction was performed in CH2Cl2 as solvent instead of 
1,1,2,2-tetrachloroethane and still high yield was obtained, 75%. The intention was to avoid 
the more toxic and cancerogenic solvent, 1,1,2,2-tetrachloroethane. In the final step, the 
Knoevenagel condensation reaction between compound 11 and 1,3-diphenylacetone
[151]
 gives 
19 as a dark green solid in 51% yield.  
 
Scheme 18: Synthesis of compound 19. 
The 
1
H-NMR spectrum of compound 19 reveals that the protons with the chemical shifts in 
the range of δ = 0.97 – 0.89 ppm can be assigned to protons H-1 and H-2 (Figure 18). The 
other clearly observed group of protons are H-3 and H-4, which can be associated to the peaks 
at δ = 4.10 and 3.38 ppm. The peaks between these two groups obviously belong to the 
protons of aliphatic chains. In the aromatic region, here again, two peaks H-5 and H-6 are 
more upfield shifted due to electron-donating effect of neighbouring –OR groups. Protons H-5 
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and H-6 can be seen at δ = 7.02, 6.93 ppm as singlets, respectively. Lastly, the phenyl protons 
are in the range of δ = 7.66 – 7.11 ppm as multiplet for ten protons. From the analysis of the 
13
C-NMR spectrum and Dept 135, the carbons C-1 and C-2 can be seen as primary carbons at 
δ = 14.07, 14.03 ppm. Other alkyl chains’ protons can be assigned to the secondary carbons at 
δ = 31.92, 31.80, 31.76, 29.43, 29.34, 29.21, 29.13, 29.03, 28.89, 28.82, 28.73, 26.04, 25.99, 
25.92, 25.80, 25.64, 22.66, 22.58, 22.55 ppm and the carbons directly connected to the 
oxygen atoms are at δ = 69.52, 68.12 ppm. There is high electron density around the two 
groups of carbons C-5 and C-6, due to the electron-donating effect of –OR group shifting 
them more upfield compared to the other aromatic carbons. They can be seen at δ = 109.13, 
112.85 ppm, respectively. Carbons C-5 are much more downfield shifted due to extra effect of 
neighbouring deshielding area of benzene rings. The phenyl groups’ tertiary carbons can be 
attributed to the peaks at δ = 130.27, 128.42, 127.79, 127.61 ppm. There are quartenary 
carbons at  δ = 151.55, 148.84, 148.40 ppm for the carbons directly connected to the –OR 
groups, at δ = 132.97 ppm for phenyls’ quartenary carbons and δ = 121.66, 121.15 ppm for 
the rest of the quarternary carbons in the compound. The peak at δ = 200.49 ppm can be 
assigned to the carbonyl carbon.  
 
Figure 18: 
1
H-NMR of 19 in CDCl3. 
The triethylene glycol monomethyl ether has a strong hydrophilic nature and its incorporation 
as side chains of phencyclone would enhance the enthalpic interactions of the structure with 
water and make it better water soluble. Therefore, in order to bring water solubility to the 
phencyclone structure, we tried to modify it with –R groups consisting of triethylene glycol 
monomethyl ether. For this purpose, triethylene glycol monomethyl ether tosylate 66 was 
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synthesized according to the published procedure
[153]
 and it was added to the mixture of 
compound 16 and K2CO3 in DMF. After 20 h of reaction time at 100 
o
C, the reaction led to 
the compound 67, in 76% yield, which was incorporated to the oxidative reaction with VOF3 
and BF3.Et2O in CH2Cl2 in order to yield compound 68. Unfortunately, after standard reaction 
conditions, the desired compound 68 could not be isolated (Scheme 19).  
 
Scheme 19: The first synthetic approach of compound 68.  
Therefore, the synthetic route was modified and the oxidative intramolecular coupling 
reaction was executed before addition of triethylene glycol monomethyl ether side chains. In 
order to synthesize 69, the removal of methyl groups of compound 14 was achieved by reflux 
in an optimized mixture of aqueous HBr, HBr in acetic acid and glacial acetic acid.
[152]
 Then, 
the crude product 69 was subjected to nucleophilic substitution with triethylene glycol 
monomethyl ether tosylate 66 in DMF to afford compound 68 in 76% yield. Unfortunately, 
after the Knoevenagel condensation reaction between compound 68 and 1,3-
diphenylacetone,
[151]
 the desired compound 70 could not be isolated.  
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Scheme 20: The synthetic approach of compound 70. 
The aim of the synthesis of modified phencyclone derivatives is to put them into the 
fluorogenic Diels-Alder reaction with some maleimide derivatives. For this purpose, 
commercially available N-phenylmaleimide and easily synthesized N-hexylmaleimide were 
used. N-hexylmaleimide was synthesized according to the procedure of Wang, et.al.
[154]
 with 
small modifications. Briefly, maleic anhydride and hexylamine were reacted in THF in the 
same pot for maleimide ring formation, followed by addition of ZnBr2 and hexamethyl 
disilazane. Purification of the mixture gave N-hexylmaleimide in good yield. These 
maleimides and modified phencyclones were reacted in a 1:1 mol ratio in CH2Cl2 and reaction 
continued for 0.5 h at room temperature to give Diels-Alder adducts in high yields (Scheme 
21).  
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Scheme 21: Diels-Alder reaction between modified phencyclone derivatives and maleimide 
derivatives. 
The Diels-Alder addition takes place approximately in 30 minutes in the situation of 1:1 
molar ratio of both substances, however, trials proved that excess addition of N-substituted 
maleimides permits the reaction to be completed much faster (approximately between 10-15 
min). On TLC, the reaction seems quite clean, however, a short column chromatography was 
performed to eliminate minor fluorescent side products to avoid interference in fluorescence 
measurements.  
To understand the 
1
H-NMR spectra of the Diels-Alder adducts, as an example, the 
1
H-NMR 
spectrum of compound 21, depicted in Figure 19, is discussed. In the aliphatic region of 
spectrum, the peaks of the side chains can be found. Protons H-1 and H-2 can be assigned to 
the peaks at δ = 0.94 ppm. Other easily discernible group of protons at δ = 3.13, 3.44 (H-4) 
and protons at between δ = 4.26 – 4.09 ppm (H-3) are downshifted due to the inductive effect 
from the neighboring oxygen atom. In between these two significant groups of protons, other 
H atoms of side chains can be depicted. Besides, the protons H-7 can be associated to the 
singlet at δ = 4.54 ppm. In the aromatic region, the usual low field position for protons H-5 in 
phenanthrene systems can be again seen here (at δ = 7.77 ppm). Interestingly protons H-6 take 
place at δ = 6.59 ppm due to the upfielding shift effect of the benzene ring above these 
protons H-6. These two groups of peaks are singlets and according to the COSY spectrum, 
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these peaks are not interacting with others. This result indicates that the most downfielded 
peak at δ = 8.44 ppm belongs to the other aromatic region hydrogens. Comparisons with other 
derivatives of Diels-Alder adducts synthesized with other maleimide derivatives proof that 
this peak can be assigned to one of the aromatic signals for phenyl groups of phencyclone. 
From the analysis of 
13
C-NMR spectrum and Dept 135, the carbons C-1 and C-2 can be 
observed as primary carbons at δ = 14.10, 14.05 ppm. Other alkyl chains’ carbons can be 
assigned to the secondary carbons at δ = 31.84, 31.79, 29.27, 29.10, 29.04, 28.77, 26.02, 
25.80, 22.63, 22.57 and oxygen neighboring carbons at δ = 69.53, 67.71, 63.24. The protons 
C-7 are a bit more downfield shifted and take place at δ = 44.94. In the aromatic region of the 
13
C-NMR, carbons C-5 and C-6 are upfield shifted as they are the characteristic peaks of 
phencyclone derivatives which are shielded by the electronic effect of the core (δ = 107.14, 
105.71 ppm, respectively). The tertiary carbons can be seen for the phencyclone core and the 
phenyl groups at δ = 148.97, 148.34, 134.50, 131.11, 125.46, 120.82 ppm. Moreover, the peak 
at δ = 173.45 ppm belongs to carbonyl carbons of the former maleimide group and the one at 
δ = 196.63 ppm to the carbonyl carbon of phencyclone. Additionally, the molecular structure 
was confirmed by mass spectrometry with a correct molar peak at [M + Na]
+
 at m/z = 
1034.5905. 
 
Figure 19: 
1
H-NMR of 21 in CDCl3. 
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2.3.2 Synthesis of Maleimide Bearing Nucleosides and Their Diels-Alder Adducts 
The modification of nucleosides for fluorescent labelling is an important tool in biological and 
analytical research.
[155-157]
 Therefore, modification of nucleosides with a flexible alkyl spacer 
bearing a maleimide group would be a good choice to use as precursors for a bioorthogonal 
click reaction. 
N-Propargylmaleimide was previously used for click modification of fluorescence substances, 
which have azide group in the side chains, to acquire thiol-reactive labels.
[158]
 By the same 
logic, we modified thymidine derivative 26
[159]
 with N-propargylmaleimide 28 via click 
reaction in order to use it in fluorogenic Diels-Alder reaction. First, the 5'-OH of 
deoxythymidine was protected with tert-butyl-dimethylsilylchloride (TBDMSCl) in the 
presence of imidazole and catalytic amount of DMAP (4-dimethylaminopyridine) in DMF in 
85% yield.
[160]
 Then 5-bromovaleric acid was reacted with the 3′-OH group of the TBDMS-
protected thymidine 24 by Steglich esterification in the presence of DCC 
(dicyclohexylcarbodiimide) and catalytic amount of DMAP to give 25 in 70% yield. 
Nucleophilic substitution of the terminal bromine in 25 with sodium azide yielded 26 in 80% 
yield. And finally, 27 was produced by click reaction of N-propargylmaleimide 28 and azido 
functionalized thymidine 26 with the catalytic system of Cu
2+
/ascorbic acid in water:THF (1:1 
mixture) in 62% yield (Scheme 22). 
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Scheme 22: The synthetic route to 27. 
The structure of maleimide side chain thymidine derivative 27 was analyzed by mass 
spectrometry and NMR spectroscopy. For 
1
H-NMR spectrum of 27, the IUPAC numbering of 
thymidine derivative
[161]
 was used and for the rest of the structure, noteworthy peaks were 
marked by letters (Figure 20). According to the 
1
H-NMR spectrum of 27, the first three 
singlets, two at δ = 0.14 ppm and one at δ = 0.93 ppm can be assigned to the protons of 
thymidine’s protecting group, tert-butyldimethylsilyl. The proton of thymidine base H-6 can 
be seen at δ = 7.54 ppm, the –NH proton at δ = 9.28 ppm and the methyl group of the base 
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interfering with one of the –CH2 group of side chain at between δ = 1.98 – 1.90 ppm as a 
multiplet. The deoxyribose’s protons of thymidine can be associated to H-1′ at δ = 6.34  ppm, 
protons H-2′ at δ = 2.11 ppm and interfering with one of the –CH2 group of side chain at δ = 
2.39 ppm as α and β, proton H-3′ downfield shifted due to neighboring ester group at δ = 5.25 
ppm, proton H-4′ at δ = 4.07 ppm and protons H-5′ at δ = 3.91 ppm as oxygen neighboring 
hydrogens. The other significant signal is the singlet of maleimides two protons H-a at δ = 
6.73 ppm and the singlet for protons H-b at δ = 4.82 ppm, triazole ring’s proton H-c as singlet 
at δ = 7.58 ppm, side chains protons H-d as triplet at δ = 4.35 ppm and protons H-e interfering 
with proton H-2' at δ = 2.39 ppm. According to the analysis of 13C-NMR and DEPT-135 
analysis, three primary at δ =  -5.56, -5.45, 25.84 ppm and one quaternary at δ = 18.24 ppm 
are the protons of the TBDMS protecting group. The carbon of methyl group of thymidine 
base can be attributed to the primary carbon at δ = 12.40 ppm and the other peaks of 
thymidine, which can be significantly chosen, quarternary carbon C-5 at δ = 111.20 ppm, 
secondary carbon C-2' at δ = 37.94 ppm, the carbonyl carbons at δ = 163.70, 150.46 ppm. The 
other specific carbons of the system are the maleimide’s tertiary carbons C-a at δ = 134.25 
ppm, the triazole’s quarternary carbon at δ = 142.56 ppm and the carbonyl carbons of ester 
and the maleimide at δ = 172.42 and 169.96 ppm, respectively. Besides, the molecular 
integrity of the system was also determined by high resolution mass measurements with a 
correct molar peak as [M + H]
+
 at m/z = 617.2750. 
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Figure 20: 
1
H-NMR of 27 in CDCl3. 
The Diels-Alder addition of modified thymidine 27 was performed under argon at room 
temperature in CH2Cl2 (Scheme 23). The starting material was consumed in half an hour, as 
usual, however, the reaction gave multiple fluorescence side products which have very close 
Rf values and column chromatography was inefficient to purify the desired product. 
Nevertheless, the product was isolated in sufficient amount for NMR-measurements after 
several column chromatography purifications. This problem coerced us to find alternative side 
chain modification methods.  
 
Scheme 23: Diels-Alder additions of modified nucleosides and 19. 
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6-Maleimido caproic acid 29 was chosen for the coupling reaction with nucleoside derivatives 
to introduce the maleimide moiety (Scheme 24). It was reacted with the 3′-OH group of the 
TBDMS-protected thymidine derivative by a Steglich esterification in the presence of 
dicyclohexylcarbodiimide (DCC) and a catalytic amount of DMAP to give 30 in 20% yield. 
Similarly, the deoxycytidine’s free –OH groups were first protected[162] and used for the 
synthesis of derivative 32 by DCC/HOBt amide coupling in 56% yield. 
 
Scheme 24: Synthesis of maleimide modified nucleosides.  
The Diels-Alder additions of these derivatives 30 and 32 were also performed under 
previously explained conditions (Scheme 23). The products were quite pure, however, a short 
column chromatography was applied to eliminate poor side products. 34 was isolated in 77% 
and 35 in 79% yield, and as mentioned previously the purified yield of click modified 
thymidine 33 was really low with only 35% yield. 
2.3.3 Optical Properties of Phencyclone Derivatives and Their Adducts 
The optical properties of phencyclone derivatives and their adducts were evaluated in CH2Cl2. 
In UV-vis absorption spectra, major differences between the phencyclone derivatives and 
their adducts can be observed (Figure 21). Generally, all UV-vis spectra of the adducts are 
almost the same and the phencyclone derivatives have quite different UV-vis spectra 
compared to the adducts.  
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Figure 21: UV-Vis spectra of phencyclone derivatives and their adducts at 1.0 x 10
-5
 M. 
The phencyclone derivatives have distinct peaks over 400 nm which disappear after the Diels-
Alder reaction. This phenomena allows the process of the reaction to be determined by color 
change. The color of the reaction turns from dark green to colorless. It is clearly seen in the 
UV-Vis spectra that the peak in the visible range disappears (Figure 21 and Figure 22). 
 
Figure 22: Illustrative presentation of colorimetric and fluorogenic Diels-Alder reaction. 
In emission spectra, the substances display two broad emission maxima at approx. 372 nm 
and 390 nm. Moreover, the phencyclone derivatives have almost no fluorescence emission. 
As it is seen, Diels-Alder reactions between these phencyclone derivatives and N-substituted 
maleimides are fluorogenic (Figure 23). A direct indication of the occurance of the Diels-
Alder reaction can also be observed by a handheld UV lamp during the fluorogenic 
conversion (Figure 22).  
2. Diels-Alder Reaction                            45 
 
 
Figure 23: Fluorescence spectra of phencyclone derivatives and their adducts at 1.0 x 10
-5
 M 
(λex = 266 nm). 
By measuring the magnitude of this fluorogenic effect, we achieved the fluorescence quantum 
yields of phencyclone derivative 19, as Φf ~ 0.0011 and its Diels-Alder adduct 22, as Φf ~ 
0.037. The enhancement of fluorescence is 33-fold for this example. The amount of 
fluorescence enhancements varies according to the substituent of maleimide derivatives 
(Table 3).  
Compound R
a
 R1
b
 Φf
c
 
20 CH3 Ph 0.015 
21 C7H15 Ph 0.033 
22 C7H15 C6H13 0.037 
34 C7H15 thymidine deriv. 0.021 
35 C7H15 cytidine deriv. 0.011 
aThe substituent of side-chain of phencyclone derivatives. bThe R1 group of maleimide 
part. cDetermined using anthracene (Φf = 0.27 in ethanol)
[163] 
Table 3: Fluorescence quantum efficiencies of Diels-Alder adducts. 
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2.4 Conclusion 
In this chapter, we focused on the fluorogenic Diels-Alder reactions. First experiments were 
performed by Diels-Alder reaction of the synthesized furo[3,4-c]coumarins. The unexpected 
optical results from these experiments directed us to investigate other fluorophores that can be 
possible candidates for fluorogenic Diels-Alder reaction. Phencyclone derivatives were 
chosen and in the second part of this chapter, the fluorogenic Diels-Alder reaction of these 
derivatives were discussed.  
In the first part of this chapter, synthesis of furo[3,4-c]coumarins and their Diels-Alder 
additions were performed. However, these first trials did not disclose the desired results. The 
Diels-Alder reactions between N-phenylmaleimide and furan part of these coumarins were not 
fluorogenic. Then, we also examined the Diels-Alder reactions of synthesized furo[3,4-
c]coumarins with PTAD, however, they resulted in decomposition of the dienes.  
In the second study, phencyclone derivatives for fluorogenic Diels-Alder addition were 
successfully synthesized. After realizing that the Diels-Alder adducts of N-substituted 
maleimides and phencyclone itself emit actually very week fluorescence, we synthesized 
systems with electron-donating –OR groups. With these phencyclone derivatives, in Diels-
Alder addition reactions, up to 33-fold of fluorescence enhancements were achieved. Very 
high yields and low reaction times at room temperature fulfill the click chemistry conditions. 
Moreover, the dark green color of phencyclone derivatives disappears by the Diels-Alder 
reaction and the reaction mixture becomes colorless. This phenomena allows us to follow the 
reaction by naked eye observations.  
In that respect, we have successfully developed a new fluorogenic system in order to monitor 
Diels-Alder reactions. This fluorogenic and colorimetric method reveals a new perspective of 
usage of Diels-Alder reaction in fluorogenic labeling. The modification of thymidine and 
deoxycytidine derivatives with maleimide side chain and their usage in fluorogenic Diels-
Alder reaction could be tested as a first example. Unfortunately, due to the lack of water 
solubility of the structures, in vitro and/or in vivo applications were not possible.  
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3 BODIPY Derivatives 
3.1 Introduction and Motivation 
During the research of fluorogenic click reactions, we encountered the impressive studies of 
BODIPY derivatives and the idea of development of new BODIPY derivatives to create 
fluorogenic click reaction came into question. Moreover, the mostly studied fluorogenic click 
reaction type is the copper catalyzed alkyne-azide click reaction (CuAAC) and with this in 
mind, we wanted to use the fluorescence quenching effect of azido group by substituting it 
into suitable positions of BODIPYs. In this third chapter of the thesis, the novel BODIPY 
derivatives and their CuAAC ligations are discussed. Besides, during this research, some 
BODIPY derivatives were isolated because of their potential interesting properties and at the 
end of chapter, their synthesis and optical properties are explained. 
Because of their excellent properties, 4,4-difluoro-4-bora-3a,4a-diaza-s-indacenes (BODIPYs) 
are commonly preferred to be designed as fluorescent probes. The optical features of 
BODIPY derivatives can be easily adjusted by desired modification of positions of either the 
BODIPY core or connected substituents.
[164]
 From literature examples, it is known that an 
azido group has a fluorescence quenching effect
[96]
 and the ortho-substitution of 8-phenyl 
BODIPYs can be effective to quench the fluorescence of BODIPYs by PET mechanism. For 
this reason, the fluorogenic effect by changing the position of azido group on phenyl 
substituent was investigated. In this respect, the BODIPY dyes containing ortho-, meta- and 
para-azidophenyl at the 8-position were synthesized. In the first part of the chapter, the 
synthesis and investigation of properties of these 8-(azidophenyl) BODIPYs are discussed. 
In the second section of this chapter, the synthesis and investigation of properties of nitro and 
amino BODIPYs are presented. The nitro group is also known for its fluorescence quenching 
effect
[165]
 and this phenomenon is investigated by addition of it to the BODIPY core.  
3.2 8-Azidophenyl BODIPYs 
For the purpose of CuAAC reaction, the introduction of an azido group to the benzene moiety 
at the 8-position of the BODIPY fluorophore was examined. There are a few examples in the 
literature that present only 8-(4-azidophenyl)BODIPY derivatives. To the best of our 
knowledge, the ortho- and meta-azido substitution at the 8-position of the BODIPY dyes have 
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not been published. Burgess and his coworkers have synthesized the 8-(4-
azidophenyl)BODIPY derivatives by reduction of the nitro group at the benzene moiety of 
BODIPY which was then converted to the azide by addition of NaN3.
[166-168]
 
In 2007, Matsumoto et al. published their results on ortho-substituted maleimide derivatives 
of BODIPY disclosing their fluorogenic behaviours in the presence of thiols (Scheme 25). By 
donor-excited photoinduced electron transfer (d-PeT) from BODIPY to the electron acceptor 
maleimide, the fluorescence of the dye is quenched. Reaction with thiols disrupts d-PeT and 
regenerates fluorescence with an enhancement of 350-fold. By the same logic, Guo et al. 
developed another BODIPY derivative by changing the electron acceptor for the PET 
mechanism. They functionalized the –OH group at the ortho-position of the benzene ring with 
2,4-dinitrobenzenesulfonyl (DNBS) to quench fluorescence and by cleavage of DNBS with 
thiols, a 300-fold of fluorescence enhancement was observed.
[169]
 
 
Scheme 25: The schematic presentation of thiol-reactive fluorogenic BODIPY probe. 
With these examples in mind, we have designed a new short synthetic route to achieve high 
yields of 8-(azidophenyl) BODIPYs by pre-synthesizing of azidobenzaldehydes and then 
using these educts in conventional one-pot BODIPY synthesis.  
3.2.1 Synthesis of Azidobenzaldehydes 
The synthesis of 2-azidobenzaldehyde 38 was easily established by nucleophilic aromatic 
substitution of 2-nitrobenzaldehyde 35 using NaN3.
[170]
 As Pelkey and Gribble explained in 
their related work, HMPA as solvent gives much higher yields and the reaction can be done at 
room temperature. Due to the carcinogenic effect of HMPA, however, we preferred DMF as 
the solvent. The reaction mixture is heated to 60 
o
C for one day to get 65% yield of 2-
azidobenzaldehyde (Scheme 26).
[171]
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Scheme 26: Synthesis of azidobenzaldehydes. 
Unfortunately, nucleophilic aromatic substitution of  nitrobenzaldehydes with NaN3 is only 
working with the activation of carbonyl group at ortho-position. Therefore, meta- and para-
azidobenzaldehydes were obtained by conversion of aminobenzylalcohols 36 and 37 to the 
azides by diazotization, followed by displacement with NaN3. Then, azido alcohols 39 and 40 
were oxidized to the aldehydes 41 and 42 with PCC (pyridinium chlorochromate), 
respectively (Scheme 26).
[172]
 All steps gave very high yields. 
3.2.2 Synthesis of 8-(Azidophenyl) BODIPYs 
The azido BODIPYs were synthesized by a one-pot procedure in good yield. 
Azidobenzaldehydes were reacted with pyrroles (2,4-dimethylpyrrole or 2,4-dimethyl-3-
diethyl pyrrole) in a 1:2 molar ratio and with TFA as an acid catalyst to give the 
corresponding dipyrromethanes. Then, these structures were oxidized by adding  2,3-dichloro-
5,6-dicyanobenzoquinone (DDQ) into dipyrromethenes and after addition of triethylamine 
and reaction with BF3
.
OEt2 (boron trifluoride etherate), the desired BODIPYs were formed as 
red solids (Scheme 27).  
2,4-Dimethyl-3-diethyl pyrrole were also used to be able to evaluate the effects of substitution 
in the BODIPY core regarding yield and optical properties. All yields are quite good and there 
is no yield difference between 43 and 44, the approximate yield being 35%. As expected, 
meta and para substituted BODIPYs 45 and 46 have higher yields, 42% and 46%, 
respectively.  
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Scheme 27: One-pot synthesis of azido BODIPYs. 
In the literature, only para substituted azido BODIPY 46 is known.
[167]
 In the published 
procedure, the yield of this azido BODIPY is nearly equal, however, on small scale 
procedure, the amount of the product is less then even 50 mg. In other examples of the same 
group, similar structures of para substituted azido BODIPYs were synthesized and again, it is 
obvious that the increase of product formation is difficult. All examples gave less than 50 mg 
of products.
[166, 168]
 However, with the pre-synthesized azidobenzaldehydes the procedure is 
much more flexible for scale up. Minimum 10 times higher starting amounts yielded 
satisfactory amounts of BODIPYs. The conversion of the –NH2 group into the –N3 group via 
conventional ways is more difficult on the BODIPY nucleus, thus processing this step in the 
starting material allowed as to achieve much higher amounts of BODIPYs. 
To proof the structure of the synthesized BODIPY fluorophores, NMR and mass spectroscopy 
was used. As an example, the 
1
H-NMR spectrum of 45 can be seen in Figure 24. In the 
1
H-
NMR spectrum of 45 in CDCl3, the protons H-1 and H-2 of methyl groups of BODIPY core 
can be assigned to the singlets in the aliphatic region δ = 1.46 and 2.58 ppm, respectively. The 
singlet at δ = 6.02 ppm obviously belongs to the protons H-3 of BODIPY. The peaks at 
δ = 7.51, 7.18, 7.13 – 7.07, 7.02 – 6.96 ppm belong to the aromatic protons of benzene 
moiety. From the analysis of 
13
C-NMR spectrum and Dept 135, the carbons C-1 and C-2 can 
be recognized as primary carbons at δ = 14.43, 14.56 ppm. The rest of the aromatic carbons 
can be observed as tertiary carbons at δ = 131.15, 130.64, 124.64, 121.40, 119.40, 118.82 
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ppm and the quaternary carbons more downfield at δ = 155.93, 142.87, 141.33, 140.01, 
136.82 ppm. Moreover, the molecular integrity of 45 is also verified by mass spectrometric 
investigation with a correct molar peak as [M + H]
+
 at m/z = 366.1696.  
 
Figure 24: 
1
H-NMR of 45 in CDCl3. 
3.2.3 Click Reaction of Azido BODIPYs 
Nucleotides and nucleosides are taking place in numerous essential biochemical processes 
like gastrointestinal tract repair after damage, immune response, iron absorption in the gut and 
metabolism of fatty acids.
[173]
 Moreover, there are very practical ways to modify nucleotides 
with an alkyne group. For these reasons, we wanted to carry out the click reaction between 
synthesized azido BODIPYs and alkyne modified nucleosides.  
5'-O-TBDMS-protected thymidine 24 can be alkylated with propargyl bromide in the 
presence of NaH. To avoid side products by alkylating –NH group in the base part of the 
nucleoside, the additions were made dropwise at 0 
o
C.
[174]
 Eventually, thymidine derivative 
47
[175]
 was isolated as alkyne modified “bio”-substance for click applications (Scheme 28).  
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Scheme 28: Synthesis of alkyne modified thymidine. 
The aim of the work was to develop fluorogenic substances on the basis of azido BODIPYs 
for click reactions. Optimization of click conditions or minimizing catalyst amounts were not 
investigated. The most common and easily feasible CuAAC would be convenient. Therefore, 
for click reaction, a standard procedure was preferred (Scheme 29).
[13-14]
 Sodium ascorbate 
and CuSO4.5H2O were used to generate Cu(I) in situ. The propargyl thymidine and an azido 
BODIPY derivative were reacted in a 1.25:1 molar ratio, respectively. To obtain high 
amounts of products and for convenient preparation of a reaction, high amounts of the 
catalysts were adjusted according to the published literature (CuSO4.H2O, 20 mol% and 
sodium ascorbate, 60 mol %).
[176]
 Catalyts and reagents were dissolved in 1:1 (v/v) mixture of 
THF/H2O and the mixture was stirred overnight at room temperature. After purification, 
except ortho-azido BODIPY derivative 44, all derivatives yielded very high yields. For meta-
azido BODIPY derivative 45, the yield is 94% and for para-azido BODIPY derivative 46, it is 
97%. 
 
Scheme 29: The click reaction of 8-(azidophenyl)BODIPYs and propargyl thymidine. 
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The chemical structures of the compounds were determined by mass and NMR investigations. 
To understand the main aspects of the analysis, compound 50 can be seen in Figure 25. The 
numbering of protons and carbons were made by using IUPAC numbering system of 
BODIPY
[6]
 and thymidine
[161]
 (to differentiate the numbers for BODIPY “B” was used in 
front of numbers, others belong to thymidine). From starting aliphatic region, first, the 
singlets can be attributed to the protons H-i at δ = 0.13 and 0.14 ppm as two singlets and 
protons H-h at δ = 0.94 ppm for nine protons of the tertiary butyl group connected to the 
silicon atom. The methyl group protons of BODIPY core can be observed as singlets; protons 
H-e at δ = 1.46 ppm and protons H-f at δ = 2.58 ppm. Thymidine’s methyl group protons H-g 
are at δ = 1.94 ppm. α,β-protons of H-2' of thymidine present different values due to their 
conformational diversity as broad multiplets at between δ = 2.08 – 2.01 and 2.55 – 2.48 ppm. 
Other protons of deoxyribose can be determined; H-5′ at δ = 3.87 ppm, ; H-4′ at δ = 4.20 ppm, 
H-3′ at δ = 4.33 ppm and H-1′ at δ = 6.36 ppm . The methylene protons H-d at the connection 
point of nucleoside and dye can be associated with the peak at δ = 4.79 ppm. The β-pyrrolic 
protons of BODIPY H-2 and H-6 are both shifted at δ = 6.03 ppm. The protons in para 
substituted benzene moiety exhibit a “roofing” effect at δ = 7.51 ppm (protons H-b) and δ = 
7.96 ppm (protons H-a). The signal of protons H-b is interfering with thymidine base’s proton 
H-6 which is shifted between δ = 7.54 – 7.48 ppm. Moreover, triazole’s proton H-c can be 
observed at δ = 8.15 ppm as a singlet which can be found in 1H-1H-COSY analysis without 
any interaction. Lastly, of course the most downfield shifted singlet belongs to the –NH of 
thymidine’s base. In 13C-NMR spectrum and DEPT-135 of 50,  three primary carbons at δ =  -
5.38, -5.51, 25.88 ppm and one quaternary carbon at δ = 18.31 ppm belong to the TBDMS 
protecting group. The primary carbons of BODIPY’s methyl groups can be seen at δ = 14.68, 
14.58 ppm as well as the thymidine base’s primary carbon at δ = 12.47 ppm. The other signals 
of the thymidine derivative can be attributed as follows: secondary carbons occur at δ = 37.90, 
62.80, 63.68 ppm and four tertiary at δ = 135.18, 84.97, 84.93, 80.02 ppm. Other tertiary 
carbons of the system are found at δ = 129.85, 121.57, 120.88, 120.65 ppm and quaternary at 
δ = 150.34, 145.80, 142.75, 139.50, 137.39, 135.68, 131.19, 111.01 ppm. Finally, two 
quaternary peak at δ = 163.63, 156.14 ppm can be associated with the carbonyl groups of 
thymidine nucleus. Moreover, the molecular structure was also proved by the mass 
spectrometry with a correct molar peak as [M + Na]
+
 at m/z = 782.3440.  
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Figure 25: 
1
H-NMR spectrum of 50 in CDCl3. 
The yields with meta- and para- azidophenyl substituted BODIPYs are very good. However, 
the yield with the ortho azido derivative 44 was not satisfactory. This can be due to steric 
hindrance of BODIPY’s methyl groups. It is known that the bulky groups, in the 8-position 
(meso) and/or at the 1- and 7-positions of BODIPYs or both, reveal steric hindrance.
[177-178]
 
Therefore, the 35% yield of click reaction between ortho-azido derivatized BODIPY 44 and 
propargyl thymidine derivative 47 is not astonishing.  
To check the influence of thymidine itself as a bulky group in this reaction, we also 
synthesized a long-side chain alkyne substituted thymidine (Scheme 30). First, 4-
propargyloxybutanoic acid 52 was synthesized starting from γ-butyrolactone via a synthetic 
approach for a similar structure published in the literature.
[179]
 The ring opening was achieved 
by addition of NaOH to yield 4-hydroxybutanate and to this structure propargyl bromide was 
added in the presence of NaH as base in DMF. Then, the coupling reaction was executed 
between the 3′-OH group of the TBDMS-protected thymidine and 4-propargyloxybutanoic 
acid by Steglich esterification in the presence of DCC and a catalytic amount of  DMAP. 
After purification, the yield of the product was 78% and this 4-propargyloxybutanoyl 
thymidine derivative was incorporated into the click reaction with the 8-(2-
azidophenyl)BODIPY derivative 44 to yield ligation product 51.  As expected, there was a 
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decent improvement by the yield, being 63%. This result led us to think that the low yields of 
these ligations are also related with the bulky group, TBDMS-protected thymidine. However, 
the yield of click reaction was still not competitive to the meta- and/or para-azido BODIPYs. 
Therefore, it can be expressed that steric compulsion of triazole group and BODIPY causes 
the system to have a fragile structure and even by soft interventions decomposition takes 
place. It is highly possible that during the flash column chromatography, the product 
decomposes. However, column chromatography is mandatory to get rid of minor but highly 
fluoroscent side products.  
 
Scheme 30: The CuAAC reaction of long chain alkyne modified thymidine 53 and 
azidophenyl substituted BODIPY 44. 
3.2.4 Optical Properties of 8-(Azidophenyl) BODIPYs and Their Click Ligations 
The optical properties of the synthesized 8-(azidophenyl) BODIPYs and their click ligation 
products were evaluated and the spectroscopic data collected in Table 4. All measurements 
were executed in CH2Cl2.  
3. BODIPY Derivatives                             56 
 
The aim of our investigation was to achieve a BODIPY structure that can undergo fluorogenic 
click reaction. None of the synthesized azido derivatized BODIPY structures were completely 
non-fluorescent. But, the quenching efficiency of –N3 group was enough to decreace 
fluorescence of the ortho-azidophenyl BODIPY derivative 44 around 10-fold compared to the 
other derivatives (Figure 26). 
 
Figure 26: Structures and the fluorescence quantum yields of compounds 44, 45 and 46.  
Generally speaking, all compounds show a strong absorption band between λ ≈ 503-531 nm 
with an absorption coefficient in the 17200-82500 M
-1
cm
-1
 range that is corresponding to the 
S0 S1 transition of the BODIPY core.
[180-181]
 The shoulder on the high-energy side, attributed 
to the 0–1 vibrational band of the same transition can be also observed.[164] Besides, a 
significantly weaker, broad absorption band at about 375 nm for BODIPY derivatives can be 
assigned to the S0 S2 transition.
[180-181]
 This transition band can not be clearly observed by 
the click ligation products. 
The BODIPY dyes are generally known for their close absorption and emission region, thus, 
disclosing a problem of the reabsorption/reemission process (self-quenching).
[182]
 
Unfortunately, both the azidophenyl BODIPY and their click ligation products exhibit quite 
small Stokes stifts (the difference between the peak excitation and peak emission 
wavelengths). Their Stokes shifts range from 7 nm to 12 nm. 
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Figure 27: The normalized UV-Vis spectra at 1.0 x 10
-5
 M in CH2Cl2 (left) and the emission 
spectra at 1.0 x 10
-6
 M in CH2Cl2 (λexc = 470 nm) (right) of the 8-(azidophenyl) BODIPYs. 
For the 8-(azidophenyl) BODIPYs, the absorption maximum of 44, 45 and 46 are λmax = 508, 
504 and 503 nm, respectively (Figure 27). The absorbance of ortho-azidophenyl BODIPY 
derivative 44 is much less then other derivatives (Table 4). Fluorescence quantum yields of 
these substances are 0.055, 0.63 and 0.56, respectively. To examine the effect of substitution 
on the core of the ortho-azidophenyl based BODIPY derivatives, we also investigated the 
optical properties of 2,6-diethyl substituted BODIPY derivative 43 (Figure 28). Introducing 
ethyl groups made the absorbance and emission maxima red-shifted and fluorescence 
quantum efficiency is increased (Table 4). Similar changes in properties have been published 
for unsubstituted phenyl derivatives of this BODIPY and its 2,6-diethyl BODIPY 
derivative.
[183]
 
 
Figure 28: The normalized UV-Vis spectra at 1.0 x 10
-5
 M in CH2Cl2 (left) and the 
normalized emission spectra at 1.0 x 10
-6
 M in CH2Cl2 (λexc = 470 nm) (right) of 43 and 44.  
The UV-vis spectra of click ligation products of BODIPY derivatives are shown in Figure 29. 
The general appearance of the absorbance spectra is almost the same in all cases. The 
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absorbance maxima of ortho-azidophenyl derivatized BODIPY compounds 48 and 51 are the 
same, as well as meta- and para-azidophenyl BODIPYs (510 nm for 48 and 51, 505 nm for 49 
and 50). 
 
Figure 29: The UV-Vis spectra of click ligations of 8-(azidophenyl) BODIPYs at 1.0 x 10
-5
 
M in CH2Cl2. 
Fluorescence emission spectra of the BODIPYs 44, 45, 46 and their click ligation products 
show that all compounds have similar spectral pattern (Figure 30). Their emission maxima are 
almost the same at λ ≈ 515 nm.  
The azido group in the ortho-position of phenyl quenches the fluorescence of the BODIPY 
compound by increasing the electron transfer to the excited BODIPY core (photoinduced 
electron transfer). The click reaction with an alkyne side chain causes restoration of 
fluorescence due to the decreased electron effect of nitrogen by the formation of triazole 
ring.
[96]
 Its low fluorescence quantum efficiency exhibits a 14-fold enhancement after click 
reaction with thymidine derivative 47. The fluorescence quantum yield of 44 is 0.055 and 
after the formation of click ligation product 48, it raises to 0.78 (Figure 31). Moreover, 
compared to this derivative, the click ligation product of ortho-azidophenyl BODIPY 
derivative 44 and the TBDMS-protected thymidine derivative 53, which has longer side chain 
with terminal alkyne, has lower fluorescence quantum yield as 0.61.  
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Figure 30: The emission spectra at 1.0 x 10
-6
 M in CH2Cl2 (λexc = 470 nm) of the 8-
(azidophenyl) BODIPYs and their click ligations. 
 
Figure 31: The schematic presentation of fluorescence enhancement of BODIPY 44 after 
click reaction. 
As seen in Table 4, in comparison to meta-azido phenyl BODIPY derivative 45, the para- 
derivative 46 has lower fluorescence quantum efficiency. This situation can be explained by 
the rotation of the aryl-ring, causing a nonradiative deactivation of the excited-state.
[184]
 It is 
worth noting that the click ligation product of derivative 50 discloses the lowest fluorescence 
quantum efficiency between all derivatives except ortho-azidophenyl BODIPY derivatives 43 
and 44. Additional groups might conduce the rotation of the aryl-ring. 
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Compound Absorbance 
λmax [nm] 
Emission 
λmax [nm] 
ε (M-1 cm-1) 
 
Фf
a 
Stoke shift 
cm
-1
 
44 508 515 17200 0.055 267 
43 531 543 17200 0.202 416 
45 504 513 58800 0.63 348 
46 503 513 56300 0.56 387 
48 510 518 82500 0.78 303 
49 505 515 80900 0.79 384 
50 505 515 72700 0.32 384 
51 510 519 70500 0.61 340 
aFluorescence quantum yields for BODIPY derivative 43 (λexc = 500 nm), other BODIPYs 44-46 and click 
ligation products 48-51(λexc = 470 nm) were calculated using rhodamine 6G (0.95 in ethanol)
[185] as standard. 
Table 4: Optical properties of the of the synthesized 8-(azidophenyl) BODIPYs and their 
click ligation products. 
3.3 Nitro and Amino BODIPY Derivatives  
During the studies for fluorogenic click derivatives of BODIPYs, the synthesis of azido 
functionalized BODIPY compounds in the position 2 and 3, with the purpose of using 
fluorescence quenching effect of azido groups, was also our intention. In order to get these 
structures, one of the key reaction in organic chemistry, the synthesis of aromatic azides from 
the corresponding amines would be convenient. However, despite several attempts, this 
approach was not successful for the synthesis of the desired compounds.  
Nevertheless, the outcome of these experiments gave some novel BODIPY derivatives that 
exhibit interesting optical properties. According to a long literature search, to the best of our 
knowledge, BODIPY derivatives containing NO2 groups at position 2 and 3 are not available. 
We managed to synthesize these derivatives successfully. Moreover, we also succeeded in 
obtaining 3-amino BODIPY derivative and again to the best of our knowledge, there is only 
one example of 3-amino BODIPY in the literature,
[186-187]
 prepared unexpectedly during the 
trials of developing 8-aza-BODIPY derivative in order to use it as laser dye. The one-pot 
synthesis started by treatment of 2,4-dimethyl-3-ethylpyrrole with aqueous NaNO2 in a 
mixture of acetic acid/acetic anhydride; and then, after evaporation of the solvent, the crude 
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mixture was dissolved in CH2Cl2 and the synthesis was completed by addition of Et3N and 
BF3.Et2O (Scheme 31). When trying to purify the reaction product, 3-amino BODIPY 
derivative 65 could be isolated only after double column chromatography (that is required in 
supporting information of the paper).  
 
Scheme 31: Published synthesis of 3-amino BODIPY. 
3.3.1 Synthesis of Nitro BODIPYs 
One of the synthetic approaches of BODIPY derivatives is to start from pyrrolic ketones. This 
approach permits chemists to achieve asymmetrical BODIPYs.
[136]
 Moreover, the 
postsynthetic modification of pyrrole would be a wise idea to avoid possible decomposition of 
BODIPY during the reaction and also multiple substitutions. Therefore, we did start our 
process by synthesizing nitro pyrrole derivatives (Scheme 32). According to the published 
procedure,
[188]
 aqueous nitric acid was added to a solution of 2-acetyl pyrrole in acetic 
anhydride to give a mixture of 5- and 4-nitro-2-acetylpyrrole (55 and 56) in 35% and 50% 
yield, respectively. Then, 55 and 56 were incorporated separately to the reaction with 2,4-
dimethyl pyrrole to furnish BODIPY derivatives 57 and 58 in 55% and 25% yield, 
respectively. For this common synthetic procedure, the pyrroles are dissolved in CH2Cl2 and 
one equivalent of POCl3 was added. After a certain time, the formed dipyrromethene was 
converted into BODIPY systems by addition of excess triethylamine and boron triﬂuoride 
etherate. Column chromatograpy was executed to purify the Nitro-BODIPYs. 
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Scheme 32: The synthetic route to Nitro-BODIPYs. 
The formation of asymmetrical Nitro-BODIPYs starts with the condensation of ketopyrroles 
and 2,4-dimethylpyrrole in the presence of POCl3. The possible reaction mechanism of this 
formation is shown in Scheme 33,
[189]
 with 2-acetyl-5-nitropyrrole as an example just for 
schematic presentation. The lewis acid POCl3 attacks to ketopyrrole and forms a vinylic 
Vilsmeier-Haack reagent. Then, electrophilic attack to the 2. position of 2,4-dimethylpyrrole 
takes place, followed by elimination of HCl to give the dipyrromethene product. 
 
Scheme 33: Proposed mechanism of formation of dipyrromethene. 
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The molecular structures of nitro BODIPYs were confirmed by NMR and mass spectrometry. 
The 
1
H-NMR spectrum of 3-nitro BODIPY 57 reveals that the singlets at δ = 2.72, 2.63 and 
2.51 ppm belong to the methyl groups of the system (Figure 32). In the aromatic region, the 
only singlet at δ = 6.42 ppm can be attributed to the proton H-6. The protons H-1 and H-2 can 
be associated to the doublets at δ = 6.93, 7.20 ppm, respectively,  with the equal J-value (3J = 
4.2 Hz). H-2 is more deshielded by the electron withdrawing nitro group and because of this, 
it is more downfield shifted. In the 
13
C-NMR of 3-nitro BODIPY 57, the aliphatic carbons are 
at δ = 16.22, 14.93 and 14.76 ppm. In the aromatic region, C-3 should have been much more 
downfield shifted due to the electronic distribution, however, because of directly substituted 
nitro group, it is less downfield shifted than C-5. These two carbons are at δ = 168.49 and 
148.31 ppm. The rest of the aromatic carbons are at δ = 139.41, 136.81, 133.88, 126.24, 
117.59, 113.58 ppm. Besides, the high resolution mass measurements gave a correct molar 
peak at [M + H]
+
 at m/z = 278.0918. 
 
Figure 32: 
1
H-NMR spectrum of 3-nitro BODIPY 57. 
The positional change of the electron withdrawing NO2 group causes differences in the 
aromatic region of 
1
H-NMR spectrum (Figure 33). In the 
1
H-NMR spectrum of 2-nitro 
BODIPY 58, it is observed that all aromatic peaks are singlets as expected. The proton H-6 is 
again in a similar position at δ = 6.40 ppm, however, the nitro group induces H-1, in both 
spectra, to a downfield shift at δ = 7.48 ppm. The proton H-2 is covered by electronegative 
atoms and electron withdrawing group, so it is highly downfield shifted and the peak at δ = 
8.15 ppm can be associated with H-2. Moreover, the molecular integrity of 58 was also 
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proven by mass spectrometric analysis with a correct molar peak at [M + Na]
+
 at m/z = 
302.0883. 
 
Figure 33: 
1
H-NMR spectrum of 3-nitro BODIPY 58. 
3.3.2 Synthesis of 3-Amino BODIPY 
Nitro groups can be readily reduced into amino groups and it was naturally the first idea to 
synthesize amino BODIPYs after obtaining nitro BODIPYs. The first experiments were based 
on again modification of pyrroles with the desired group before formation of BODIPY 
(Scheme 35). For this purpose, reduction of 2-nitropyrrole was carried out by hydrogenation 
in the presence of Pd/C catalyst in methanol. But, there is a problem in the BODIPY 
synthesis, as phosphorus oxychloride definitely reacts with the free amino group. However, it 
would be worth to look at the competition between the two active groups reacting with POCl3. 
To a mixture of 2-acetyl-5-aminopyrrole 60 and 2,4-dimethylpyrrole, POCl3 was added and 
after some time by the addition of Et3N and BF3.Et2O, 3-amino BODIPY 63 was formed. 
However, the yield was quite low with only 5%. Purification of the product is not a problem 
because, the structure is fluorescent and due to this, it can easily isolated by column 
chromatography. 
The same route was also studied in order to synthesize 2-amino BODIPY derivative with 
starting 2-acetyl-4-aminopyrrole 61, but unfortunately, the product 64 was not isolated 
(Scheme 34). 
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Scheme 34: The synthetic route of 2-amino BODIPY derivative. 
In the literature, there are a lot of examples of very low yields in the formation of BODIPYs, 
nevertheless, the idea of protecting amino group before BODIPY formation would be a wise 
solution. The TBDMS-protected pyrrole derivative 62 seemed to be a good choice, but the 
isolation of TBDMS-protected BODIPY was not successful (Scheme 35). Again, unprotected 
3-amino BODIPY derivative 63 was obtained, unfortunately, in only 5% yield. The low yield 
of BODIPY formation and the extra reaction step for protection of pyrrole derivative is indeed 
causing this second idea impossible to use.  
 
Scheme 35: Synthesis of 3-amino BODIPY via amino-acetylpyrrole. 
Direct reduction of nitro BODIPYs into amino BODIPYs were also studied. Hydrogenation 
were executed with H2 gas and Pd/C catalyst at room temperature. After 2 hours of stirring, 
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the desired derivative 63 could be isolated in a quite high yield (65%). The 2-amino BODIPY 
derivative 64, however, could not be isolated (Scheme 36).  
 
Scheme 36: Hydrogenation of nitro BODIPYs. 
This surprising result gave us the opportunity to use this new route to increase the amount of 
3-amino BODIPY 63 and to investigate its optical and physical properties. 
3.3.3 Optical Properties of 2- and 3-Nitro BODIPYs and 3-Amino BODIPY 
The optical properties of the synthesized nitro and amino BODIPY derivatives were evaluated 
and the spectroscopic data collected in Table 5. The measurements were executed for 57 and 
58  in CH2Cl2 and for 63 in CH2Cl2 and also in EtOH. 
All compounds show a strong absorption band between λ ≈ 464-507 nm with an absorption 
coefficient in the 10749-39163 M
-1
cm
-1
 range that is corresponding to the S0 S1 transition of 
the BODIPY core.
[180-181]
 
 
Figure 34: The normalized UV-Vis spectra at 1.0 x 10
-5
 M in CH2Cl2 (left) and the 
normalized emission spectra at 1.0 x 10
-6
 M in CH2Cl2 (right) of 57 (λexc = 470 nm) and 58 
(λexc = 445).  
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Figure 34 shows normalized absorbance (left) and ﬂuorescence (right) spectra for compounds 
57 and 58. In the absorbance spectrum of 57, one of the characteristic peaks of BODIPY 
derivatives, the 0-1 vibrational band of the S0 S1 transition (the shoulder on the high-energy 
side of it) can not be observed and interestingly, in the absorbance spectrum of 58, it is 
significantly strong at λ = 444 nm. The structural change, the different position of the electron 
withdrawing NO2 group might be the reason of this phenomenon.  Moreover, both 57 and 58 
have large Stokes shifts, 2050 and 1018 cm
-1 
(normally, BODIPYs have small Stokes shifts in 
the range of 500 cm
−1
). The bathochromic shift in the fluorescence band of 3-nitro BODIPY 
57 is higher and the absorption bands are almost the same giving rise to a larger Stokes shift 
than 58. 
In the absorbance spectra of nitro BODIPY derivatives 57 and 58, the peaks around 350 nm 
can be assigned to the S0 S2 transition. They come out at higher energy region than the 
generally observed area for BODIPYs (around at λ ≈ 375 nm).[180-181]  
Figure 35 shows the normalized UV-Vis spectra (left) and the normalized emission spectra 
(right) of 3-amino BODIPY 63 in both CH2Cl2 and EtOH. Its absorption and emission are 
dependent on solvent polarity. The absorption EtOH maximum 507 nm in CH2Cl2 and it is 7 
nm blue shifted (hypsochromic shift) in EtOH, and also the fluorescence emission maximum 
shows 4 nm blue shift in EtOH compared to DCM solution (Table 5).  
 
Figure 35: The normalized UV-Vis spectra at 1.0 x 10
-5
 M (left) and the normalized emission 
spectra at 1.0 x 10
-6
 M (right) of 63 in CH2Cl2 and EtOH.  
Moreover, compared to the nitro BODIPY derivatives, the introduction of an amine group 
into position 3 of BODIPY core induces large bathochromic shifts of the absorption and 
emission maxima. This bathochromic shifts occur due to extented delocalization of the π –
system by the amino group.
[186]
 Furthermore, lower Stokes shifts, in both CH2Cl2 and EtOH, 
are observed (748 and 879 cm
-1
, respectively). From all nitrogen substituted BODIPYs, the 
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highest fluorescence quantum efficiency and molar extinction coefficient are obtained by 3-
amino BODIPY 63. It also means, it is the brightest derivative (Table 5).
[190]
  
The fluorescence quantum yield of the 3-amino BODIPY 63 alters according to the solvent, 
too. The polar solvent (ethanol), the quantum yield of 63 decreases, it is 0.81 in DCM and 
0.58 in EtOH solution. This might be due to the aggregation of the dye, because in the study 
of Banuelos et al., the fluorescence quantum yield of amino BODIPY derivative (introduced 
in chapter 3.3) is nearly solvent independent.
[186]
  
Compound Absorbance 
λmax [nm] 
Emission 
λmax [nm] 
ε (M-1 cm-1) 
 
Фf
a 
Stoke shift 
cm
-1
 
57 465 514 10700 0.10 2050 
58 444, 464 487 25500 0.74 1018 
63 (CH2Cl2) 507 527 39100 0.81 748 
63 (EtOH) 500 523 25000 0.58 879 
aFluorescence quantum yields for nitro BODIPY derivatives 57 and 58 (λexc = 470 nm) were calculated using 
rhodamine 6G (0.95 in ethanol)[185] as standard while for amino BODIPY 63 (λexc = 445 nm)  was calculated 
using acridine yellow (0.47 in ethanol)[191] as reference. 
Table 5: Optical properties of the of the synthesized nitro BODIPYs 57, 58 and amino 
BODIPY derivatives 63. 
3.3.4 Conclusion 
During this work, the influence of the substitution of position 2 and 3 with nitrogen 
containing groups have been investigated. For this purpose, 2- and 3-nitro BODIPY 57, 58 
and 3-amino BODIPY derivatives 63 have been synthesized. The synthesis of these 
derivatives start with the nitration of 2-acetyl pyrrole and after separation of the two nitro 
compound, they were separately introduced into the conventional one-pot synthesis of 
BODIPY derivatives with 2,4-dimethylpyrrole to yield 57 and 58 in 55% and 25%, 
respectively. Besides, the reduction of 5- and 4-nitro-2-acetylpyrroles 55 and 56 in the 
presence of Pd/C gave amino pyrroles 60 and 61. However, only 3-amino BODIPY derivative 
63 starting from 2-acetyl-5-aminopyrrole 60 was successfully achieved in 5% yield. Indeed, 
direct reduction of 3-nitro BODIPY 57 allows to obtain the 3-amino BODIPY derivative 63 in 
65% yield.  
The investigation of the optical properties of nitro BODIPY derivatives showed that the 
position of the nitro group of BODIPY derivatives have significant influence on the 
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photophysical properties of the compounds. The main difference is found in the fluorescence 
spectra of these compounds. Compared to 58, 3-nitro BODIPY 57 exhibits a bathochromic 
shift in the fluorescence band and this is the reason of its larger Stokes shift. However, the 
fluorescence quantum efficiency of 3-nitro BODIPY 57 is not satisfactory (0.10). This is 
understandable, because the substitution at the positions 3 and 5 of the BODIPYs are strongly 
influencing the fluorescence properties of the system and it is known that a nitro group is 
inherently an effective fluorescence quencher. Interestingly, the fluorescence quantum yield 
of 2-nitro BODIPY 58 is 0.74. 
The 3-amino BODIPY also presented interesting optical properties. The functionalization of 
position 3 of BODIPY exposed large bathochromic shifts of the absorption and emission 
maxima. Its molar extinction coefficient is higher than nitro derivatives, but the Stokes shift is 
not improved than the BODIPY dyes. 
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4 Summary 
In the beginning of this thesis, the aim was to develop new fluorogenic click reactions. During 
the studies, we managed to achieve fluorogenic Diels-Alder reactions of novel phencyclone 
derivatives and fluorogenic Huisgen 1,3-dipolar cycloaddition of a 8-(2-azidophenyl) 
BODIPY derivative. Moreover, other outcomes of these studies were some new BODIPY 
derivatives with interesting optical properties.  
With the aim of obtaining fluorogenic Diels-Alder reaction, novel phencyclone derivatives 
were synthesized. In a short time and convenient reaction conditions, the conversion of Diels-
Alder adducts were observed by color-change and up to 33-fold enhancement of fluorescence. 
The modification of thymidine and deoxycytidine derivatives with maleimide side chain and 
their usage in fluorogenic Diels-Alder reaction is also reported. From the results, it is also 
obvious that the adducts present relatively lower quantum efficiencies than most of the 
studied fluorescent dyes and their low excitation and emission maxima are not satisfactory for 
biological applications. Further studies will allow the improvement of optical properties of 
this fast and efficient fluorogenic Diels-Alder reaction. 
We then moved onto the investigation of BODIPY based fluorogenic reactions. The ortho, 
meta, and para azido substituted meso-phenyl ring of BODIPYs have been studied to examine 
the substituent effect in the optical properties of BODIPYs. The ortho-substitution by an azide 
group successfully quenched the fluorescence of azidophenyl BODIPY derivative 44 
compared to other derivatives. The fluorescence quantum efficiency of 44 is 0.055, and after 
its copper(I) catalyzed alkyne-azide cycloaddition with TBDMS-protected thymidine 
derivative 47, a 14-fold of fluorescence enhancement was observed.  
The properties of other 8-(azidophenyl) BODIPY derivatives and their click ligation products 
with TBDMS-protected thymidine derivatives were also investigated. The fluorescence 
quantum yield of 8-(3-azidophenyl) BODIPY derivative 45 is improved by click reaction 
(from 0.63 to 0.79). However, interestingly, a decrease was observed by formation of the click 
ligation product of the 8-(4-azidophenyl) BODIPY derivative 46 (from 0.56 to 0.32).  
Moreover, the click reaction of 8-(2-azidophenyl) BODIPY derivative 44 with TBDMS-
protected thymidine derivative 47 was quite low and the solution to increase it was to increase 
the distance of BODIPY derivative and TBDMS-protected thymidine. For this purpose, a 
terminal alkyne carrying longer chain was used to synthesize a new TBDMS-protected 
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thymidine derivative 53 and usage of this derivative into the CuAAC reaction with 8-(2-
azidophenyl) BODIPY derivative 44 nearly doubles the reaction yield. 
In addition to these studies, some interesting novel nitro and amino BODIPYs, emerged 
during search of the fluorogenic click reactions, were also investigated. The pre-synthetic 
modification of pyrrole derivatives ensure the one-pot synthesis of nitro BODIPYs 57 and 58. 
However, for the amino BODIPY 63, this method did not work quite effective, so it was 
synthesized by direct reduction of nitro BODIPY 57 in 65% yield.  
The fluorescence quantum yield 3-nitro BODIPY 57 was quite poor, however, by 2-nitro 
BODIPY 58, the quenching effect of nitro group was not so efficient and the fluorescence 
quantum efficiency was 0.74. Additionally, these two compound’s Stokes shifts were 
relatively higher than common BODIPY dyes. Besides, the optical properties of 3-amino 
BODIPY 63 was examined in CH2Cl2 and also in EtOH. Higher extinction coefficients were 
obtained and the brightest derivative between all three BODIPYs was determined as 3-amino 
BODIPY 63 due to its high extinction coefficient and fluorescence quantum yield in CH2Cl2. 
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5 Experimental 
5.1 Chemicals and Materials 
All chemical reagents were purchased from Sigma-Aldrich, Acros and ABCR and used 
without purification. All solvents were applied in commercial p.a. quality and dried/ distilled 
prior to use. All experiments were carried out under standard Schlenk conditions and argon 
atmosphere. 
5.2 Equipments 
NMR Spectroscopy 
The 
1
H and 
13
C {1H} NMR spectra were recorded on an ARX 400 or Avance III 600 NMR 
spectrometer from Bruker, using deuterated solvents. The chemical shift is given in ppm. The 
coupling constant J is expressed in Hz. As a reference, the 
1
H- and 
13
C-signal of the 
deuterated solvent used. 
The measured values are given in the following order: 
NMR experiment (measurement frequency, solvent, temperature): δ [ppm] = value (spin 
multiplicity; if necessary number of cores; optionally coupling constant; optionally 
assignment).   
Spin-spin couplings are abbreviated as follows: 
s= Singlet, d = Doublet, t = Triplet, q = Quartet, m = Multiplet, dd = Doublet of Doublets, dt 
= Doublet of Triplet. Additionally, b is used for „broad“ (for example, bs ≡ broad Singlet). 
Mass Spectrometry 
The GC-MS analysis were performed on a GC 17A Shimadzu QP 5050. Electron impact (EI) 
ionization was used, and the ionization energy was 70 eV. 
The ESI-measurements were performed by a Bruker Daltronic micrOTOF. 
UV/Vis Spectroscopy 
The UV/Vis spectra were recorded with a V-670 spectrometer from Jasco. 
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Fluorescence Spectroscopy 
The Fluorescence spectra were recorded with a Varian CARY Eclipse F2500 Fluorescence 
spectrometer. 
A 10 mm quartz cuvette was used in all measurements. For all measurements, the slit width 
was constant. Fluorescence quantum efficiencies of the products were determined by 
comparing the areas under the emission spectra of the samples and a solution of reference in 
ethanol excited at the same wavelength of products. For derivatives of phencyclone, 
anthracene in ethanol (Φf = 0.27 in ethanol)
[163]
 and for BODIPY derivatives, rhodamine 6G 
in ethanol (Φf = 0.95)
[185]
 was used as references. Quantum yields were determined using: 
       (
  
   
 ) (
   
  
) (
  
 
   
 ) 
where φst is the reported quantum yield of the standard, I is the area of the integrated emission 
spectra, A is the absorbance at the excitation wavelength and η is the refractive index of the 
solvent. The subscripts “x” and “st” denote sample and standard, respectively. 
Thin layer chromatography 
Thin layer chromatography was applied by silica gel plates, SIL ® ALUGRAM G/UV254 
from Macherey-Nagel (slice thickness 0.2 mm). The visualization was performed using a UV 
lamp working at 254 and 366 nm. 
Column Chromatography  
By preparative chromatography, Kieselgel  60 (0.040 – 0.063  mm) from Merck was used. 
5.3 Synthesis 
5.3.1 General Synthesis of 1-Aryl-2-nitro-prop-1-ene Derivatives 
To a mixture of 0.05 mol of nitromethane and 0.05 mol of aldehyde, 2.5 ml of methylamine 
solution (33% in ethanol) was added dropwise until solution occurred. The solution was 
placed in the refrigerator for fifteen hours. The resultant bright yellow crystals were filtered, 
washed with ether and dried in the vacuum. The product was pure enough for the next step. 
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5.3.1.1 (E)-1-Methoxy-2-(2-nitroprop-1-en-1-yl)benzene (1) [142] 
 
3.75 g. (0.05 mol) of nitromethane and 6.81 g. (0.05 mol) of o-anisaldehyde were reacted 
according to the general procedure (5.3.1). Yield: 8.9 g (93 %) of yellow crystals. 
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 8.30 (s, 1H, CH), 7.47 – 7.39 (m, 1H, HAr), 7.32 
(dd, J = 7.7, 1.3 Hz, 1H, HAr), 7.07 – 7.01 (m, 1H, HAr), 6.98 (d, J = 8.3 Hz, 1H, HAr), 3.90 (s, 
3H, OCH3), 2.40 (s, 3H, CH3). 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 158.06, 147.47, 131.48, 129.91, 129.72, 121.44, 
120.43, 110.80, 55.50, 14.04. 
GC-MS (EI, 70 eV): tR = 7,3 min, m/z = 193 [M]
+
. 
5.3.1.2 (E)-2,4-Dimethoxy-1-(2-nitroprop-1-en-1-yl)benzene (2)[142] 
 
3.75 g. (0.05 mol) of nitromethane and 8.31 g. (0.05 mol) of 2,4-dimethoxybenzaldehyde 
were reacted according to the general procedure (5.3.1). Yield: 9.3 g (83%) of yellow crystals.  
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 8.32 (s, 1H, CH), 7.30 (d, J = 8.6 Hz, 1H, HAr), 6.57 
(dd, J = 8.6, 2.4 Hz, 1H, HAr), 6.51 (d, J = 2.4 Hz, 1H, HAr), 3.88 (s, 3H, OCH3), 2.42 (d, J = 
1.0 Hz, 3H, CH3).    
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 162.86, 159.84, 145.68, 131.06, 129.54, 114.28, 
104.96, 98.36, 55.60, 55.49, 14.26. 
GC-MS (EI, 70 eV): tR = 8,4 min, m/z = 223 [M]
+
. 
5.3.2 General Synthesis of Furan Carboxylate Derivatives 
To a solution of the appropriate 1-aryl-2-nitro-prop-1-ene (0.026 mol) in 40 mL of methanol, 
3-4 drops of piperidine were added at room temperature. After that, ethyl acetoacetate (3.37 g, 
3.27 ml, 0.026 mol) was also added dropwise. The reaction mixture was then refluxed for 4 h. 
Methanol was evaporated by rotary and the residue was poured into water and extracted with 
chloroform (3  x  30  mL). The chloroform extract was washed with dil. HCl and water 
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successively. Organic layers were collected and dried over Na2SO4. After removal of 
chloroform, the resulting oily mixture was purified by column chromatography on silica gel 
(3:1 Hexane/EtOAc) to afford the furans as thick oils. 
5.3.2.1 Ethyl 4-(2-methoxyphenyl)-2,5-dimethylfuran-3-carboxylate (3)[141] 
 
5 g (0.026 mol) (E)-1-methoxy-2-(2-nitroprop-1-en-1-yl)benzene was used in the reaction 
according to the general procudure (5.3.2). Yield: 2.85 g (40%) of colourless thick oil.  
Rf = 0.45 (3:1 Hexane/EtOAc) 
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 7.35 – 7.30 (m, 1H, HAr), 7.17 (dd, J = 7.4, 1.7 Hz, 
1H, HAr), 6.99 (td, J = 7.4, 1.0 Hz, 1H, HAr), 6.95 – 6.90 (m, 1H, HAr), 4.10 (q, J = 7.1 Hz, 
2H, OCH2), 3.78 (s, 3H, OCH3), 2.58 (s, 3H, CH3), 2.20 (s, 3H, CH3), 1.06 (t, J = 7.1 Hz, 3H, 
CH3). 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 164.49, 157.43, 156.58, 147.12, 131.08, 128.45, 
122.52, 120.09, 117.32, 114.50, 110.29, 77.21, 77.00, 76.79, 59.45, 55.27, 13.86, 13.78, 
11.75. 
GC-MS (EI, 70 eV): tR = 7,9 min, m/z = 274 [M]
+
. 
5.3.2.2 Ethyl 4-(2,4-dimethoxyphenyl)-2,5-dimethylfuran-3-carboxylate (4)[141] 
 
5.8 g (0.026 mol) (E)-2,4-dimethoxy-1-(2-nitroprop-1-en-1-yl)benzene was used in the 
reaction according to the general procudure (5.3.2). Yield: 3.5 g (44%) of colourless thick oil.  
Rf = 0.49 (3:1 Hexane/EtOAc) 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 7.06 (dd, J = 7.7, 0.9 Hz, 1H, HAr), 6.52 (d, J = 7.7 
Hz, 2H, HAr), 4.11 (q, J = 7.1 Hz, 2H, CH2), 3.86 (s, 3H, OCH3), 3.75 (s, 3H, OCH3), 2.57 (s, 
3H, CH3), 2.18 (s, 3H, CH3), 1.10 (t, J = 7.1 Hz, 3H, CH3). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 162.86, 159.84, 145.68, 131.06, 129.54, 114.28, 
104.96, 98.36, 55.60, 55.49, 14.26. 
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HR-MS (ESI):  calc. 327.1208; found 327.1203 [M + Na]
+
. 
5.3.3 General Synthesis of Furo[3,4-c]coumarins 
Furan carboxylate derivative (0.01 mol) and 45 ml of 33% HBr solution in acetic acid are 
added into a 100 ml round bottom flask and heated at 130 
o
C for 4 h. After cooling down to 
room temperature, the reaction mixture was poured into crushed ice, extracted with 
chloroform (3 x 30 mL), washed with saturated sodium bicarbonate (3 x 30 mL), water (2 x 
30 mL) and brine (2 x 30mL). The chloroform layer was dried over Na2SO4, filtered and the 
solvent was evaporated in vacuum. The crude product was purified by column 
chromatography using silica gel (3:1 Hexan/EtOAc). 
5.3.3.1 1,3-Dimethyl-4H-furo[3,4-c]chromen-4-one (5)[141] 
 
2.74 g of 4-(2-methoxyphenyl)-2,5-dimethylfuran-3-carboxylate was used in the reaction 
according to the general procudure (5.3.3). Yield: 1.08 g (50%) of white solid.  
Rf = 0.44 (3:1 Hexane/EtOAc) 
M.p. 172
o
C (Lit.
[141]
 175
 o
C) 
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 7.64 (dd, J = 7.8, 1.5 Hz, 1H, HAr), 7.36 – 7.18 (m, 
3H, HAr), 2.70 (s, 3H, CH3), 2.66 (s, 3H, CH3). 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 158.58, 157.53, 151.39, 144.15, 128.08, 124.28, 
123.39, 117.66, 116.00, 114.35, 107.92, 13.75, 13.38. 
HR-MS (ESI):  calc. 215.0703; found 215.0630 [M + H]
+
. 
UV/Vis (DCM): λ [nm] = 230, 269, 295. 
FL λExc = 266 nm (DCM): λmax = 366, 383 nm. 
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5.3.3.2 7-Methoxy-1,3-dimethyl-4H-furo[3,4-c]chromen-4-one (6)[141] 
 
3.04 g of 4-(2-methoxyphenyl)-2,5-dimethylfuran-3-carboxylate was used in the reaction 
according to the general procudure (5.3.3). Yield: 1.12 g (46%) of white solid.  
Rf = 0.60 (1:1 Hexane/EtOAc) 
M.p. 164
o
C (Lit.
[141]
 168
 o
C) 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 7.51 (d, J = 8.5 Hz, 1H, HAr), 6.84 – 6.71 (m, 2H, 
HAr), 3.83 (s, 3H, OCH3), 2.67 (s, 3H, CH3), 2.60 (s, 3H, CH3). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 159.49, 158.69, 157.46, 152.41, 142.60, 124.04, 
114.23, 111.38, 108.70, 107.47, 102.35, 55.46, 13.53, 13.36. 
HR-MS (ESI):  calc. 245.0736; found 245.0808 [M + H]
+
. 
UV/Vis (DCM): λ [nm] = 238, 268, 305. 
FL λExc = 266 nm (DCM): λmax = 366, 382 nm. 
5.3.4 General Reaction of Diels-Alder Adducts of Coumarin Derivatives 
N-Phenylmaleimide (1 eq.) and furo[3,4-c]coumarin (1 eq.) were placed in a reaction flask 
and dissolved in 10 ml toluene. Reaction mixture was heated at 100 
o
C for 2 h and cooled 
down to room temperature. Hexane was added until precipitation of a solid substance. 
Filtration and washing with a small amount of hexane gave the product as a white solid. 
5.3.4.1 Diels-Alder reaction of 1,3-dimethyl-4H-furo[3,4-c]chromen-4-one and N-
phenylmaleimide (7) 
 
0.12 g (0.69 mmol) of 1,3-dimethyl-4H-furo[3,4-c]chromen-4-one and N-phenylmaleimide 
(0.12 g, 0.69 mmol)  were used in the process explained in 5.3.4. Yield: quant. 
Rf = 0.48 (1:1 Hexane/EtOAc) 
M.p. 119
o
C 
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1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 7.86 (d, J = 7.9 Hz, 1H, HAr), 7.70 – 7.59 (m, 1H, 
HAr), 7.57 – 7.32 (m, 7H, HAr), 3.24 (d, J = 6.6 Hz, 1H, CH), 3.15 (d, J = 6.6 Hz, 1H, CH), 
2.25 (s, 3H, CH3), 2.13 (s, 3H, CH3).
 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 172.22, 159.97, 156.19, 155.52, 132.72, 132.27, 
131.58, 129.21, 128.94, 126.47, 124.80, 124.01, 117.95, 114.45, 87.82, 86.95, 77.21, 77.00, 
76.79, 52.84, 52.40, 16.87, 14.66. 
HR-MS (ESI):  calc. 410.1004; found 410.0999 [M + Na]
+
. 
UV/Vis (DCM): λ [nm] = 230, 288, 327. 
FL λExc = 500 nm (DCM): λmax = 366, 384 nm. 
5.3.4.2 Diels-Alder reaction of 7-methoxy-1,3-dimethyl-4H-furo[3,4-c]chromen-4-
one and N-phenylmaleimide (8) 
 
0.15 g (0.615 mmol) of 7-methoxy-1,3-dimethyl-4H-furo[3,4-c]chromen-4-one N-phenyl-
maleimide (0.106 g, 0.615 mmol) were used in the process explained in 5.3.4. Yield: quant. 
Rf = 0.42 (1:1 Hexane/EtOAc) 
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 7.78 – 7.71 (m, 1H, HAr), 7.55 – 7.48 (m, 2H, HAr), 
7.47 – 7.41 (m, 1H, HAr), 7.36 – 7.32 (m, 2H, HAr), 6.96 (dq, J = 4.9, 2.5 Hz, 2H, HAr), 3.93 
(s, 3H, OCH3), 3.23 (d, J = 6.6 Hz, 1H, CH), 3.12 (d, J = 6.6 Hz, 1H, CH), 2.21 (s, 3H, CH3), 
2.11 (s, 3H, CH3). 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 172.60, 172.39, 163.48, 160.25, 157.65, 156.51, 
131.61, 129.18, 128.89, 128.39, 126.47, 124.94, 113.28, 107.80, 101.69, 87.73, 86.87, 55.89, 
53.08, 52.47, 16.84, 14.72. 
HR-MS (ESI):  calc. 440.1110; found 440.1105 [M + Na]
+
. 
UV/Vis (DCM): λ [nm] = 229, 338. 
FL λExc = 266 nm (DCM): λmax = 367, 385 nm. 
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5.3.5 Synthesis of Phencyclone and Maleimide Adducts 
Maleimide derivative (1 eq.) and phencyclone (1 eq.) were placed in a reaction flask and 
dissolved in 10 ml toluene. Reaction mixture was heated to reflux for 1 h and cooled down to 
room temperature. Hexane was added in order to precipitate solid substance. Filtration and 
washing with a small amount of hexane gave the product as a white solid. 
5.3.5.1 Phencyclone and N-phenylmaleimide adduct (9) 
 
According to the reaction procedure (5.3.5), phencyclone (0.05 g, 0.1307 mmol) and N-
phenylmaleimide (0.023 g, 0.1307 mmol) were reacted. 0.065 g of product was isolated. 
Yield: 90%.  
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 8.70 (d, J = 8.4 Hz, 2H, Hcore), 8.39 (d, J = 7.8 Hz, 
2H, Hcore), 7.74 (t, J = 7.6 Hz, 2H, Hcore), 7.56 (t, J = 7.4 Hz, 4H, HAr), 7.47 (t, J = 7.6 Hz, 2H, 
Hcore), 7.37 – 7.14 (m, 6H, HAr), 7.06 (t, J = 7.4 Hz, 1H, HAr), 6.97 (t, J = 7.7 Hz, 2H, HAr), 
5.91 (d, J = 7.9 Hz, 2H, HAr), 4.62 (s, 2H, CH). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 196.94, 173.35, 133.72, 133.41, 131.23, 130.93, 
129.36, 129.12, 128.71, 128.65, 128.46, 127.17, 126.82, 126.28, 125.85, 125.62, 123.02, 
63.58, 44.76. 
HR-MS (ESI):  calc. 578.1732; found 578.1727 [M + Na]
+
. 
5.3.5.2 Phencyclone and N-(4-Bromophenyl)maleimide Adduct (10) 
 
According to the reaction procedure (5.3.5), phencyclone (0.05 g, 0.1307 mmol) and N-(4-
bromophenyl)maleimide (0.033 g, 0.1307 mmol) were reacted. 0.124 g of product was 
isolated. Yield: 95%.  
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1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 8.69 (d, J = 8.3 Hz, 2H, Hcore), 8.36 (d, J = 7.8 Hz, 
2H, Hcore), 7.75 (td, J = 7.7, 1.2 Hz, 2H, Hcore), 7.62 – 7.53 (m, 4H, HAr), 7.48 (td, J = 7.7, 1.2 
Hz, 2H, Hcore), 7.31 (d, J = 7.9 Hz, 2H, HAr), 7.25 (ddd, J = 8.1, 6.9, 1.0 Hz, 2H, HAr), 7.20 
(dd, J = 8.4, 1.1 Hz, 2H, HAr), 7.12 – 7.08 (m, 2H, HAr), 5.88 – 5.73 (m, 2H, HAr), 4.62 (s, 2H, 
CH). 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 197.00, 173.03, 133.57, 133.34, 131.93, 131.20, 
130.90, 129.41, 128.99, 128.72, 128.54, 127.29, 127.10, 126.87, 126.21, 125.81, 123.06, 
63.58, 44.74. 
HR-MS (ESI):  calc. 656.0837; found 656.0832 [M + Na]
+
. 
5.3.5.3 Phencyclone and N-methylmaleimide Adduct (11) 
 
According to the reaction procedure (5.3.5), phencyclone (0.05 g, 0.1307 mmol) and N-
methylmaleimide (0.0145 g, 0.1307 mmol) were reacted. 0.12 g of product was isolated. 
Yield: 94%.  
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 8.67 (d, J = 8.3 Hz, 2H, Hcore), 8.36 (d, J = 7.8 Hz, 
2H, Hcore), 7.75 (td, J = 7.7, 1.1 Hz, 2H, Hcore), 7.56 (m, 4H, HAr), 7.45 (td, J = 7.7, 1.1 Hz, 
2H, Hcore), 7.27 – 7.21 (m, 4H, HAr), 7.18 (dd, J = 8.4, 1.0 Hz, 2H, HAr), 4.46 (s, 2H, CH), 
2.24 (s, 3H, CH3). 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 196.71, 174.26, 133.79, 133.24, 131.15, 130.93, 
129.37, 129.08, 128.59, 128.39, 127.04, 126.56, 126.06, 125.83, 122.96, 63.33, 44.71, 24.86. 
HR-MS (ESI):  calc. 516.1576; found 516.1570 [M + Na]
+
. 
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5.3.6 3,3',4,4'-Tetramethoxybenzoin (12)[148] 
 
15 gr (0.09 mol) veratraldeyhde and 3 gr KCN (0.046 mol) are dissolved in 45 ml ethanol-15 
ml water mixture. The mixture is heated to reflux under H2 bubbling for 5 h. After cooling, 
dry ice is added until the water is saturated then it is extracted with ether, dried with Na2SO4 
and evaporated.  The compound is purified by coloumn chromatography (Diethylether : 
MeOH, 100 : 1) and 7.47 g of product is obtained as light yellow solid. Yield: 50% 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 7.54 (m, 2H, HAr), 6.96 – 6.71 (m, 4H, HAr), 5.86 (s, 
1H, CH), 4.57 (s, 1H, OH), 3.90 (s, 3H, CH3), 3.89 (s, 3H, CH3), 3.84 (s, 6H, CH3). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 197.27, 153.84, 149.46, 149.19, 148.98, 132.27, 
126.35, 124.16, 120.44, 111.36, 111.11, 110.24, 110.06, 75.54, 55.99, 55.88, 55.85, 55.80. 
HR-MS (ESI):  calc. 355.1158; found 355.1152 [M + Na]
+
. 
5.3.7 3,3',4 ,4'-Tetramethoxybenzil (13)[148] 
 
To a solution of 3,3',4,4'-tetramethoxybenzoin (2.94 g, 8.83 mmol) in 10 ml DMSO, HBr (48 
wt % in water, 2.4 mL, 44.17 mmol) was added dropwise during 1 h. The solution was stirred 
at 50 
o
C for 3 h, after that heated to 90 
o
C and continued mixing overnight at this temperature. 
After cooling to room temperature, the mixture was poured into water whereupon a yellow 
solid precipitated, filtrated and washed with water and dried to obtain 2.62 g of product pure 
enough for next step. Yield: 90% 
Rf = 0.64 (70:1 DCM/MeOH)  
M.p. 223
o
C (Lit.
[192]
 225) 
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 7.61 (d, J = 2.0 Hz, 2H, HAr), 7.50 (dd, J = 8.4, 2.0 
Hz, 2H, HAr), 6.91 (s, 1H, HAr), 6.90 (s, 1H, HAr), 3.97 (d, J = 2.0 Hz, 12H, CH3). 
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13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 193.43, 154.82, 149.54, 126.47, 126.22, 110.36, 
110.33, 56.18, 56.06. 
HR-MS (ESI):  calc. 353.1001; found 353.0996 [M + Na]
+
.  
5.3.8 3,3',4, 4'-Tetrahydroxybenzil (16)[192] 
 
In a 250 ml three-neck ﬂask, 3,3',4,4'-tetramethoxybenzil (4 g, 12.12 mmol), 25 ml of 48% 
aqueous HBr, 25 ml of a 33% solution of HBr in acetic acid, and 40 ml of glacial acetic acid 
was added and the mixture was heated to reﬂux for 12 h. The solution was poured into water 
and extracted in diethylether. Drying on Na2SO4, filtration and evaporation of the solvent 
gave the wanted crude sticky yellow product which could be used in next step without further 
purifications. Yield: quant. 
M.p. 216-218
o
C 
Rf = 0.67 (8:2 DCM/MeOH) 
HR-MS (ESI):  calc. 297.0375; found 297.0370 [M + Na]
+
.  
5.3.9 3,3',4, 4'-Tetraheptyloxybenzil (17) 
 
To a 100-mL round-bottom flask, 3,3',4,4'-tetrahydroxybenzil (0.5 g, 1.82 mmol), 1-
bromoheptane (1.44 g, 8.02 mmol), K2CO3 (2.52 g, 18.23 mmol) and 15 ml of DMF were 
added. This suspension was heated for 12 h at 80 °C under a nitrogen atmosphere. Then, 
DMF was removed under  reduced  pressure. The mixture was extracted with water (2 times), 
the organic phase was dried with Na2SO4 and evaporation of the solvent gave 1.14 g of the 
product as a yellow solid. Yield: 94% 
Rf = 0.60 (DCM) 
M.p. 89-91
o
C 
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1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 7.59 (s, 2H, HAr), 7.46 (d, J = 8.4 Hz, 2H, HAr), 6.87 
(d, J = 8.4 Hz, 2H, HAr), 4.08 (td, J = 6.5, 3.3 Hz, 8H, CH2), 1.95 – 1.79 (m, 8H, CH2), 1.55 – 
1.44 (m, 8H, CH2), 1.39 (dd, J = 17.7, 10.2 Hz, 8H, CH2), 1.34 (dd, J = 10.5, 6.3 Hz, 16H, 
CH2), 0.95 – 0.89 (m, 12H, CH3). 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 193.78, 154.99, 149.30, 126.21, 126.07, 112.34, 
111.62, 69.23, 69.10, 31.77, 31.73, 29.06, 29.02, 28.96, 28.92, 25.92, 25.85, 22.57, 22.55, 
14.05, 14.03. 
HR-MS (ESI):  calc. 689.4757; found 689.4752 [M + Na]
+
. 
5.3.10 General Synthesis of 2,3,6,7-Tetrakis(alkyloxy)phenanthrene-9,10-diones[150] 
3,3’,4,4’-Tetrakis(alkyloxy)benzyl (1 eq.) was placed in a 100 ml three neck flask, dry 
dichloromethane (approx. 100 mL) was added and the flask was purged with argon. VOF3 
(3.45 eq.) was also added under argon atmosphere. Then, BF3.Et2O (2.25 eq.) was added via 
syringe and the reaction mixture was stirred for 1 hour before being quenched with an 
aqueous citric acid solution (7 eq.). The mixture was extracted with dichloromethane (3 
times). The extracts were washed with water, dried with Na2SO4, filtered and evaporated. 
Column chromatography (silica gel) with dichloromethane was done to purify the product. 
5.3.10.1 2,3,6,7-Tetramethoxyphenanthrene-9,10-dione (14)[150] 
 
3,3',4 ,4'-tetramethoxybenzil (2 g, 6.05 mmol), VOF3 (2.59 g, 20.89 mmol), BF3.Et2O (1.93 g, 
1.68 ml, 13.62 mmol), citric acid solution (8.14 g, 42.38 mmol in 50 ml water) and 40 ml 
1,1,2,2-tetrachloroethane (instead of dichloromethane) were used in the reaction process 
according to the general procedure (5.3.10). 1.57 g of product was isolated. Yield: 79% 
Rf = 0.28 (70:1 DCM/MeOH) 
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 7.48 (s, 2H, HAr), 7.09 (s, 2H, HAr), 4.10 (s, 6H, 
CH3), 3.97 (s, 6H, CH3). 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 178.94, 155.49, 149.53, 131.12, 111.55, 105.36, 
56.36, 56.17. 
HR-MS (ESI):  calc. 329.1025; found 329.1020 [M + H]
+
. 
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5.3.10.2 2,3,6,7-Tetrakis(heptyloxy)phenanthrene-9,10-dione (18) 
 
3,3',4 ,4'-tetraheptyloxybenzil (1.11 g, 1.66 mmol), VOF3 (0.71 g, 5.73 mmol), BF3.Et2O (0.53 
g, 0.461 ml, 3.73 mmol), citric acid solution (2.23 g, 11.62 mmol in 20 ml water) in 25 ml 
dichloromethane were reacted according to the general procedure (5.3.10). 0.825 mg of 
product was isolated. Yield: 75% 
Rf = 0.29 (DCM) 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 7.39 (s, 2H, HAr), 7.00 (s, 2H, HAr), 4.17 (t, J = 6.4 
Hz, 4H, CH2), 4.01 (t, J = 6.4 Hz, 4H, CH2), 1.99 – 1.78 (m, 8H, CH2), 1.59 – 1.28 (m, 32H, 
CH2), 0.92 (dt, J = 6.9, 3.4 Hz, 12H, CH3). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 179.04, 155.47, 149.28, 130.96, 124.30, 112.76, 
106.93, 69.41, 68.98, 31.75, 29.11, 29.03, 25.94, 25.88, 22.54, 14.01. 
HR-MS (ESI):  calc. 665.4781; found 665.4776 [M + H]
+
. 
5.3.11 2,3,6,7-Tetrahydroxyphenanthrene-9,10-dione (69) 
 
In a 250 ml three-neck ﬂask, 2,3,6,7-tetramethoxyphenanthrene-9,10-dione  (1.25 g, 3.81 
mmol), 7 ml of 48% aqueous HBr, 7 ml of a 33% solution of HBr in acetic acid and 11 ml of 
glacial acetic acid was added and the mixture was heated to reﬂux for 12 h. The solution was 
poured into water and extracted in diethyl ether. Drying on Na2SO4, filtration and evaporation 
of the solvent gave the crude product as a sticky yellow solid which was used in next step 
without further purification. Yield: 87%. 
HR-MS (ESI):  calc. 273.0399; found 273.0394 [M + H]
+
.  
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5.3.12 Triethylene Glycol  Monomethyl Ether Tosylate (66) 
 
NaOH (0.8 g, 20 mmol) was dissolved in 5 ml of water and added to solution of triethylene 
glycol monomethyl ether (2.3 g, 10 mmol) in 5 ml of THF. The reaction flask was placed in 
an ice bath and cooled down. Then, a solution of p-toluene sulfonyl chloride (2.5 g, 10 mmol) 
in 5 ml of THF was added dropwise over 1 hour and the reaction mixture was stirred at ice 
bath temperature for an additional 1h. The mixture was poured into the ice and extracted with 
CH2Cl2. The combined organic layers were washed with water and brine, dried over Na2SO4 
and the solvent was removed under vacuum to give 2.7 g of clear oil. Yield: 85%. 
Rf = 0.45 (EtOAc) 
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 7.80 (d, J = 8.3 Hz, 2H, HAr), 7.34 (d, J = 8.0 Hz, 
2H, HAr), 4.18 – 4.14 (m, 2H, CH2), 3.71 – 3.66 (m, 2H, CH2), 3.63 – 3.56 (m, 6H, CH2), 3.55 
– 3.51 (m, 2H, CH2), 3.37 (s, 3H, CH3), 2.45 (s, 3H, CH3). 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 144.68, 132.99, 129.72, 127.86, 71.81, 70.64, 
70.45, 69.15, 68.57, 58.89, 21.51. 
HR-MS (ESI): calc. 341.1035; found 341.1029 [M + Na]
+
. 
5.3.13 General Synthesis of Triethylene Glycol Monomethyl Ether modified 
Compounds 
Tetrahydroxy compound (1 eq) and anhydrous K2CO3 (16 eq) were mixed in dry DMF and 
stirred at 100 
o
C for 20 min. Then triethylene glycol monomethyl ether tosylate (5 eq) was 
added dropwise. The reaction mixture was stirred at 100 
o
C for 20 h. After evaporation of 
solvent under vacuum, the residue was dissolved in ethyl acetate and extracted with water (3 
times). The organic layer was dried over Na2SO4 and the solvent was evaporate. The column 
chromatography (8:2 EtOAc/MeOH as eluent) was used to purify the product as yellowish oil.  
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5.3.13.1 1,2-Bis(3,4-bis(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)phenyl)ethane-1,2-
dione (67) 
 
3,3',4,4'-Tetrahydroxybenzil (0.3 g, 1.09 mmol), K2CO3 (2.42 g, 17.5 mmol), in 10 ml DMF 
and triethylene glycol monomethyl ether tosylate (1.74 g, 5.47 mmol) were reacted according 
to the general procedure (5.3.13). Yield: 76% 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 7.58 (d, J = 1.9 Hz, 2H, HAr), 7.45 (d, J = 2.0 Hz, 
1H, HAr), 7.43 (d, J = 2.0 Hz, 1H, HAr), 6.91 (s, 1H, HAr), 6.89 (s, 1H, HAr), 4.21 (dd, J = 10.2, 
5.6 Hz, 8H, CH2), 3.88 (dd, J = 7.1, 2.9 Hz, 8H, CH2), 3.73 (dt, J = 5.4, 3.7 Hz, 8H, CH2), 
3.68 – 3.60 (m, 16H, CH2), 3.56 – 3.49 (m, 8H, CH2), 3.36 (s, 6H, CH3), 3.35 (s, 6H, CH3). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 193.32, 154.62, 148.96, 126.47, 126.14, 113.17, 
112.35, 71.83, 71.81, 70.84, 70.79, 70.58, 70.57, 70.45, 70.44, 69.43, 69.26, 68.76, 68.59, 
58.89. 
5.3.13.2 2,3,6,7-Tetrakis(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)phenanthrene-9,10-
dione (68) 
 
2,3,6,7-Tetrahydroxyphenanthrene-9,10-dione (130 mg, 0.48 mmol), K2CO3 (1.06 g, 7.64 
mmol), in 5 ml DMF and triethylene glycol monomethyl ether tosylate (760 mg, 2.39 mmol) 
were reacted according to the general procedure (5.3.13). Yield: 76% 
Rf = 0.17 (8:2 EtOAc/MeOH) 
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 7.59 (s, 2H, HAr), 7.24 (s, 2H, HAr), 4.38 (t, J = 4.9 
Hz, 4H, CH2), 4.29 – 4.23 (m, 4H, CH3), 3.99 – 3.94 (m, 4H, CH2), 3.93 – 3.88 (m, 4H, CH2), 
3.79 (dd, J = 5.6, 4.0 Hz, 4H, CH2), 3.76 (dd, J = 5.6, 4.0 Hz, 4H, CH2), 3.70 – 3.64 (m, 16H, 
CH2), 3.58 – 3.55 (m, 4H, CH2), 3.55 – 3.52 (m, 4H, CH2), 3.38 (s, 6H, CH3), 3.36 (s, 6H, 
CH3). 
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13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 178.96, 155.36, 149.31, 131.31, 124.84, 113.70, 
108.37, 71.92, 71.88, 70.93, 70.89, 70.67, 70.65, 70.55, 70.50, 69.58, 69.45, 69.23, 68.70, 
58.97, 58.95. 
HR-MS (ESI): calc. 879.3990; found 879.3985 [M + Na]
+
. 
5.3.14 General Synthesis of Knoevenagel Condensation Adducts  
To a dry 50 ml flask, 2,3,6,7-Tetrakis(alkyloxy)phenanthrene-9,10-dione (1 eq.), 1,3-diphen-
ylpropan-2-one (1.1 eq.), potassium hydroxide (1.25 eq.) and methanol were added under 
argon atmosphere. The reaction mixture was heated to reflux with stirring for 1 h. A dark 
green precipitate appeared during the reaction and it was filtered off, washed with ethanol and 
dried to give the product, pure enough for the next step.  
5.3.14.1 5,6,9,10-Tetramethoxy-1,3-diphenyl-2H-cyclopenta[l]phenanthren-2-one (15) 
 
2,3,6,7-tetramethoxyphenanthrene-9,10-dione (0.56 g, 1.72 mmol), 1,3-diphenylpropan-2-one 
(0.4 g, 1.89 mmol), potassium hydroxide (0.12 g, 2.15 mmol) in 25 ml methanol were reacted 
according to the general procedure (5.3.14) and 0.293 g dark green product was obtained. 
Yield: 34% 
Rf = 0.54 (70:1 DCM/MeOH) 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 7.47 – 7.33 (m, 10H, HAr), 7.03 (s, 2H, HAr), 6.96 
(s, 2H, HAr), 3.98 (s, 6H, CH3), 3.33 (s, 6H, CH3). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 200.51, 151.63, 134.14, 130.30, 128.51, 127.85, , 
121.79, 121.43  111.38, 106.49, 55.99, 55.11. 
UV/Vis (DCM): λ [nm] = 273, 318, 391. 
5. Experimental                                        88 
 
5.3.14.2 5,6,9,10-Tetrakis(heptyloxy)-1,3-diphenyl-2H-cyclopenta[l]phenanthren-2-
one (19) 
 
2,3,6,7-tetrakis(heptyloxy)phenanthrene-9,10-dione (0.825 g, 1.24 mmol), 1,3-diphenylpro-
pan-2-one (0.287 g, 1.36 mmol), potassium hydroxide (87 mg, 1.55 mmol) in 20 ml methanol 
were reacted according to the general procedure (5.3.14) and 0.53 g dark green product was 
obtained. Yield: 51% 
Rf = 0.24 (1:1 DCM/Hexane) 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 7.66 – 7.11 (m, 10H, HAr), 7.02 (s, 2H, HAr), 6.93 
(s, 2H, HAr), 4.10 (dd, J = 12.1, 5.6 Hz, 4H, CH2), 3.38 (t, J = 6.8 Hz, 4H, CH2), 1.86 (dd, J = 
14.3, 7.2 Hz, 4H, CH2), 1.64 – 1.55 (m, 4H, CH2), 1.54 – 1.45 (m, 4H, CH2), 1.43 – 1.25 (m, 
28H, CH2), 0.97 – 0.89 (m, 12H, CH3). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 200.49, 151.55, 148.84, 148.40, 132.97, 130.27, 
128.42, 127.79, 127.61, 121.66, 121.15, 112.85, 109.13, 69.52, 68.12, 31.92, 31.80, 31.76, 
29.43, 29.34, 29.21, 29.13, 29.03, 28.89, 28.82, 28.73, 26.04, 25.99, 25.92, 25.80, 25.64, 
22.66, 22.58, 22.55, 14.07, 14.03. 
UV/Vis (DCM): λ [nm] = 276, 321, 395. 
FL λExc = 266 nm (DCM): λmax = 367, 383 nm. 
5.3.15 Synthesis of Maleimide Derivatives 
5.3.15.1 N-Hexylmaleimide (23)[193] 
 
The solution of n-octylamine (0.94 g, 1.22 ml, 9.27 mmol) in 15 ml of  benzene was added to 
maleic anhydride (1 g, 10.20 mmol) suspension in 25 ml benzene and the mixture was stirred 
at 30 °C for 1 h. Then, ZnBr2 (2.3 g, 10.20 mmol), followed by hexamethyl disilazane (2.09 g, 
2.69 ml, 12.98 mmol) in 20 ml of benzene were added. The mixture was refluxed for 2 h, 
cooled down to room temperature and poured into 75 ml of 0.5 M HCl. The benzene phase 
5. Experimental                                        89 
 
was separated and the aqueous phase was extracted with EtOAc (2x100 ml). The combined 
organic layers were washed with saturated aq. NaHCO3 (2x50 ml), brine, and dried over 
Na2SO4. It was then filtered, dried and evaporated. Column chromatography, with dichloro-
methane as eluent, gave the product as white solid (1.54 g). Yield: 92% 
Rf = 0.56 (DCM) 
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 6.65 (s, 2H, CH), 3.56 (t, 2H, CH2), 1.62 – 1.42 (m, 
2H, CH2), 1.33 – 1.11 (m, 6H, CH2), 0.83 (t, 3H, CH3). 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 170.70, 133.89, 37.74, 31.13, 28.33, 26.23, 22.32, 
13.80. 
5.3.15.2 6-Maleimidocaproic acid (29)[194] 
 
6-Aminocaproic acid (1 g, 7.62 mmol) was added to a stirred solution of maleic anhydride 
(747.54 mg, 7.62 mmol) in acetic acid. After mixing 3 h at room temperature, precipitated 
white solid was collected by filtration. Without further purification, the solid was dissolved in 
10 ml acetic anhydride and sodium acetate (0.32 g, 3.88 mmol) was added. The mixture was 
heated to 90
o
C for 2 h. The solvent was removed under reduced pressure and the remaining 
solid was dissolved in ethyl acetate (30 ml) and extracted with water (30 ml), followed by 
brine (30 ml). The ethyl acetate phase was dried over Na2SO4 and filtrated. After evaporation 
of the solvent, the white solid was purified by column chromatography (ethyl acetate as 
eluent) to give 6-maleimidocaproic acid as a white solid. Yield: 70% 
Rf = 0.46 (EtOAc) 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 10.57 (s, 1H, OH), 6.69 (s, 2H, CH=CH), 3.51 (t, J 
= 7.2 Hz, 2H, CH2), 2.34 (t, J = 7.4 Hz, 2H, CH2), 1.75 – 1.49 (m, 4H, CH2), 1.34 (m, 2H, 
CH2). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 179.42, 170.81, 134.00, 37.49, 33.68, 28.05, 26.02, 
23.99. 
HR-MS (ESI):  calc. 234.0742; found 234.0737 [M + Na]
+
. 
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5.3.15.3 N-Propargylmaleimide (28)[158] 
 
2 g of maleic anhydride (0.02 mol, 1 eq) was dissolved in 15 ml of acetone and the mixture 
was heated to reflux. To this solution, 1.37 ml of propargylamine (1.99 g, 0.02 mol, 1 eq) was 
added dropwise. Then, it was refluxed for 1 h, cooled and the solvent was removed under 
vacuo. A red solid precipitated and was recrystallized, by dissolving in ether and addition of 
methanol, to yield 1.84 g maleic acid N-propargylmonoamide as colorless crystals. Yield: 
60% 
1
H-NMR (400 MHz, d-DMSO) : δ [ppm] = 9.30 (s, 1H, NH), 6.28 (q, J = 12.4 Hz, 2H, 
CH=CH), 3.97 (d, J = 1.6 Hz, 2H, CH2), 3.17 (t, J = 2.5 Hz, 1H, CH). 
13
C-NMR (101 MHz, d-DMSO) : δ [ppm] = 166.25, 164.64, 132.29, 130.36, 80.00, 73.66, 
28.24. 
To close the ring, 1.35 g of maleic acid N-propargylmonoamide (8.82 mmol, 1 eq) and 1. 92 g 
of ZnBr2 (8.82 mmol, 1 eq) were added into 15 ml of THF and 2.55 ml of hexamethyl 
disilazane (1.99 g, 12.34 mmol, 1.4 eq) was added dropwise. The resulting suspension was 
refluxed for 2 h and cooled to room temperature. It was poured into 50 ml of 0.5 M HCl and 
extracted with EtOAc. The water phase was extracted with EtOAc (2 x 50 ml) and the 
combined organic layers were washed with NaHCO3 (2 x 50 ml) and brine. After drying over 
Na2SO4, the solvent was evaporated under vacuo. A short column chromatography using 
CH2Cl2 gave 1.07 g of product as a white solid. Yield: 90% 
Rf = 0.56 (DCM) 
M.p. 54
o
C (Lit.
[158]
 54
o
C) 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 6.76 (s, 2H, HC=CH), 4.27 (d, J = 2.5 Hz, 2H, 
CH2), 2.21 (t, J = 2.5 Hz, 1H, CH). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 169.16, 134.38, 71.46, 26.68. 
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5.3.16 Synthesis of Nucleoside Derivatives 
5.3.16.1 5'-O-(tert-Butyldimethylsilyl)thymidine (24)[160] 
 
To a solution of thymidine (0.48 g, 2 mmol, 1 eq), imidazole (0.409 g, 6 mmol, 3 eq), and 
DMAP (24.4 mg, 0.2 mmol, 0.1 eq) in 10 ml of DMF was added dropwise a solution of 
TBDMSCl (tert-butyldimethylsilyl chloride, 0.3 g, 2 mmol, 1 eq) in 5 ml of DMF at 0 °C. 
The mixture was stirred at room temperature for 1 h, quenched using 10 ml of saturated 
aqueous solution of ammonium chloride and extracted with ethyl acetate (3 x 20 ml). The 
combined organic layers were dried over Na2SO4, concentrated under vacuo and TBDMS-
thymidine was purified as a white solid by flash chromatography using 3:1 EtOAc/hexane 
solvent mixture. Yield: 85%. 
Rf = 0.2 (3:1 EtOAc/Hexane) 
M.p. 197
o
C (Lit.
[160]
 198-200
o
C) 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 9.84 (s, 1H, NH), 7.55 (d, J = 1.2 Hz, 1H, H6), 6.40 
(dd, J = 8.3, 5.6 Hz, 1H, H1′), 4.44 (dt, J = 5.6, 1.9 Hz, 1H, H3′), 4.08 (d, J = 2.3 Hz, 1H, 
H4′), 3.87 (m, 2H, H5′), 2.42 (ddd, J = 13.3, 5.6, 2.0 Hz, 1H, H2′), 2.07 (ddd, J = 8.3, 7.1, 3.5 
Hz, 1H, H2′), 1.91 (d, J = 1.1 Hz, 3H, CH3), 0.92 (s, 9H, SiC(CH3)3), 0.11 (s, 3H, SiCH3), 
0.10 (s, 3H, SiCH3). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 164.17, 150.73, 135.54, 110.88, 87.43, 85.07, 
72.41, 63.59, 41.04, 25.86, 18.28, 12.44, -5.49. 
HR-MS (ESI):  calc. 379.1665; found 379.1660 [M + Na]
+
. 
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5.3.16.2 5'-O-(tert-Butyldimethylsilyl)-3'-O-(5-bromopentanoyl)-thymidine (25)[159] 
 
5'-O-tert-butyl-dimethylsilyl-thymidine (0.55 g, 1.5 mmol), DMAP (19 mg, 0.15 mmol) and 
DCC (0.318 g, 1.5 mmol) were dissolved in 15 ml CH2Cl2 and cooled to 0 °C. A solution of 
5-bromovaleric acid (0.42 g, 2.3 mmol) in 5 ml CH2Cl2 were added and the mixture was 
stirred for 3 hours. After filtration through Celite, the solvent was evaporated in vacuo and the 
product was purified by column chromatography with a solvent mixture of EtOAc/hexane 
yielding the product as a colourless solid. Yield: 70%. 
Rf = 0.64 (2:1 EtOAc/Hexane) 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 8.93 (s, 1H, NH), 7.57 (d, J = 1.2 Hz, 1H, H6), 6.37 
(dd, J = 9.2, 5.2 Hz, 1H, H1’), 5.28 (d, J = 6.1 Hz, 1H, H3’), 4.10 (d, J = 1.5 Hz, 1H, H4’), 
3.94 (d, J = 1.4 Hz, 2H, H5’), 3.44 (t, J = 6.5 Hz, 3H, CH2Br), 2.41 (m, 3H, H2’+CH2), 2.19 – 
2.08 (m, 1H, H2’), 1.96 – 1.93 (m, 5H, CH2 and CH3), 1.85 – 1.80 (m, 2H, CH2), 0.95 (s, 9H, 
SiC(CH3)3), 0.16 (s, 6H, SiCH3). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 172.76, 163.78, 150.31, 135.13, 111.19, 85.49, 
84.74, 75.43, 63.57, 38.04, 33.66, 33.15, 32.78, 31.88, 25.90, 23.29, 18.31, 12.44, -5.39, -
5.50. 
HR-MS (ESI):  calc. 541.1345; found 541.1340 [M + Na]
+
. 
5.3.16.3 5'-O-(tert-Butyldimethylsilyl)-3'-O-(5-azidopentanoyl)-thymidine (26)[159] 
 
5'-O-(tert-Butyldimethylsilyl)-3'-O-(5-bromopentanoyl)-thymidine (533 mg, 1.03 mmol) and 
NaN3 (333 mg, 5.13 mmol) in 15 ml of DMF were stirred overnight at 80 °C. Then, DMF was 
removed under vacuum and the residue was dissolved in diethyl ether and extracted with sat. 
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NaHCO3 solution. The separated aqueous layer was extracted with diethyl ether (3 x 30 ml) 
and the collected organic layers were dried over Na2SO4. After removal of solvent in vacuo, 
the product was purified by flash column chromatography with a solvent mixture of 
EtOAc/hexane yielding the product as a white solid. Yield: 80%. 
Rf = 0.70 (3:1 EtOAc /Hexane) 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 9.75 (bs, 1H, NH), 7.52 (d, J = 1.2 Hz, 1H, H6), 
6.36 (dd, J = 9.2, 5.2 Hz, 1H, H1’), 5.25 (d, J = 6.0 Hz, 1H, H3’), 4.06 (d, J = 1.4 Hz, 1H, 
H4’), 3.90 (d, J = 1.2 Hz, 2H, H5’), 3.30 (t, J = 6.6 Hz, 2H, CH2N3), 2.39 (m, 3H, H2’+CH2), 
2.16 – 2.04 (m, 1H, H2’), 1.91 (d, J = 1.1 Hz, 3H, CH3), 1.75 – 1.59 (m, 4H, CH2), 0.92 (s, 
9H, SiC(CH3)3), 0.12 (s, 6H, SiCH3). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 172.68, 163.88, 150.60, 134.81, 111.17, 85.31, 
84.55, 77.32, 77.00, 76.68, 75.31, 63.46, 50.86, 37.88, 33.38, 28.11, 25.78, 21.81, 18.18, 
12.35, -5.53, -5.64. 
HR-MS (ESI):  calc. 504.2254; found 504.2249 [M + Na]
+
. 
5.3.16.4 5'-O-(tert-Butyldimethylsilyl)-3'-O-(6-maleimidohexanoyl)-thymidine (30) 
 
120 mg (0.336 mmol, 1 eq) of 5'-O-tert-butyl-dimethylsilyl-thymidine, 71 mg of 6-maleimi-
docaproic acid (0.336 mmol, 1 eq) and 4.12 mg of DMAP (0.034 mmol, 0.1 eq) were 
dissolved in 10 ml of dry CH2Cl2 and cooled down to 0 
o
C. 69.5 mg of DCC (0.336 mmol, 1 
eq), dissolved in 5 ml of dry CH2Cl2, was added dropwise within 1 h, and the solution stirred 
at room temperature for 1 day. The solution was ﬁltered and evaporated in vacuo. The residue 
was chromatographed on a silica gel column (hexane/ethyl acetate 1:3) to afford the desired 
product as a colorless solid. Yield: 20%. 
Rf = 0.5 (3:1 EtOAc/Hexane) 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 9.30 (s, 1H, NH), 7.54 (d, J = 1.2 Hz, 1H, H6), 6.70 
(s, 2H, CH), 6.36 (dd, J = 9.2, 5.3 Hz, 1H, H1′), 5.25 (d, J = 6.1 Hz, 1H, H3′), 4.07 (d, J = 1.5 
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Hz, 1H, H4′), 3.95 – 3.90 (m, 2H, H5′), 3.52 (t, J = 7.2 Hz, 2H, CH2), 2.40 (dd, J = 13.5, 5.4 
Hz, 1H, H2′), 2.34 (t, J = 7.4 Hz, 2H, CH2), 2.16 – 2.05 (m, 1H, H2′), 1.92 (d, J = 1.1 Hz, 3H, 
CH3), 1.64 (m, 4H, CH2), 1.38 – 1.28 (m, 2H, CH2), 0.93 (s, 9H, SiC(CH3)3), 0.13 (s, 6H, 
SiCH3). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 173.04, 170.75, 163.76, 150.46, 134.96, 134.01, 
111.15, 85.42, 84.63, 77.32, 77.00, 76.68, 75.21, 63.53, 37.94, 37.48, 33.83, 28.10, 26.09, 
25.85, 24.14, 18.25, 12.41, -5.45, -5.56. 
HR-MS (ESI):  calc. 572.2404; found 572.2399 [M + Na]
+
. 
5.3.16.5 2'-Deoxy-3',5'-bis-O-(tert-butyldimethylsilyl) cytidine (31)[162] 
 
2'-deoxycytidine monochlorid (1.58 g, 12.0 mmol), TBDMSCl (3.96 g, 26 mmol) and 
imidazole ( 3.60 g, 52 mmol) are dissolved in 6 ml dry DMF. The mixture was stirred at room 
temperature for 24 h. Then, 30 ml of water was added and this solution was extracted with 
CH2Cl2 (3 x 20 ml). The combined organic layers were washed with water, dried over Na2SO4 
and evaporated under vacuo. A short column chromatography was carried out in order to 
obtain product as white solid. Yield: 65%. 
Rf = 0.2 (19:1 DCM/MeOH)  
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 7.89 (d, J = 7.4 Hz, 1H, H6), 6.25 (t, J = 5.8 Hz, 
1H, H1'), 5.75 (d, J = 7.4 Hz, 1H, H5), 4.36 (dd, J = 10.4, 5.5 Hz, 1H, H4'), 3.92 – 3.83 (m, 
2H, H5'), 3.75 (dd, J = 12.1, 3.2 Hz, 1H, H3'), 2.37 (ddd, J = 13.3, 6.3, 5.5 Hz, 1H, H2'), 2.09 
– 1.98 (m, 1H, H2'), 0.92 – 0.89 (m, 9H, SiC(CH3)2), 0.89 – 0.84 (m, 9H, SiC(CH3)2), 0.09 
(two singlets, 6H, Si(CH3)2), 0.05 (s, 6H, Si(CH3)2). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 165.81, 155.87, 140.76, 94.34, 87.16, 85.69, 70.38, 
61.97, 50.28, 42.03, 25.81, 25.63, 18.25, 17.85, -4.67, -5.00, -5.56, -5.64. 
HR-MS (ESI):  calc. 456.2714; found 456.2708 [M + H]
+
. 
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5.3.16.6 2'-Deoxy-3',5'-bis-O-(tert-butyldimethylsilyl)-N4-(6-maleimidohexanoyl)-
cytidine (32) 
 
To a solution of 82 mg of 6-maleimidocaproic acid (0.38 mmol, 2.2 eq), 59 mg of HOBT, (1-
hydroxybenzotriazole, 0.38 mmol, 2.2 eq) and 2.14 mg of DMAP (0.175 mmol, 0.1 eq) in dry 
CH2Cl2, 76 mg of DCC (0.37 mmol, 2.1 eq) in dry CH2Cl2 was added dropwise and the 
mixture stirred for half an hour at room temperature. Then, undissolved material was filtrated 
removed by filtration. The mixture of the filtrate and Et3N (49 mml, 0.35 mmol, 2 eq) were 
added dropwise into a solution of 2'-deoxy-3',5'-bis-O-(tert-butyldimethylsilyl)-cytidine in dry 
CH2Cl2 over 30 min at room temperature under stirring. The mixture was extracted with brine 
and separated organic phase was dried over Na2SO4, evaporated in vacuo, and applied to a 
silica gel column to obtain the product as a colorless solid. Yield: 56%. 
Rf = 0.21 (30:1 DCM/MeOH)  
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 9.30 (s, 1H, NH), 8.41 (d, J = 7.4 Hz, 1H, H6), 7.39 
(d, J = 7.4 Hz, 1H, H5), 6.69 (s, 2H, CH=CH), 6.32 – 6.15 (m, 1H, H1′), 4.40 (m, 1H, H4′), 
4.02 – 3.89 (m, 2H, H5′), 3.79 (m, 1H, H3′), 3.52 (t, J = 7.2 Hz, 2H, CH2), 2.57 – 2.42 (m, 
3H, CH2 and H2′) , 2.17 (dd, J = 7.4, 3.9 Hz, 1H, H2′), 1.80 – 1.67 (m, 2H, CH2), 1.63 (m, 
2H, CH2), 1.36 (m, 2H, CH2), 0.94 (s, 9H), 0.89 (s, 9H), 0.13 (d, J = 4.4 Hz, 6H), 0.07 (d, J = 
5.1 Hz, 6H). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 170.77, 161.98, 144.96, 134.04, 95.97, 87.80, 
86.81, 69.91, 61.70, 42.28, 37.49, 37.29, 28.20, 26.07, 25.88, 25.66, 24.06, 18.34, 17.90, -
4.61, -4.96, -5.48, -5.53. 
HR-MS (ESI):  calc. 649.3453; found 649.3447 [M + H]
+
. 
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5.3.16.7 CuAAC between N-propargyl maleimide and 5'-O-(tert-butyldimethylsilyl)-
3'-O-(5-azidopentanoyl)-thymidine (27) 
 
5'-O-(tert-Butyldimethylsilyl)-3'-O-(5-azidopentanoyl)-thymidine (200 mg, 0.415 mmol), N-
propargylmaleimide (70.14 mg, 0.519 mmol), sodium ascorbate (49.36 mg, 0.249 mmol) and 
CuSO4.5H2O (20.74 mg, 0.083 mmol) were dissolved in 1:1 mixture of water and THF. After 
stirring overnight, THF was evaporated under vacuum and the water phase was extracted with 
dichloromethane (3 x 20 ml). The combined organic layers were dried over Na2SO4 and 
filtrated. The solvent was evaporated under vacuo and flash column chromatography (EtOAc 
as eluent) was performed to obtain the desired product. Yield: 62%. 
Rf = 0.26 (EtOAc)  
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 9.28 (s, 1H, NH), 7.58 (s, 1H, CH), 7.54 (d, J = 1.1 
Hz, 1H, H6), 6.73 (s, 2H, HC=CH), 6.34 (dd, J = 9.3, 5.2 Hz, 1H, H1′), 5.25 (d, J = 6.0 Hz, 
1H, H3′), 4.82 (s, 2H, CH2), 4.35 (t, J = 7.1 Hz, 2H, CH2), 4.07 (d, J = 1.2 Hz, 1H, H4′), 3.91 
(d, J = 1.8 Hz, 2H, H5′), 2.39 (m, 3H, H2′+CH2), 2.11 (ddd, J = 13.9, 9.3, 6.1 Hz, 1H, H2′), 
1.98 – 1.90 (m, 5H, CH2+CH3), 1.69 – 1.62 (m, 2H, CH2), 0.93 (s, 9H, SiCCH3), 0.14 (two s, 
6H, SiCH3).  
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 172.42, 169.96, 163.70, 150.46, 142.56, 134.90, 
134.25, 122.57, 111.20, 85.27, 84.58, 75.48, 63.52, 49.81, 37.94, 33.19, 32.78, 29.42, 25.84, 
21.56, 18.24, 12.40, -5.45, -5.56. 
HR-MS (ESI):  calc. 617.2755; found 617.2750 [M + H]
+
. 
5.3.17 General Synthesis of Diels Alder Adducts of Phencyclone Derivatives 
Diels Alder educt (1 eq.) and maleimide derivative (1 eq.) were added in 10 ml 
dichloromethane in a dry flask under argon. The reaction was stirred half an hour at room 
temperature and then the solvent was evaporated. The residue was purified by coloum 
chromatography to give desired product.  
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5.3.17.1 5,6,9,10-Tetramethoxy-1,3-diphenyl-2H-cyclopenta[l]phenanthren-2-one and 
N-phenylmaleimide adduct (20) 
 
According to the general reaction procedure (5.3.17), 5,6,9,10-tetramethoxy-1,3-diphenyl-2H-
cyclo-penta[l]phenanthren-2-one (0.164 g, 0.32 mmol) and N-phenylmaleimide (56.5 mg, 
0.32 mmol) were reacted. 0.183 g of product was isolated. Yield : 87%.  
Rf = 0.57 (70:1 DCM/MeOH) 
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 8.43 (d, J = 7.8 Hz, 2H, HAr), 7.74 (s, 2H, Hcore), 
7.72 – 7.67 (m, 2H, HAr), 7.54 – 7.47 (m, 4H, HAr), 7.40 – 7.35 (m, 2H, HAr), 7.11 (t, J = 7.5 
Hz, 1H, HAr), 7.04 (t, J = 7.8 Hz, 2H, HAr), 6.63 (s, 2H, Hcore), 6.00 (d, J = 7.6 Hz, 2H, HAr), 
4.51 (s, 2H, CH), 4.04 (s, 6H, CH3), 3.32 (s, 6H, CH3). 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 196.47, 173.47, 149.40, 148.34, 134.37, 131.24, 
130.22, 129.41, 129.17, 128.84, 128.78, 128.47, 128.27, 125.88, 125.61, 120.81, 106.24, 
103.03, 63.27, 55.93, 55.00, 44.92. 
HR-MS (ESI):  calc. 698.2155; found 698.2149 [M + Na]
+
. 
UV/Vis (DCM): λ [nm] = 279, 289. 
FL λExc = 266 nm (DCM): λmax = 369, 387 nm. 
5.3.17.2 5,6,9,10-Tetrakis(heptyloxy)-1,3-diphenyl-2H-cyclopenta[l]phenanthren-2-
one and N-phenylmaleimide adduct (21) 
 
According to the general reaction procedure (5.3.17), 5,6,9,10-tetrakis(heptyloxy)-1,3-
diphenyl-2H-cyclopenta[l]phenanthren-2-one (0.174 g, 0.21 mmol) and N-phenylmaleimide 
(35.9 mg, 0.21 mmol) were reacted. 0.193 g of product was isolated. Yield: 91%.  
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Rf = 0.4 (3:1 DCM/Hexane) 
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 8.44 (d, J = 7.8 Hz, 2H, HAr), 7.77 (s, 2H, Hcore), 
7.74 – 7.63 (m, 2H, HAr), 7.56 – 7.44 (m, 4H, HAr), 7.42 – 7.33 (m, 2H, HAr), 7.11 (ddd, J = 
6.8, 4.0, 1.0 Hz, 1H, HAr), 7.03 (dd, J = 10.8, 4.9 Hz, 2H, HAr), 6.59 (s, 2H, Hcore), 6.05 – 5.91 
(m, 2H, HAr), 4.54 (s, 2H, CH), 4.26 – 4.09 (m, 4H, CH2), 3.44 (dt, J = 9.3, 7.0 Hz, 2H, CH2), 
3.13 (dt, J = 9.3, 7.0 Hz, 2H, CH2), 1.96 – 1.80 (m, 4H, CH2), 1.65 (dd, J = 13.9, 6.9 Hz, 4H, 
CH2), 1.53 (dt, J = 15.2, 7.3 Hz, 4H, CH2), 1.47 – 1.30 (m, 28H, CH2), 0.94 (dt, J = 18.5, 7.0 
Hz, 12H, CH3). 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 196.63, 173.45, 148.97, 148.34, 134.50, 131.27, 
131.11, 130.00, 129.39, 129.09, 128.78, 128.71, 128.38, 128.14, 125.92, 125.46, 120.82, 
107.14, 105.71, 69.53, 67.71, 63.24, 44.94, 31.84, 31.79, 29.27, 29.10, 29.04, 28.77, 26.02, 
25.80, 22.63, 22.57, 14.10, 14.05. 
HR-MS (ESI):  calc. 1034.5911; found 1034.5905 [M + Na]
+
. 
UV/Vis (DCM): λ [nm] = 282, 292. 
FL λExc = 266 nm (DCM): λmax = 372, 390 nm. 
5.3.17.3 5,6,9,10-Tetrakis(heptyloxy)-1,3-diphenyl-2H-cyclopenta[l]phenanthren-2-
one and N-hexylmaleimide adduct (22) 
 
According to the general reaction procedure (5.3.17), 5,6,9,10-tetrakis(heptyloxy)-1,3-
diphenyl-2H-cyclopenta[l]phenanthren-2-one (0.12 g, 0.143 mmol) and N-hexylmaleimide 
(25.92 mg, 0.143 mmol) were reacted. And column chromatography was used (1:3 
Hexane/DCM) to purified 0.125 g of product. Yield : 86%. 
Rf = 0.4 (3:1 DCM/Hexane) 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 8.41 (d, J = 7.3 Hz, 2H, HAr), 7.79 – 7.64 (m, 4H, 
Hcore and HAr), 7.55 – 7.42 (m, 4H, HAr), 7.38 – 7.29 (m, 2H, HAr), 6.56 (s, 2H, Hcore), 4.35 (s, 
2H, CH), 4.13 (t, J = 6.6 Hz, 4H, CH2), 3.49 (dt, J = 9.1, 6.8 Hz, 2H, CH2), 3.23 – 3.08 (m, 
2H, CH2), 2.95 – 2.79 (m, 2H, CH2), 1.95 – 1.82 (m, 4H, CH2), 1.68 (d, J = 6.3 Hz, 4H, CH2), 
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1.55 – 1.46 (m, 4H, CH2), 1.34 (m, 28H, CH2), 0.96 (t, J = 6.8 Hz, 6H, CH3), 0.91 (t, J = 6.8 
Hz, 6H, CH3), 0.88 – 0.80 (m, 2H, CH2), 0.71 (t, J = 7.2 Hz, 3H, CH3), 0.64 (dd, J = 15.1, 7.4 
Hz, 2H, CH2), 0.48 (dd, J = 15.3, 7.8 Hz, 2H, CH2), -0.16 – -0.33 (m, 2H, CH2). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 196.63, 174.30, 148.88, 148.13, 134.65, 131.27, 
129.91, 129.42, 129.06, 128.68, 128.08, 125.51, 120.88, 107.20, 105.34, 69.36, 67.77, 63.04, 
44.58, 38.70, 31.87, 31.80, 31.09, 29.25, 29.10, 28.79, 26.38, 26.04, 25.82, 25.69, 22.66, 
22.57, 21.94, 14.14, 14.05, 13.98. 
HR-MS (ESI):  calc. 1042.6531; found 1042.6537 [M + Na]
+
. 
UV/Vis (DCM): λ [nm] = 280, 291. 
FL λExc = 266 nm (DCM): λmax = 373, 391 nm. 
5.3.17.4 5,6,9,10-Tetrakis(heptyloxy)-1,3-diphenyl-2H-cyclopenta[l]phenanthren-2-
one and click modified maleimide thymidine adduct (27) 
 
According to the general reaction procedure (5.3.17), 5,6,9,10-tetrakis(heptyloxy)-1,3-
diphenyl-2H-cyclopenta[l]phenanthren-2-one (41 mg, 0.049 mmol) and click derivatized 
maleimide thymidine (30 mg, 0.049 mmol) were reacted. Column chromatography (1:1 
hexane/EtOH) gave 24.5 mg of pure product. Yield: 35%. 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 8.60 (s, 1H, NH), 8.39 (d, J = 7.6 Hz, 2H, HAr), 
7.80 – 7.59 (m, 4H, 2HAr and 2Hcore), 7.54 (d, J = 1.2 Hz, 1H, H6), 7.52 – 7.37 (m, 5H, HAr 
and CH), 7.25 (d, J = 7.5 Hz, 2H, HAr), 6.53 (s, 2H, Hcore), 6.32 (dd, J = 9.0, 5.2 Hz, 2H, H1′), 
5.24 (d, J = 5.9 Hz, 1H, H3′), 4.44 (s, 2H, CH), 4.21 – 4.04 (m, 7H, CH2), 3.98 (dd, J = 10.8, 
4.4 Hz, 2H, H4′), 3.92 (d, J = 1.2 Hz, 2H, H5′), 3.45 (dd, J = 11.6, 4.6 Hz, 2H, CH2), 3.21 – 
3.04 (m, 2H, CH2), 2.42 – 2.30 (m, 3H, H2′ and CH2), 2.17 – 2.03 (m, 1H, H2′), 1.93 (t, J = 
3.2 Hz, 3H, CH3), 1.87 (dd, J = 14.6, 6.8 Hz, 4H, CH2), 1.56 (m, 12H, CH2), 1.44 – 1.31 (m, 
32H, CH2), 0.98 – 0.89 (m, 21H, SiC(CH3)3 and CH3), 0.15 (d, J = 1.1 Hz, 6H, SiCH3). 
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13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 195.90, 173.82, 172.41, 163.42, 148.94, 148.23, 
134.93, 134.37, 131.21, 129.98, 129.38, 129.09, 128.64, 128.10, 125.18, 120.57, 111.15, 
107.26, 105.51, 85.36, 84.65, 77.32, 77.00, 76.68, 75.49, 69.54, 67.79, 63.56, 63.00, 49.62, 
45.03, 37.98, 33.18, 31.84, 31.77, 29.65, 29.38, 29.30, 29.09, 29.04, 28.78, 26.04, 25.88, 
25.81, 22.63, 22.55, 21.54, 18.28, 14.11, 14.04, 12.43, -5.43, -5.53. 
HR-MS (ESI):  calc. 1455.8291; found 1455.8286 [M + H]
+
. 
UV/Vis (DCM): λ [nm] = 278. 
FL λExc = 266 nm (DCM): λmax = 373, 391 nm. 
5.3.17.5 5,6,9,10-Tetrakis(heptyloxy)-1,3-diphenyl-2H-cyclopenta[l]phenanthren-2-
one and maleimide thymidine adduct (34) 
 
According to the general reaction procedure (5.3.17), 5,6,9,10-tetrakis(heptyloxy)-1,3-
diphenyl-2H-cyclopenta[l]phenanthren-2-one (25 mg, 0.030 mmol) and maleimide thymidine 
derivative (16.4 mg, 0.030 mmol) were reacted. Column chromatography was used (2:1 
hexane/ EtOAc) to give 32 mg of pure product. Yield: 77%. 
Rf = 0.3 (2:1 Hexane/EtOAc) 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 8.62 (s, 1H, NH), 8.41 (s, 1H, HAr), 8.39 (s, 1H, 
HAr), 7.75 (two singlets, 2H, Hcore), 7.72 – 7.63 (m, 2H, HAr), 7.55 (d, J = 1.2 Hz, 1H, H6), 
7.51 – 7.40 (m, 4H, HAr), 7.30 (dd, J = 5.4, 3.6 Hz, 2H, HAr), 6.56 (s, 2H, Hcore), 6.33 (dd, J = 
9.2, 5.3 Hz, 1H, H1′), 5.18 (d, J = 6.0 Hz, 1H, H3′), 4.35 (s, 2H, CH), 4.01 (d, J = 1.4 Hz, 1H, 
H4′), 3.91 (d, J = 1.7 Hz, 2H, H5′), 3.49 (dt, J = 13.8, 6.8 Hz, 2H, CH2), 3.14 (dt, J = 9.3, 7.1 
Hz, 2H, CH2), 2.89 (t, J = 7.5 Hz, 2H, CH2), 2.35 (dd, J = 13.4, 5.4 Hz, 1H, H2′), 2.15 – 2.07 
(m, 1H, H2′), 1.93 (d, J = 1.0 Hz, 3H, CH3), 1.87 (m, 6H, CH2), 1.68 (dd, J = 8.5, 4.8 Hz, 4H, 
5. Experimental                                        101 
 
CH2), 1.55 – 1.45 (m, 4H, CH2), 1.43 – 1.18 (m, 28H, CH2), 0.96 – 0.88 (m, 21H, SiC(CH3)3 
and CH3), 0.56 – 0.38 (m, 2H, CH2), 0.15 (d, J = 1.3 Hz, 6H, SiCH3), 0.01 – -0.19 (m, 2H, 
CH2). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 196.47, 174.29, 172.92, 163.48, 150.14, 148.93, 
148.14, 135.02, 134.58, 131.24, 129.92, 129.39, 129.05, 128.65, 128.06, 125.47, 120.82, 
111.07, 107.16, 105.39, 85.44, 84.66, 75.05, 69.36, 67.74, 63.57, 63.01, 44.60, 38.37, 37.95, 
33.47, 31.84, 31.77, 29.26, 29.12, 29.06, 28.78, 26.16, 26.05, 26.03, 25.89, 25.79, 25.49, 
23.97, 22.64, 22.55, 18.29, 14.12, 14.04, 12.43, -5.43, -5.51. 
HR-MS (ESI):  calc. 1410.7940; found 1410.7935 [M + Na]
+
. 
UV/Vis (DCM): λ [nm] = 275, 291. 
FL λExc = 266 nm (DCM): λmax = 373, 391 nm. 
5.3.17.6 5,6,9,10-Tetrakis(heptyloxy)-1,3-diphenyl-2H-cyclopenta[l]phenanthren-2-
one and maleimide cytidine adduct (35) 
 
According to the general reaction procedure (5.3.17), 5,6,9,10-tetrakis(heptyloxy)-1,3-
diphenyl-2H-cyclopenta[l]phenanthren-2-one (20 mg, 0.024 mmol) and maleimide cytidine 
derivative (16 mg, 0.024 mmol) were reacted. Column chromatography was used (2:1 hexane/ 
EtOAc) to give 28 mg of pure product. Yield: 79%. 
Rf = 0.35 (1:1 Hexane/EtOAc) 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 8.40 (d, J = 7.7 Hz, 2H, HAr), 8.36 (d, J = 7.4 Hz, 
1H, H6), 7.78 (s, 2H, Hcore), 7.71 (t, J = 6.9 Hz, 2H, HAr), 7.53 – 7.42 (m, 4H, HAr), 7.36 – 
7.28 (m, 3H, HAr and H5), 6.56 (s, 2H, Hcore), 6.31 – 6.20 (m, 1H, H1′), 4.40 (d, J = 4.8 Hz, 
1H, H3′), 4.36 (s, 2H, CH), 4.16 (d, J = 5.1 Hz, 4H, CH2), 4.03 – 3.92 (m, 2H, H5′), 3.84 – 
3.75 (m, 1H, H4′), 3.57 – 3.42 (m, 2H), 3.15 (dd, J = 15.1, 7.9 Hz, 2H), 2.93 (d, J = 6.7 Hz, 
2H), 2.55 (m, 1H, H2′), 2.18 – 2.07 (m, 1H, H2′), 1.85 (m, 6H), 1.68 (d, J = 4.6 Hz, 4H), 1.47 
(d, J = 15.9 Hz, 4H), 1.37 (m, 28H), 1.07 (d, J = 5.8 Hz, 2H), 0.95 (t, J = 3.2 Hz, 18H), 0.90 
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(d, J = 5.1 Hz, 18H), 0.38 (s, 2H), 0.13 (d, J = 3.3 Hz, 6H), 0.08 (d, J = 1.7 Hz, 6H), -0.06 (s, 
2H). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 196.47, 174.38, 148.97, 148.19, 134.55, 131.22, 
129.97, 129.41, 129.10, 128.66, 128.09, 125.52, 120.85, 107.23, 105.61, 87.76, 86.77, 70.07, 
69.53, 69.48, 67.81, 63.03, 61.78, 44.64, 42.33, 38.73, 38.21, 36.99, 33.90, 31.85, 31.77, 
29.25, 29.10, 29.06, 28.78, 26.22, 26.01, 25.87, 25.80, 25.67, 25.31, 24.92, 23.79, 22.65, 
22.56, 18.33, 17.91, 14.12, 14.05, -4.61, -4.97, -5.49, -5.55. 
HR-MS (ESI):  calc. 1487.8989; found 1487.9062 [M + H]
+
. 
UV/Vis (DCM): λ [nm] = 282, 292. 
FL λExc = 266 nm (DCM): λmax = 373, 391 nm. 
5.3.18 General Synthesis of Nitro Pyrrole Derivatives 
65% nitric acid (4.12 ml, 91.64 mmol, 2 eq) was added dropwise to a solution of 2-acetyl 
pyrrole (5 g, 45.82 mmol, 1 eq) in 30 ml of acetic anhydride, at - 40 
o
C over 30 min. The 
mixture was warmed to room temperature with stirring over 2 h, and then poured into ice-
cooled water. It was extracted with ethyl acetate (3x50 ml) and the combined organic layers 
were dried over anhydrous Na2SO4, filtered and evaporated. Flash column chromatography of 
the residue with dichloromethane-ethyl acetate (19:1) gave 2- or 3-nitro pyrrole derivatives as 
product. 
5.3.18.1 2-Acetyl-5-nitropyrrole (55)[188] 
 
The product was synthesized according to the general reaction procedure (5.3.18) and 2.48 g 
of light yellow product was isolated. Yield: 35% 
Rf = 0.49 (19:1 DCM/EtOAc)     
M.p. 232
o
C (Lit.
[195]
 234
o
C) 
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 10.42 (br s, 1H, NH), 7.10 (dd, J = 4.2, 2.7 Hz, 1H), 
6.89 (dd, J = 4.2, 2.7 Hz, 1H), 2.56 (s, 3H, CH3). 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 188.78, 132.55, 115.31, 110.46, 25.85. 
HR-MS (ESI):  calc. 153.0300; found 153.0306 [M - H]
+
. 
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5.3.18.2 2-Acetyl-4-nitropyrrole (56)[188] 
 
After the general procedure explained in 5.3.19, 3.54 g of orange coloured product was 
obtained. Yield: 50% 
Rf = 0.38 (19:1 DCM/EtOAc)     
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 12.94 (s, 1H, NH), 8.07 (dd, J = 3.7, 1.6 Hz, 1H), 
7.61 (dd, J = 2.5, 1.7 Hz, 1H), 2.44 (s, 3H, CH3). 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 188.26, 136.64, 131.42, 125.00, 110.97, 25.68. 
HR-MS (ESI):  calc. 153.0300; found 153.0306 [M - H]
+
. 
5.3.19 General Synthesis of Amino Pyrrole Derivatives 
Nitro pyrrole derivative (1 eq.) in methanol was reduced over 10% palladium on carbon (0.05 
eq.) under hydrogen (1 atm) at room temperature for 2 h. Filtration on Celite and evaporation 
of the solvent under reduced pressure gave the product as a solid. 
5.3.19.1 2-Acetyl-5-aminopyrrole (60) 
 
2-Acetyl-5-nitropyrrole (1.56 g, 10.12 mmol) and 10% palladium on carbon (0.54 g, 0.507 
mmol) in 30 ml methanol were reacted according to the general reaction procedure (5.3.19). 
1.18 g of product was obtained as a dark green solid. Yield: 94% 
Rf = 0.23 (19:1 DCM/MeOH) 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 6.96 (d, J = 4.2 Hz, 1H), 5.43 (d, J = 4.2 Hz, 1H), 
4.89 (s, broad, 3H, NH2 and NH), 2.23 (s, 3H, CH3). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 183.57, 150.15, 125.41, 125.31, 95.95, 23.60 
HR-MS (ESI):  calc. 125.0637; found 125.0709 [M - H]
+
. 
5.3.19.2 2-Acetyl-4-aminopyrrole (61) 
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2-Acetyl-4-nitropyrrole (2 g, 12.98 mmol) and 10% palladium on carbon (0.69 g, 0.649 
mmol) in 35 ml methanol was used according to the general reaction procedure (5.3.19). 1.56 
g of product was obtained as a dark green solid. Yield: 97% 
Rf = 0.25 (19:1 DCM/MeOH) 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 10.96 (s, 1H, NH), 6.44 (dd, J = 2.6, 1.9 Hz, 1H), 
6.31 (dd, J = 2.6, 1.9 Hz, 1H), 3.92 (br s, 2H, NH2), 2.24 (s, 3H, CH3). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 185.68, 134.65, 129.33, 111.85, 106.02, 25.32. 
HR-MS (ESI):  calc. 125.0637; found 125.0709 [M - H]
+
. 
5.3.20 5-Acetyl-2-(tert-butyldimethylsilyl)amino-1H-pyrrole (62) 
 
To a solution of 2-acetyl-5-aminopyrrole (0.3 g, 2.42 mmol) in 15 ml dry THF, Et3N (0.506 
ml, 3.62 mmol) was added dropwise and the reaction mixture was stirred for half an hour. 
Then, it was cooled to 0 ° C, followed by addition of a solution of ClSiMe2
t
Bu (TBDMS-Cl) 
(0.364 g, 2.42 mmol) in 10 ml THF. The reaction mixture was allowed to warm to room 
temperature and stirred for a further 4 h. After that, THF was evaporated and the residue was 
dissolved in CH2Cl2 and extracted with water (2x100 ml). The organic phase was then dried 
with Na2SO4, filtered and evaporated in vacuo. 0.348 gr of beige product was isolated by 
column chromatography with DCM/MeOH (19:1). Yield: 60% 
Rf = 0.64 (19:1 DCM/MeOH) 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 11.13 (br s, 1H, NH), 6.89 (dd, J = 4.0, 2.5 Hz, 1H), 
5.42 (dd, J = 4.0, 2.5 Hz, 1H), 5.23 (br s, 1H, SiNH), 2.29 (s, 3H, CH3), 1.01 (s, 9H, CH3), 
0.26 (s, 6H, CH3). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 182.30, 148.69, 124.04, 122.95, 94.81, 25.97, 
23.77, 17.56, -4.75. 
5.3.21 General Synthesis of Amino and Nitro BODIPY Derivatives  
Pyrrole derivative (1 eq.) and 2,4-dimethylpyrrole (1 eq.) were dissolved in CH2Cl2 under 
argon atmosphere. The mixture was then cooled to 0 °C in an ice bath, followed by the 
addition of POCl3 (1 eq.) and the solution was stirred at room temperature for an appropriate 
time. Meanwhile the mixture turned dark. Triethylamine (10 eq.) was added and the mixture 
was stirred for 10 minutes while being cooled to 0 °C. Then, borontrifluoride etherate 
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(BF3.Et2O) (1.1 eq.) was added dropwise and the reaction mixture is than stirred at room 
temperature for 1 h. After that, CH2Cl2 was added to the reaction mixture and extracted with 
water (3 × 200 ml). The organic phase was dried over Na2SO4, filtered and evaporated on 
rotary. To obtain pure product column chromatography was used.  
5.3.21.1 3-Nitro-5,7,8-trimethyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (57) 
 
2-Acetyl-5-nitropyrrole (0.25 g, 1.62 mmol), 2,4-dimethylpyrrole (0.154 g, 0.17 ml, 1.62 
mmol) in 5 ml CH2Cl2 and POCl3 (0.249 g, 0.151 ml, 1.62 mmol), triethylamine (2.26 ml, 
16.2 mmol), BF3.Et2O (2.26 ml, 17.84 mmol) were used according to the general reaction 
procedure (5.3.21). After column chromatography with dichloromethane, 0.248 g of a brown 
solid was obtained. Yield: 55% 
Rf = 0.18 (DCM)  
M.p. >250
o
C 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 7.20 (d, J = 4.2 Hz, 1H, Hcore), 6.93 (d, J = 4.2 Hz, 
1H, Hcore), 6.42 (s, 1H, Hcore), 2.72 (s, 3H, CH3), 2.63 (s, 3H, CH3), 2.51 (s, 3H, CH3). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 168.49, 148.31, 139.41, 136.81, 133.88, 126.24, 
117.59, 113.58, 16.22, 14.93, 14.76. 
HR-MS (ESI):  calc. 278.0912; found 278.0918 [M + H]
+
. 
UV/Vis (DCM): λmax [nm] = 465. 
FL λExc = 470 nm (DCM): λmax  = 514 nm. 
5.3.21.2 2-Nitro-5,7,8-trimethyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (58) 
 
2-Acetyl-4-aminopyrrole (0.886 g, 5.75 mmol), 2,4-dimethylpyrrole (0.547 g, 0.592 ml, 5.75 
mmol) in 15 ml CH2Cl2 and POCl3 (0.881 g, 0.536 ml, 5.75 mmol), triethylamine (8.02 ml, 
57.49 mmol), BF3.Et2O (8.01 ml, 63.24 mmol) were reacted according to the general reaction 
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procedure (5.3.21). After column chromatography with dichloromethane, 0.4 g of a light 
brown solid was obtained. Yield: 25% 
Rf = 0.45 (DCM)  
M.p. 252
o
C (dec.) 
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = δ 8.15 (s, 1H), 7.48 (s, 1H), 6.40 (s, 1H), 2.68 (s, 
3H), 2.64 (s, 3H), 2.52 (s, 3H). 
HR-MS (ESI):  calc. 302.0888; found 302.0883 [M + Na]
+
. 
UV/Vis (DCM): λmax [nm] = 444, 464. 
FL λExc = 445 nm (DCM): λmax = 487 nm. 
5.3.21.3 3-Amino-5,7,8-trimethyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (63) 
 
Route A 
2-Acetyl-5-aminopyrrole (0.331 g, 2.67 mmol), 2,4-dimethylpyrrole (0.253 g, 0.274 ml, 2.67 
mmol) in 20 ml CH2Cl2 and POCl3 (0.409 g, 0.248 ml, 2.67 mmol), triethylamine (3.72 ml, 
26.6 mmol), BF3.Et2O (3.72 ml, 29.33 mmol) were reacted according to the general reaction 
procedure (5.3.21). After column chromatography with dichloromethane, 34 mg of a dark red 
solid was obtained. Yield: 5% 
Route B 
2-Acetyl-5-(tert-butyldimethylsilyl)aminopyrrole (0.311 g, 1.30 mmol) and 2,4-dimethyl-
pyrrole (0.124 g, 0.134 ml, 1.30 mmol) in 15 ml CH2Cl2 and POCl3 (0.2 g, 0.122 ml, 1.30 
mmol), triethylamine (1.82 ml, 13.05 mmol), BF3.Et2O (1.82 ml, 14.35 mmol) were reacted 
according to the reaction procedure (5.3.21). After column chromatography with 
dichloromethane, 24 mg of a dark red solid was obtained. Yield: 5% 
Route C 
3-Nitro-5,7,8-trimethyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (50 mg, 0.179 mmol, 1 
eq.) in 5 ml methanol was reduced over 10% palladium on carbon (9.53 mg, 0.009 mmol, 
0.05 eq.) under hydrogen (1 atm) at room temperature for 1 h. The mixture was filtrated on 
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Celite and the solvent was evaporated under reduced pressure. After column chromatography 
with dichloromethane, 29 mg of a dark red solid was obtained. Yield: 65% 
Rf = 0.71 (19:1 DCM/MeOH) 
M.p. 168 
o
C (dec.) 
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 7.18 (d, J = 4.7 Hz, 1H), 5.95 (s, 1H), 5.93 (d, J = 
4.7 Hz, 1H), 5.41 (br s, 2H, NH2), 2.49 (s, 3H, CH3), 2.43 (s, 3H, CH3), 2.38 (s, 3H, CH3). 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 158.60, 149.84, 145.99, 132.51, 130.87, 120.42, 
117.90, 112.83, 108.40, 99.58, 15.96, 15.74, 13.90. 
HR-MS (ESI):  calc. 249.1249; found 249.1358 [M + H]
+
. 
UV/Vis λmax [nm] = 507 (DCM), 500 (EtOH). 
FL λExc = 470 nm : λmax = 527 nm (DCM), 523 nm (EtOH). 
5.3.22 2-Azidobenzaldehyde (38)[171] 
 
To a stirring solution of 2-nitrobenzaldehyde (2.5 g, 16.5 mmol) in DMF (40 mL) was added 
NaN3 (2.145 g, 33 mmol) at 0 °C. Then, the mixture was heated to 60 
o
C for 24 h. After that, 
it was was poured onto ice and extracted with methyl tert-butyl ether (100 ml). The organic 
phase was washed with water (2×100 ml), dried over Na2SO4, filtered and the solvent was 
evaporated. Column chromatography with hexane/EtOAc (7:3) was used to give 1.58 g of 
pure product. Yield: 65% 
Rf = 0.60 (7:3 Hexane/EtOAc on  Et3N-treated SiO2 plate) 
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 10.36 (s, 1H, HCO), 7.89 (dd, J = 8.0, 2.0 Hz, 1H, 
HAr), 7.63 (m, 1H, HAr), 7.29 (d, J = 7.9 Hz, 1H, HAr), 7.24 (t, J = 7.9 Hz, 1H, HAr) 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 188.72 , 143.36 , 135.55, 129.35, 127.01, 124.95, 
119.11. 
5.3.23 Synthesis of 3- and 4-Azidobenzyl Alcohol[196] 
Aminobenzyl alcohol (2.50 g, 20.3 mmol) was dissolved in 6.0 M HCl (21 mL) at 0 
o
C. 1.2 M  
NaNO2 solution (25 mL, 30.4 mmol, 2.07 g) was added dropwise over 20 min and the  
mixture was stirred at 0 
o
C for 20 min, followed by the addition of 1.6 M NaN3 solution (5.2 g 
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NaN3, 50 ml, 81.1 mmol). The mixture was stirred at 0 
o
C for 30 min. The solution was 
extracted with diethylether (3x60 ml). The organic layer was washed with brine, saturated 
NaHCO3 solution and brine and dried over Na2SO4, ﬁltrated and concentrated. The residue 
was puriﬁed by column chromatography with AcOEt/ hexane (1:3).  
5.3.23.1 3-Azidobenzyl alcohol (39)[196] 
 
3-Aminobenzyl alcohol was used and 2.9 g of product was obtained as a yellow oil according 
to the general reaction procedure (5.3.23). Yield : 96% 
Rf = 0.25 (3:1 Hexane/EtOAc) 
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 7.31 (t, J = 7.9 Hz, 1H, HAr), 7.07 (d, J = 7.6 Hz, 
1H, HAr), 6.97 (s, 1H, HAr), 6.93 (dd, J = 7.9, 2.0 Hz, 1H, HAr), 4.58 (s, 2H, CH2), 3.56 (s, 1H, 
OH). 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 142.68, 139.97, 129.61, 123.00, 117.82, 117.04, 
64.06. 
5.3.23.2 4-Azidobenzyl alcohol (40)[172] 
 
4-Aminobenzyl alcohol was used and 2.88 g of product was obtained as a yellow oil 
according to the general reaction procedure (5.3.23). Yield: 95% 
Rf = 0.21 (3:1 Hexane/EtOAc) 
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 7.26 (d, J = 8.8 Hz, 2H, HAr), 6.96 (d, J = 8.8 Hz, 
2H, HAr), 4.53 (s, 2H, CH2), 3.74 (s, 1H, OH). 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 138.89, 137.34, 128.18, 118.73, 63.89. 
5.3.24 Synthesis of 3- and 4-Azidobenzaldehyde[172] 
PCC (3.67 g, 17.08 mmol) was added in one portion to a solution of azidobenzyl alcohol (1.5 
g, 10.05 mmol) in 40 ml CH2Cl2. Then, the mixture was stirred at room temperature for 1 h, 
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followed by filtration over a pad of silica gel on a fritted funnel. The solvent was removed on 
rotary, affording pure product as a thick oil. 
5.3.24.1 3-Azidobenzaldehyde (41)[196] 
 
3-Azidobenzyl alcohol (1.5 g, 10.05 mmol) was used in the general reaction process (5.3.24) 
and 1.38 g of product was obtained as yellow oil. Yield : 93% 
Rf = 0.26 (3:1 Hexane/EtOAc) 
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 10.01 (s, 1H, CH), 7.66 (dd, J = 7.6, 0.9 Hz, 1H, 
HAr), 7.56 (s, 1H, HAr), 7.54 (d, J = 7.7 Hz, 1H, HAr), 7.28 (ddd, J = 7.9, 1.5, 0.9 Hz, 1H, HAr). 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 191.13, 141.44, 137.83, 130.44, 126.58, 124.83, 
118.97. 
5.3.24.2 4-Azidobenzaldehyde (42)[172] 
 
4-Azidobenzyl alcohol (1.5 g, 10.05 mmol) was used in the general reaction process (5.3.24) 
and 1.32 g of product was obtained as yellow oil. Yield: 89% 
Rf = 0.22 (3:1 Hexane/EtOAc) 
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 9.94 (s, 1H, CH), 7.88 (d, J = 8.5 Hz, 2H, HAr), 7.16 
(d, J = 8.5 Hz, 2H, HAr). 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 190.43, 146.18, 133.20, 131.44, 119.39. 
5.3.25 General Synthesis of 8-(Azidophenyl)-BODIPY Derivatives 
In a 1000 mL flask, equipped with septum, azidobenzaldehyde (1 eq.) and 2,4-dimethyl-
pyrrole (or 2,4-dimethyl-3-diethyl pyrrole) (2 eq.) were dissolved in CH2Cl2 and the solution 
was purged with argon (bubbling). One drop of TFA was added and the mixture was stirred at 
room temperature for 3 h. After that, a solution of (1 eq.) of DDQ (2,3-dichloro-5,6-dicyano-
p-benzoquinone) in CH2Cl2 was added. After 3 h, Et3N (10 eq.) was added and followed by 
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BF3.OEt2 (11 eq.). The reaction mixture was washed with water (3x100 ml), dried over  
Na2SO4 and concentrated on rotary. Then crude product was purified by silica gel column 
chromatography hexane/CH2Cl2 (1:1). 
5.3.25.1 8-(2-Azidophenyl)-1,3,5,7-tetramethyl-4,4-difluoro-4-bora-3a,4a-diaza-s-
indacene (44) 
 
2-Azidobenzaldehyde (0.3 g, 2.04 mmol), 2,4-dimethylpyrrole (0.39 g, 0.42 mL, 4.08), in 300 
ml CH2Cl2, DDQ (0.463 g, 2.04 mmol), Et3N (2.85 mL, 20.4 mmol), BF3.OEt2 (2.84 mL, 
22.43 mmol) were reacted according to the general procedure (5.3.25). After purification, 
0.26 g of dark red solid was obtained. Yield: 35% 
Rf = 0.25 (1:1 Hexane/CH2Cl2) 
M.p. 128-130
o
C (dec.)  
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 7.55 (ddd, J = 8.2, 7.3, 1.7 Hz, 1H, HAr), 7.28 (ddd, 
J = 11.5, 9.2, 4.9 Hz, 3H, HAr), 6.01 (s, 2H, Hcore), 2.58 (s, 6H, CH3), 1.45 (s, 6H, CH3). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 155.81, 142.45, 138.36, 130.76, 130.04, 126.42, 
125.65, 121.26, 118.78, 14.60, 13.82. 
HR-MS (ESI):  calc. 366.1702; found 366.1696 [M + H]
+
. 
UV/Vis (DCM): λmax [nm] = 508. 
FL λExc = 470 nm (DCM): λmax = 515 nm. 
5.3.25.2 8-(2-Azidophenyl)-2,6-diethyl-1,3,5,7-tetramethyl-4,4-difluoro-4-bora-3a,4a-
diaza-s-indacene (43) 
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2-Azidobenzaldehyde (0.4 g, 2.72 mmol), 2,4-dimethyl-3-diethyl pyrrole (0.67 g, 5.44), in 
350 ml CH2Cl2, DDQ (0.617 g, 2.72 mmol), Et3N (3.79 mL, 27.2 mmol), BF3.OEt2 (3.79 mL, 
29.9 mmol) were reacted according to the general procedure (5.3.25). After purification, 
0.386 g of red solid was obtained. Yield: 35% 
Rf = 0.32 (1:1 Hexane/CH2Cl2) 
M.p. 161-163
o
C (dec.)  
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 7.55 (ddd, J = 8.2, 7.5, 1.8 Hz, 1H, HAr), 7.34 – 7.24 
(m, 3H, HAr), 2.56 (s, 6H, CH3), 2.34 (q, J = 7.6 Hz, 4H, CH2), 1.36 (s, 6H, CH3), 1.03 (t, J = 
7.6 Hz, 6H, CH3). 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 154.11, 138.55, 137.68, 135.80, 132.80, 130.55, 
130.37, 127.31, 125.56, 118.72, 17.09, 14.58, 12.54, 11.08. 
HR-MS (ESI):  calc. 444.2147; found 444.2142 [M + Na]
+
. 
UV/Vis (DCM): λmax [nm] = 531. 
FL λExc = 470 nm (DCM): λmax = 543 nm. 
5.3.25.3 8-(3-Azidophenyl)-1,3,5,7-tetramethyl-4,4-difluoro-4-bora-3a,4a-diaza-s-
indacene (45) 
 
3-Azidobenzaldehyde (0.4 g, 2.72 mmol), 2,4-dimethylpyrrole (0.517 g, 0.56 mL, 5.44), in 
350 ml CH2Cl2, DDQ (0.617 g, 2.72 mmol), Et3N (3.79 mL, 27.2 mmol), BF3.OEt2 (3.79 mL, 
29.9 mmol) were reacted according to the general procedure (5.3.25). After purification, 
0.417 g of red solid was obtained. Yield: 42% 
Rf = 0.25 (1:1 Hexane/CH2Cl2)  
M.p. 168-171
o
C (dec.)  
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 7.51 (t, J = 7.9 Hz, 1H, HAr), 7.18 (ddd, J = 8.1, 2.3, 
1.0 Hz, 1H, HAr), 7.13 – 7.07 (m, 1H, HAr), 7.02 – 6.96 (m, 1H, HAr), 6.02 (s, 2H, Hcore), 2.58 
(s, 6H, CH3), 1.46 (s, 6H, CH3). 
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13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 155.93, 142.87, 141.33, 140.01, 136.82, 131.15, 
130.64, 124.64, 121.40, 119.40, 118.82, 14.56, 14.43. 
HR-MS (ESI):  calc. 366.1702; found 366.1696 [M + H]
+
. 
UV/Vis (DCM): λmax [nm] = 504. 
FL λExc = 470 nm (DCM): λmax = 513 nm. 
5.3.25.4 8-(3-Azidophenyl)-1,3,5,7-tetramethyl-4,4-difluoro-4-bora-3a,4a-diaza-s-
indacene (46) 
 
3-Azidobenzaldehyde (0.4 g, 2.72 mmol), 2,4-dimethylpyrrole (0.517 g, 0.56 mL, 5.44), in 
350 ml CH2Cl2, DDQ (0.617 g, 2.72 mmol), Et3N (3.79 mL, 27.2 mmol), BF3.OEt2 (3.79 mL, 
29.9 mmol) were reacted according to the general procedure  (5.3.25). After purification, 0.45 
g of red solid was obtained. Yield: 46% 
Rf = 0.26 (1:1 Hexane/CH2Cl2) 
M.p. 148-150
o
C (dec.)  
1
H-NMR (600 MHz, CDCl3) : δ [ppm] = 7.29 (d, J = 8.5 Hz, 2H, HAr), 7.18 (d, J = 8.5 Hz, 
2H, HAr), 6.01 (s, 2H, Hcore), 2.58 (s, 6H, CH3), 1.45 (s, 6H, CH3). 
13
C-NMR (151 MHz, CDCl3) : δ [ppm] = 155.72, 142.88, 141.04, 140.55, 131.51, 131.46, 
129.64, 121.34, 119.71, 14.55, 14.52.  
HR-MS (ESI):  calc. 388.1521; found 388.1516 [M + Na]
+
. 
UV/Vis (DCM): λmax [nm] = 503. 
FL λExc = 470 nm (DCM): λmax = 513 nm. 
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5.3.26 5'-O-tert-Butyldimethylsilyl-3'-O-propargylthymidine (47)[175] 
 
A solution of  0.5 g of 5'-O-(tert-butyldimethylsilyl)thymidine (1.37  mmol) in 10 ml of dry 
THF was cooled down to 0°C and a 60% dispersion of NaH in oil (29 mg, 0.73 mmol) was 
added. After stirring at 0°C for 1 h, 0.32 ml of propargyl bromide (3.61 mmol) was added 
dropwise and the mixture was stirred at room temperature for 24 h. Then, extra 0.29 g of NaH 
(7.17 mmol) was added. Stirring was continued for another 4 h and the reaction was quenched 
by addition of water. After extraction with diethyl ether (3 x 50 ml), the combined organic 
phases were collected and washed with brine. The organic layer was dried over Na2SO4 and 
evaporated under vacuum. The product was isolated by flash column chromatography (95:5 
DCM/MeOH as eluent) as an colorless oil. Yield: 45% 
Rf = 0.45 (95:5 DCM/MeOH) 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 9.74 (s, 1H, NH), 7.48 (d, J = 1.2 Hz, 1H, H6), 6.33 
– 6.15 (m, 1H, H1′), 4.34 (dt, J = 6.0, 1.9 Hz, 1H, H3′), 4.19 (dt, J = 5.8, 3.2 Hz, 2H, CH2), 
4.13 – 4.09 (m, 1H, H4′), 3.84 (m, 2H, H5′), 2.57 – 2.39 (m, 2H, C=CH and H2′), 1.98 (ddd, J 
= 13.8, 10.9, 6.6 Hz, 1H, H2′), 1.91 (t, J = 3.8 Hz, 3H, CH3), 0.95 – 0.87 (m, 9H, SiC(CH3)3), 
0.11 (two singlets, 6H, SiCH3). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 164.06, 150.45, 135.15, 110.79, 84.84, 84.77, 
79.05, 78.41, 74.94, 63.37, 56.24, 37.51, 25.79, 18.21, 12.39, -5.50, -5.60. 
HR-MS (ESI):  calc. 417.1822; found 417.1816 [M + Na]
+
. 
5.3.27 4-Propargyloxybutanoic acid (52)[179] 
 
Into a 50 ml flask, γ-butyrolactone (2 g, 23 mmol, 1 eq) and an aqueous solution of NaOH 
(1.07 g, 27 mmol, 1.15 eq) was added at room temperature and the mixture was stirred for 24 
h. The reaction mixture was evaporated to dryness and the residue was washed with ethanol to 
yield sodium 4-hydroxybutanate as a white solid. The product was used in next step without 
further purification. Yield: 85%  
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In the next step, sodium 4-hydroxybutanate (1 g, 7.93 mmol, 1 eq) was dissolved in DMF and 
a 60% dispersion of NaH in oil (952 mg, 24 mmol, 3 eq) was added at room temperature. The 
reaction mixture was stirred for 24 h and propargyl bromide (943 mg, 684 mml, 7.93 mmol, 1 
eq) was added dropwise. After stirring another 24 h, the mixture was evaporated to dryness 
under vacuo. The residue was dissolved in 25 ml of water and extracted with diethyl ether in 
order to remove by-product. The aqueous phase was then neutralized by 1 M HCl, causing 
precipitation of a solid which was filtrated, extracted with 25 ml of ethyl acetate and washed 
by water. The combined organic phases were concentrated under vacuum to yield 4-
propargyloxybutanoic acid as a brown oil. Yield: 25% 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 10.11 (s, 1H, OH), 4.12 (t, J = 3.1 Hz, 2H, CH2), 
3.58 – 3.53 (m, 2H, CH2), 2.48 – 2.41 (m, 3H, CH2 and CH), 1.94 – 1.86 (m, 2H, CH2). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 179.23, 79.55, 74.35, 68.60, 57.91, 30.60, 24.40. 
5.3.28 5'-O-(tert-Butyldimethylsilyl)-3'-O-(4-propargyloxybutanoyl)-thymidine (53) 
 
85 mg (0.24 mmol, 1 eq) of 5'-O-tert-butyldimethylsilyl thymidine, 34 mg of 4-
propargyloxybutanoic acid (0.24 mmol, 1 eq) and 2.92 mg of DMAP (0.023 mmol, 0.1 eq) 
were dissolved in 10 ml of dry CH2Cl2 and cooled down to 0 
o
C. 49.2 mg of DCC (0.24 
mmol, 1 eq), dissolved in 5 ml of dry CH2Cl2, was added dropwise within 1 h and the solution 
stirred at room temperature for 24 h. The solution was ﬁltered over Celite and evaporated in 
vacuo. The residue was chromatographed on a silica gel column (ethyl acetate/hexane 3:1) to 
afford the desired product as colorless solid. Yield: 78% 
Rf = 0.56 (3:1 EtOAc/Hexane) 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 9.67 (s, 1H, NH), 7.52 (d, J = 1.2 Hz, 1H, H6), 6.34 
(dd, J = 9.2, 5.3 Hz, 1H, H1′), 5.23 (d, J = 6.1 Hz, 1H, H3′), 4.10 (d, J = 1.8 Hz, 2H, CH2), 
4.08 – 4.05 (m, 1H, H4′), 3.94 – 3.81 (m, 2H, H5′), 3.54 (t, J = 6.0 Hz, 2H, CH2), 2.46 – 2.36 
(m, 4H, CH2, H2′, CCH), 2.13 – 2.03 (m, 1H, H2′), 1.93 – 1.88 (m, 5H, CH3 and CH2), 0.90 
(s, 9H, SiC(CH3)3), 0.11 (s, 6H, SiCH3). 
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13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 172.97, 163.87, 150.51, 134.86, 111.07, 85.23, 
84.58, 79.57, 75.20, 74.33, 68.61, 63.47, 57.94, 37.87, 32.50, 30.90, 30.69, 26.08, 25.77, 
24.61, 18.17, 12.34, -5.53, -5.64. 
HR-MS (ESI):  calc. 503.2189; found 503.2184 [M + Na]
+
. 
5.3.29 General Synthesis of Click Derivatives 
Azido BODIPY derivative (1 eq), alkyne modified thymidine (1.25 eq), sodium ascorbate (0.6 
eq) and CuSO4.5H2O (0.2 eq) were dissolved in a 1:1 mixture of water and THF in a small 
test tube. After stirring overnight, THF was evaporated in vacuo and the water phase was 
extracted with ethyl acetate (3 x 10 ml). The combined organic layers were dried over Na2SO4 
and filtrated. The solvent was evaporated in vacuum and a flash column chromatography was 
performed to obtain the desired product. 
5.3.29.1 Click Reaction of 8-(2-Azidophenyl)BODIPY and 5'-O-(tert-Butyldimethyl-
silyl)- 3'-O-propargyl-thymidine (48) 
 
8-(2-Azidophenyl)-2,6-diethyl-1,3,5,7-tetramethyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene 
(30 mg, 0.082 mmol), 5'-O-tert-butyldimethylsilyl-3'-O-propargyl-thymidine (40.5 mg, 0.103 
mmol), sodium ascorbate (9.76 mg, 0.049 mmol) and CuSO4.5H2O (4.1 mg, 0.017 mmol) 
were reacted according to the general procedure (5.3.29). After purification, 21.8 mg of red 
solid was isolated. Yield: 35% 
Rf = 0.4 (3:1 EE/Hexane) 
M.p. 82-84
o
C 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 8.74 (s, 1H, NH), 7.89 (d, J = 7.8 Hz, 1H, CH), 7.69 
(dt, J = 21.7, 7.5 Hz, 2H, HAr), 7.59 (s, 1H, H6), 7.54 – 7.41 (m, 2H, HAr), 6.24 (dd, J = 8.3, 
5.7 Hz, 1H, H1′), 6.00 (s, 2H, Hcore), 4.58 (m, 2H, CH2), 4.36 (t, J = 7.0 Hz, 1H, H3′), 4.06 (d, 
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J = 2.0 Hz, 1H, H4′), 3.86 (dd, J = 11.4, 2.4 Hz, 1H, H5′), 3.75 (dd, J = 11.3, 2.1 Hz, 1H, H5′), 
2.52 (s, 6H, CH3), 2.34 (dd, J = 13.4, 5.6 Hz, 1H, H2′), 1.96 (d, J = 9.0 Hz, 1H, H2′), 1.93 (s, 
3H, CH3), 1.49 (s, 6H, CH3), 0.92 (s, 9H, SiC(CH3)3), 0.10 (s, 6H, SiCH3). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 163.68, 156.86, 156.71, 150.19, 144.90, 142.38, 
142.28, 135.42, 135.29, 135.21, 131.05, 130.84, 130.20, 130.09, 128.64, 126.39, 123.00, 
122.01, 110.80, 84.97, 84.83, 79.64, 63.52, 62.58, 37.86, 29.64, 29.30, 25.89, 18.30, 14.62, 
13.96, 12.44, -5.43, -5.51. 
HR-MS (ESI):  calc. 782.3445; found 782.3440 [M + Na]
+
. 
UV/Vis (DCM): λmax [nm] = 510. 
FL λExc = 470 nm (DCM): λmax = 518 nm. 
5.3.29.2 Click Reaction of 8-(3-Azidophenyl)BODIPY and 5'-O-(tert-Butyldimethyl-
silyl)- 3'-O-propargyl-thymidine (49) 
 
8-(3-Azidophenyl)-2,6-diethyl-1,3,5,7-tetramethyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene 
(20 mg, 0.055 mmol), 5'-O-tert-butyldimethylsilyl-3'-O-propargyl-thymidine (27 mg, 0.068 
mmol), sodium ascorbate (6.51 mg, 0.033 mmol) and CuSO4.5H2O (2.7 mg, 0.011 mmol) 
were reacted according to the general procedure (5.3.29). After purification, 39.3 mg of red 
solid was isolated. Yield: 94% 
Rf = 0.34 (3:1 EE/Hexane)  
M.p. 212-214
o
C (dec.) 
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 8.58 (s, 1H, NH), 8.09 (s, 1H, CH), 7.96 (ddd, J = 
8.1, 2.2, 1.0 Hz, 1H, HAr), 7.79 (t, J = 1.8 Hz, 1H, HAr), 7.71 (t, J = 7.9 Hz, 1H, HAr), 7.51 (d, J 
= 1.2 Hz, 1H, H6), 7.46 – 7.41 (m, 1H, HAr), 6.33 (dd, J = 8.7, 5.4 Hz, 1H, H1′), 6.03 (s, 2H, 
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Hcore), 4.77 (s, 2H, CH2), 4.31 (d, J = 5.8 Hz, 1H, H3′), 4.19 (q, J = 2.3 Hz, 1H, H4′), 3.92 (dd, 
J = 11.3, 2.7 Hz, 1H, H5′), 3.83 (dd, J = 11.3, 2.5 Hz, 1H, H5′), 2.58 (s, 6H, CH3), 2.54 – 2.46 
(m, 1H, H2′), 2.05 – 1.98 (m, 1H, H2′), 1.93 (d, J = 1.1 Hz, 3H, CH3), 1.47 (s, 6H, CH3), 0.93 
(s, 9H, SiC(CH3)3), 0.13 (s, 3H, SiCH3), 0.12 (s, 3H, SiCH3). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 163.51, 156.28, 150.19, 142.71, 137.72, 136.98, 
135.19, 130.79, 128.58, 122.15, 121.63, 120.78, 120.54, 120.12, 110.95, 84.99, 84.95, 80.13, 
63.68, 62.84, 37.87, 25.88, 18.30, 14.69, 14.60, 12.47, 12.29, -5.39, -5.50. 
HR-MS (ESI):  calc. 782.3445; found 782.3440 [M + Na]
+
. 
UV/Vis (DCM): λmax [nm] = 505. 
FL λExc = 470 nm (DCM): λmax = 515 nm. 
5.3.29.3 Click Reaction of 8-(4-azidophenyl)BODIPY and 5'-O-(tert-Butyldimethyl-
silyl)- 3'-O-propargyl-thymidine (50) 
 
8-(4-Azidophenyl)-2,6-diethyl-1,3,5,7-tetramethyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene 
(20 mg, 0.055 mmol), 5'-O-tert-butyldimethylsilyl-3'-O-propargyl-thymidine (27 mg, 0.068 
mmol), sodium ascorbate (6.51 mg, 0.033 mmol) and CuSO4.5H2O (2.7 mg, 0.011 mmol) 
were reacted according to the general procedure (5.3.29). After purification, 40.5 mg of red 
solid was isolated. Yield: 97% 
Rf = 0.32 (3:1 EE/Hexane) 
M.p. 118-120
o
C (dec.) 
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1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 8.89 (s, 1H, NH), 8.15 (s, 1H, CH), 7.96 (d, J = 8.6 
Hz, 2H, HAr), 7.54 – 7.48 (m, 3H, HAr and H6), 6.36 (dd, J = 8.7, 5.4 Hz, 1H, H1′), 6.03 (s, 
2H, Hcore), 4.79 (d, J = 3.3 Hz, 2H, CH2), 4.33 (d, J = 5.8 Hz, 1H, H3′), 4.20 (dd, J = 4.4, 2.4 
Hz, 1H, H4′), 3.89 – 3.84 (m, 2H, H5′), 2.58 (s, 6H, CH3), 2.55 – 2.48 (m, 1H, H2′), 2.08 – 
2.01 (m, 1H, H2′), 1.94 (d, J = 1.1 Hz, 3H, CH3), 1.46 (s, 6H, CH3), 0.94 (s, 9H, SiC(CH3)3), 
0.14 (s, 3H, SiCH3), 0.13 (s, 3H, SiCH3). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 163.63, 156.14, 150.34, 145.80, 142.75, 139.50, 
137.39, 135.68, 135.18, 131.19, 129.85, 121.57, 120.88, 120.65, 111.01, 84.97, 84.93, 80.02, 
63.68, 62.80, 37.90, 25.88, 18.31, 14.68, 14.58, 12.47, -5.38, -5.51. 
HR-MS (ESI):  calc. 782.3445; found 782.3440 [M + Na]
+
. 
UV/Vis (DCM): λmax [nm] = 505. 
FL λExc = 470 nm (DCM): λmax = 515 nm. 
5.3.29.4 Click Reaction of 8-(2-Azidophenyl)BODIPY and 5'-O-(tert-Butyldimethyl-
silyl)- 3'-O-(4-propargyloxybutanoyl)-thymidine (51) 
 
8-(2-Azidophenyl)-2,6-diethyl-1,3,5,7-tetramethyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene 
(15 mg, 0.041 mmol), 5'-O-(tert-butyldimethylsilyl)-3'-O-(4-propargyloxybutanoyl)-
thymidine (24.7 mg, 0.051 mmol), sodium ascorbate (4.88 mg, 0.025 mmol) and 
CuSO4.5H2O (2.05 mg, 0.008 mmol) were reacted according to the general procedure 
(5.3.29). After purification, 22 mg of red solid was isolated. Yield: 63% 
Rf = 0.32 (3:1 EE/Hexane) 
M.p. 75-77
o
C  
1
H-NMR (400 MHz, CDCl3) : δ [ppm] = 8.53 (d, J = 28.1 Hz, 1H, NH), 7.90 (d, J = 7.7 Hz, 
1H, CH), 7.72 (td, J = 7.8, 1.5 Hz, 1H, HAr), 7.66 (td, J = 7.6, 1.0 Hz, 1H, HAr), 7.60 – 7.56 
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(m, 2H, HAr and H6), 7.47 (dd, J = 7.5, 1.4 Hz, 1H, HAr), 6.35 (dd, J = 9.2, 5.3 Hz, 1H, H1′), 
6.00 (s, 2H, Hcore), 5.27 (d, J = 6.1 Hz, 1H, H3′), 4.57 (s, 2H, CH2), 4.10 (d, J = 1.4 Hz, 1H, 
H4′), 3.96 – 3.88 (m, 2H, H5′), 3.37 (t, J = 6.1 Hz, 2H, CH2), 2.53 (s, 6H, CH3), 2.42 (dd, J = 
13.8, 5.3 Hz, 1H, H2′), 2.38 (t, J = 7.4 Hz, 2H, CH2), 2.12 (ddd, J = 13.9, 9.2, 6.2 Hz, 1H, 
H2′), 1.94 (d, J = 0.7 Hz, 3H, CH3), 1.87 – 1.83 (m, 2H, CH2), 1.49 (s, 6H, CH3), 0.95 (s, 9H, 
SiC(CH3)3), 0.16 (2s, total 6H, SiCH3). 
13
C-NMR (101 MHz, CDCl3) : δ [ppm] = 173.10, 163.47, 156.77, 150.15, 142.39, 135.40, 
135.30, 135.10, 131.06, 130.82, 130.12, 130.07, 128.63, 126.40, 122.81, 121.95, 111.05, 
85.41, 84.73, 75.22, 68.86, 63.85, 63.59, 38.71, 38.00, 31.88, 30.93, 29.65, 29.32, 25.90, 
24.75, 22.65, 18.30, 14.62, 14.07, 13.96, 12.43, -5.41, -5.50. 
HR-MS (ESI):  calc. 868.3813; found 868.3807 [M + Na]
+
. 
UV/Vis (DCM): λmax [nm] = 510. 
FL λExc = 470 nm (DCM): λmax = 519 nm. 
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6.2 List of Symbols and Abbreviations 
AcOH   Acetic acid 
ALO   Arylless cyclooctyne 
aq.   Aqueous 
BARAC  biarylazacyclooctynone  
BCN   Bicyclononyne 
Bu   Butyl 
cat.   Catalyst 
COSY   Correlation spectroscopy 
CuAAC  Copper(I)-catalyzed Azide-Alkyne Cycloaddition 
d   day  
DCM   Dichloromethane 
DEPT     Distortionless Enhancement by Polarization Transfer  
DDQ   2,3-dichloro-5,6-dicyanobenzoquinone 
DIBAC  Dibenzoazacyclooctyne  
DIBO   Dibenzocyclooctyne  
DIFO   Difluorocyclooctyne (1st, 2nd, 3rd generation) 
DIMAC  Dimethoxyazacyclooctyne  
DMAP  4-Dimethylaminopyridine 
DMF   N,N-Dimethylformamide 
DMSO  Dimethylsulfoxide 
eq   equivalent 
ESI   Electrospray ionization 
EtOAc   Ethylacetat 
EtOH   Ethanol 
GC   Gas chromatography 
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h   hour  
HAr   Aromatic Hydrogen  
Hcore   Hydrogen at core structure  
HMPA   Hexamethylphosphoramide  
HOMO  highest occupied molecular orbital 
HR   High resolution 
Hz   Hertz 
IR   Infrared 
K   Kelvin 
LUMO  lowest unoccupied molecular orbital 
M   Molarity 
MeOH   Methanol 
MOFO   Monofluorinated cyclooctyne   
MS   Mass spectroscopy 
Mw   Molecular weight 
N   Normality 
NIR   Near Infraret 
NMR   Nuclear Magnetic Resonance 
NOFO   Nonfluorocyclooctyne 
OCT    Cyclooctyne (1st generation) 
PCC   Pyridinium chlorochromate 
Pd/C   Palladium on carbon 
PET   Photoinduced electron transfer  
Ph   Phenyl 
ppm   parts per million 
Rf   Retention time 
RT   Room temperature 
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T   Temperature 
TBDMS-Cl   tert-Butyldimethylsilyl chloride  
THF   Tetrahydrofuran 
TLC   Thin Layer Chromatography 
UV/Vis  Ultraviolet/visible spectroscopy 
λ   Wavelength 
λExc   Excitation wavelength  
δ   Chemical shift [ppm] 
Ф   Fluorescence quantum efficiency 
ε   Molar extinction coefficient 
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